<html xmlns="http://www.w3.org/1999/xhtml" class=" js flexbox flexboxlegacy canvas canvastext webgl no-touch geolocation postmessage no-websqldatabase indexeddb hashchange history draganddrop websockets rgba hsla multiplebgs backgroundsize borderimage borderradius boxshadow textshadow opacity cssanimations csscolumns cssgradients no-cssreflections csstransforms csstransforms3d csstransitions fontface generatedcontent video audio localstorage sessionstorage webworkers applicationcache svg inlinesvg smil svgclippaths"><!--MODERNIZED PAGE--><head id="coid_website_head" profile="http://www.w3.org/2005/10/profile"><style type="text/css">@charset "UTF-8";[ng\:cloak],[ng-cloak],[data-ng-cloak],[x-ng-cloak],.ng-cloak,.x-ng-cloak,.ng-hide{display:none !important;}ng\:form{display:block;}.ng-animate-block-transitions{transition:0s all!important;-webkit-transition:0s all!important;}</style>
	<meta http-equiv="content-type" content="text/html; charset=UTF-8">
	<meta http-equiv="X-UA-Compatible" content="IE=edge">
	<meta name="description" content="View on Westlaw or start a FREE TRIAL today, Amgen Inc. v. F. Hoffman-La Roche Ltd, Cases">







<script>
	

	(function () {
		window['$$errors'] = [];

		//handle js errors (it will be overwritten in GlobalPageHandlers.js. And any error will be processed when this script is loaded on the page.)
		window.onerror = function() {
			window['$$errors'].push(arguments);
		}
	})();
</script>




	<title>Amgen Inc. v. F. Hoffman-La Roche Ltd | Cases | Westlaw</title>

	
	



	
	
	



	




    
    <link href="https://ca.next.westlaw.com/StaticContent_40.1.1015/css/v2/utilities.css" type="text/css" rel="stylesheet">
<link href="https://ca.next.westlaw.com/StaticContent_40.1.1015/css/v2/core.css" type="text/css" rel="stylesheet">
<link href="https://ca.next.westlaw.com/StaticContent_40.1.1015/css/v2/components.css" type="text/css" rel="stylesheet">
<link href="https://ca.next.westlaw.com/StaticContent_40.1.1015/css/v2/features.css" type="text/css" rel="stylesheet">
<link href="https://ca.next.westlaw.com/StaticContent_40.1.1015/css/v2/document.css" type="text/css" rel="stylesheet">
<link href="https://ca.next.westlaw.com/StaticContent_40.1.1015/css/v2/print.css" type="text/css" rel="stylesheet" media="print">
<!--[if gte IE 6]>
<link href='https://ca.next.westlaw.com/StaticContent_40.1.1015/css/v2/ie.css' type='text/css' rel='stylesheet' />
<![endif]-->


	<link rel="shortcut icon" type="image/vnd.microsoft.icon" href="https://ia.next.westlaw.com/favicon.ico">
	<link rel="apple-touch-icon" href="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/v2/iphone-webclip-icon.png">
<script type="text/javascript" crossorigin="anonymous" charset="utf-8" src="//ja.next.westlaw.com/StaticContent_40.1.1015/webpack/Products/WestlawNext/js/bundle.923c80f054c89ca796f84c4fbed803b0.dll.js"></script><script type="text/javascript" crossorigin="anonymous" charset="utf-8" src="//ja.next.westlaw.com/StaticContent_40.1.1015/webpack/Products/WestlawNext/js/bundle.e94d5ee75e94c1087b529e979a552bed.dll.js"></script><script type="text/javascript" crossorigin="anonymous" charset="utf-8" src="//ja.next.westlaw.com/StaticContent_40.1.1015/webpack/Products/WestlawNext/js/bundle.83634f9482d1ddf27e96c8f1d9498ac3.dll.js"></script><script type="text/javascript" crossorigin="anonymous" charset="utf-8" src="//ja.next.westlaw.com/StaticContent_40.1.1015/webpack/Products/WestlawNext/js/bundle.82967e6fecb235c1f97c6591de01f9f7.dll.js"></script><script type="text/javascript" crossorigin="anonymous" charset="utf-8" src="//ja.next.westlaw.com/StaticContent_40.1.1015/webpack/Products/WestlawNext/js/Website/Views/Document/DocumentTabView.bootstrap.js"></script><link id="Markman_MarkmanDisplayState"><link id="Markman"></head>



<body class="co_t2Left co_docDisplay">
	<div id="co_pageContainer" class="co_bodyToolbar">
		<div id="co_mainContainer">
			











<div id="co_headerWrapper" class="wlnv2 ">
	<div id="co_newHeader"><div id="co_privacyPolicyContainer"> 
	<p id="co_privacyPolicy">
		<b>We've updated our Privacy Statement.</b> Before you continue, please read our new <a id="coid_website_privacyPolicyLinkOut" href="javascript:void(0)">Privacy Statement</a> and familiarize yourself with the terms.
		<button type="button" id="coid_website_privacyPolicyAcknowledged" title="Close message to acknowledge privacy statement" class="co_absolute">
			<span class="icon25 icon_close_x"></span>
		</button>
	</p>
</div>
		<div id="co_headerContainer">
			<div id="co_newHeader_top" class="headerContent" role="banner">
					<div class="skipButtonContainer"><a href="javascript:void(0);" data-jumpto="co_docHeaderTitle" class="co_tbButton skipButton">Skip to Document</a><a href="javascript:void(0);" data-jumpto="co_footerLinks" class="co_tbButton skipButton">Skip to Footer</a></div>
						<ul id="co_mainNav" class="co_inlineList" role="navigation">
							
														<li id="co_kmFirmNameContainer"></li>


	<li id="co_clientIdContainer" class="navigation_link co_menuListFirst"><div id="co_clientID_title_0" class="co_dropdownTabCollapsed"><span class="co_clientID_label" id="co_clientID_label_0">Client ID:</span><span></span></div><div id="co_clientID_list_0" class="co_clientID_list co_hideState" aria-hidden="true">

<div class="co_dropdownBoxExpanded">
	<div class="co_dropdownBoxHeader">
		<span></span>
	</div>
	<div class="co_dropdownBoxContent">
		<button id="co_clientID_close_0" class="co_overlayBox_closeButton" type="button">Close</button>
		<div class="co_dropdownBoxContentRight" id="co_clientID_content_0"></div>
	</div>
	<div class="co_dropdownBoxFooter">
		<span></span>
	</div>
</div></div></li>
									<li id="co_recentHistoryContainer"><div id="tabIndicator" class="co_dropdownTabCollapsed"><div class="co_dropdownTab"><a href="javascript:void(0);" class="co_dropdownBoxanchorLabel"><span class="icon"></span>History</a><button class="co_hasTooltip co_dropdownArrowCollapsed" title="Recent History Menu"><span class="th_simple_icon icon_down_arrow reversed"></span><span class="co_accessibilityLabel" aria-hidden="true" id="coid_dropdownAriaLabel_1">History Menu</span> </button></div></div><div class="co_dropdownBoxCollapsed" aria-hidden="true" aria-labelledby="coid_dropdownAriaLabel_1"><span class="co_accessibilityLabel">Beginning of history window.</span><div class="co_dropdownBoxContent"><div class="co_recentResearch iac-a11y-header-redesign" id="co_recentResearch">
	<div class="co_recentDocuments co_floatLeft">
		<div class="co_globalNavDropdownBox_header">
			<h3 class="co_recentDocumentsHeader">Recent Documents</h3>
			<a class="co_floatRight co_recentDocumentsAll" href="javascript:void(0);" id="co_recentDocumentsLink">View all</a>
		</div>
		<div class="co_scrollWrapper">
			<ul class="co_recentDocumentsList" id="co_recentDocumentsList"></ul>
		</div>
	</div>
	<div class="co_recentSearches co_floatRight">
		<div class="co_globalNavDropdownBox_header">
			<h3 class="co_recentSearchesHeader">Recent Searches</h3>
			<a class="co_floatRight co_recentSearchesAll" href="javascript:void(0);" id="co_recentSearchesLink">View all</a>
		</div>
		<div class="co_scrollWrapper">
			<ul class="co_recentSearchesList" id="co_recentSearchesList"></ul>
		</div>
	</div>
	<div class="co_clear"></div>
</div></div><button class="co_overlayBox_closeButton" type="button" title="Close history menu">Close Recent History window</button><span class="co_accessibilityLabel">End of history window.</span></div></li>
								<li id="co_signOffContainer" class="">

									<div class="co_dropdownTabCollapsed">
										<div class="co_dropdownTab">
											<button id="coid_website_signOffRegion" class="co_dropdownBoxanchorLabel co_hasTooltip iac-a11y-header-redesign" title="Settings &amp; Sign Off">
												<span class="th_simple_icon icon_user reversed"></span>
												<span class="th_simple_icon icon_down_arrow reversed"></span>
												<span class="co_accessibilityLabel" aria-hidden="true">Settings &amp; Sign Off</span>
											</button>
										</div>
									</div>
									<div class="co_dropdownBoxCollapsed co_globalNavDropdownBox" aria-hidden="true" aria-labelledby="coid_dropdownAriaLabel_0"><span class="co_accessibilityLabel">Beginning of profile settings window.</span>
										<div class="co_globalNavDropdownBox_header">
											<h3 id="coid_dropdownAriaLabel_0">Profile Settings</h3>
										</div>
										<div class="co_globalNavDropdownBox_content">
											<div class="co_signOff_profile">
												<h4></h4>
												<ul>
													<li></li>
												</ul>
											</div>

											<div class="co_signOff_links">
												<ul>


	<li>
		<a id="coid_website_mycontent" href="/MyPlan/Show\?transitionType=Default&amp;contextData=(sc.Default)">My Content</a>
	</li>


													<li>
														<a id="coid_website_userSetting" href="javascript:void(0);">My Preferences</a>
													</li>
													<li>
														<a class="co_signOff_updateProfile" href="https://onepass.westlaw.com/v2/profile/general?productid=CBT&amp;viewproductid=&amp;returnto=1.next.westlaw.com">Update OnePass Profile</a>
													</li>
												</ul>

											</div>

											<div class="co_signOff_buttons">
												<div>
													<button type="button" class="co_primaryBtn js_website_signoff">Sign Off</button>
												</div>
											</div>
										</div>
									<button class="co_overlayBox_closeButton" type="button" title="Close profile menu">Close Profile Settings window</button><span class="co_accessibilityLabel">End of profile settings window.</span></div>

								</li>
						</ul>

			</div>
			<div id="co_newHeader_bottom" class="headerContent">







<div id="headerLogo" class="" data-compartment-start-page-id="">

	<a id="coid_website_logo" href="/?transitionType=Default&amp;contextData=(sc.Default)" tabindex="1" class="co_hasTooltip">
		<img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/v2/logo.png" title="Westlaw Home">
		<span class="co_accessibilityLabel" aria-hidden="true">Westlaw Home</span>
	</a>
</div>







<div id="coid_website_searchWidget" style="display:none;"></div>
<div id="co_headerSearch" class="">
	<div id="co_searchWidgetInnerId" class="co_noAdvancedSearch">
		<form action="" onsubmit="return false;">
			<div id="co_searchFormLeft">
				<a href="javascript:void(0);" id="co_categorySearchButton">
					<span id="co_currentSelectedCategoryText">291 PATENTS</span>
					<span id="co_currentSelectedCategoryToggle" class="th_simple_icon icon_down_arrow co_hasTooltip">
						<span class="co_accessibilityLabel">Content Menu</span>
					</span>
				</a>
				<div class="co_dropdownBoxCollapsed" id="co_searchCategoryDropdown"><ul>  <li class="co_tabLeft" id="co_searchWidgetAllWestlawTab" title="Search All Content">    <div class="co_tabRight"><a href="#" onclick="return false;">All Content</a></div>  </li>  <li class="co_tabLeft co_hideState" id="co_searchWidgetCompartmentCustomTab" title="compartmentCustomTab">    <div id="compartmentCustomTabDivId" class="co_tabRight"><a title="Search " href="#" onclick="return false;">{compartmentCustomTabLinkText}</a></div>  </li>  <li class="co_tabActive co_tabLeft" id="co_searchWidgetCustomTab">    <div id="customTabDivId" class="co_tabRight"><a title="Search 291 PATENTS" href="#" onclick="return false;">291 PATENTS</a></div>  </li></ul>

				</div>
			</div>
			<div class="co_searchFormOuter">
				<div class="co_searchInputContainer" id="co_searchInputContainer">
					<div class="co_inputTop">
						<div class="co_inputTopRight"></div>
					</div>
					<div class="co_inputMidLeft">
						<div class="co_inputMidRight">
							<!-- Search text box -->
							<div class="co_textarea">
								<label id="searchInputIdLabel" for="searchInputId">Search:</label>
									<textarea style="" title="Search" name="searchInputId" aria-label="Westlaw Search. Search suggestions available after typing 3 characters. Use arrow keys to navigate suggestions." id="searchInputId" rows="1" spellcheck="false" autocorrect="off" autocapitalize="off" class="co_defaultInput"></textarea>
							</div>

							<!-- Medical litigator check box container -->
							<div id="co_medLitExpandedTerms" class="co_floatRight co_formInline"></div>



<!-- Recent search query toggle -->
<a id="co_searchLast10Link" class="th_simple_icon icon_down_arrow co_hasTooltip" href="#" onclick="return false;" title="Recent Searches Menu">
		<span class="co_accessibilityLabel">Recent Searches Menu</span>
</a>
						</div>
					</div>
					<div class="co_inputBottom">
						<div class="co_inputBottomRight"></div>
					</div>


<!-- Hold recent query drop down -->
<div id="co_recentQueryListBox" class="co_hideState">
	<ul class="co_searchSuggestionContainer" id="co_searchLast10List"></ul>
</div>
				<span role="application" id="searchBoxIndexSpan" style="display: none;"><p class="co_accessibilityLabel" id="co_resultsAvailable">Results are available, use up and down arrow keys to navigate</p><p class="co_accessibilityLabel" id="co_endOfList">End Of List</p><div id="co_typeAheadStatusAlert" aria-live="assertive" role="alert" aria-labelledby="co_resultsAvailable"></div><ul class="co_searchSuggestionContainer" aria-live="polite" aria-relevant="additions removals" id="co_searchSuggestion" style="display: none;" tabindex="-1"><li class="co_autoCompleteSection" id="coid_westlawanswers_elastic_westlawanswers_allcases" style="display:none"></li><li class="co_autoCompleteSection" id="coid_westlawanswers_elastic_westlawanswers" style="display:none"></li><li class="co_autoCompleteSection" id="coid_westlawanswers_elastic_westlawanswers" style="display:none"></li><li class="co_autoCompleteSection" id="coid_snapshotExactMatch_elastic_snapshots" style="display:none"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_categorypage"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_case"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_docket"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_statute"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_regulation"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_admindecision"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_analytical"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_pendingstatute"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_othercourtdocument"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_snapshots"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_westlawanswers"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_westlawanswers_static_questions"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_westlawanswers_static_questions_allcases"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_westlawanswers_it_depends_question"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_antitrust"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_arbitration"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_bankruptcy"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_capmarket_corpgovern"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_commtrans"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_corp_mna"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_empbenefits_excomp"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_fedcivilpract"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_finance"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_inhousecounsel"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_intelprop_tech"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_labor_emp"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_realestate"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_startup_smallbus"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_trust_estate"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointpicks_practicallaw"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointpicks_forms"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointpicks_secondarysrc"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepoint_rulebooks"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepoint_categorypage"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicallaw"></li></ul></span></div>
			</div>
			<div id="co_searchFormRight">
				<div id="co_searchFormRightWrapper">
					<!-- Jurisdiction selected -->
					<div id="co_jurisdictionWidgetContainer" class="">

<a class="co_jurisdictionSelectorDropDownArrowCollapsed" href="javascript:void(0);" id="jurisdictionId">
    <span id="jurisdictionIdInner">Federal Circuit</span>
</a>
</div>
					<!-- Search button -->
					<button title="Search" id="searchButton" class="co_hasTooltip" aria-label="Search 291 PATENTS">


						Search Westlaw
						<span class="co_accessibilityLabel">Search 291 PATENTS</span>
					</button>
					<!-- Advanced search -->
					<a href="#" onclick="return false;" class="co_hideState" id="co_search_advancedSearchLink" title="Advanced Search">Advanced</a>
					<!-- Holder jurisdiction pop up -->
					<div id="co_searchJurisdictionHoverContainer"></div>
				</div>
			</div>
			<!-- Search error container -->
			<div id="co_searchInputErrorMessageContainer" class="co_hideState"></div>
		</form>
	</div>
</div>
						<div id="coid_website_searchWidget" class="co_hideState"></div>
						<div id="co_researchAcceleratorWrapper">
							
						</div>
						<div class="co_skipToLink">
							<a id="coid_website_startContent" name="coid_website_startContent"></a>
						</div>

			</div><!--newHeader_bottom-->
		</div><!--headerContainer-->
	</div><!--newHeader-->
</div><!--co_headerWrapper-->




	
	
<!-- moved delivery toolbar to separate ascx control -->	








	<div id="co_body">
		<!-- BODY HEADER -->
		<div id="co_bodyHeader"></div>
		

	
	<!-- Reporting Name is "CTA" for document with guid "Ie59924e3a21711dea82ab9f4ee295c21". -->
	
	<!-- CENTER COLUMN -->  
	<div id="co_contentWrapper">
		<div id="co_contentColumn">
			<div class="co_innertube">










<div id="co_docHeaderContainer">
	<a class="co_skipToLink" href="#coid_website_errorsSummaryPlaceHolder">
		Skip Page Header
	</a>
	<div id="co_docHeader">
		<div id="co_docFixedHeader"><div id="co_docHeaderTitle"><h2 id="co_docHeaderTitleLine" title="Amgen Inc. v. F. Hoffman-La Roche Ltd"><span id="title"><a class="co_drag co_draggabled co_drag_0 ui-draggable" href="https://1.next.westlaw.com/Document/Ie59924e3a21711dea82ab9f4ee295c21/View/FullText.html?listSource=Search&amp;navigationPath=Search%2fv1%2fresults%2fnavigation%2fi0ad6ad3e0000016314b8705c8686bce0%3fNav%3dCUSTOMDIGEST%26fragmentIdentifier%3dIe59924e3a21711dea82ab9f4ee295c21%26startIndex%3d1%26contextData%3d%2528sc.CustomDigest%2529%26transitionType%3dCustomDigestItem&amp;list=CUSTOMDIGEST&amp;rank=170&amp;listPageSource=1b34510ac2bede0102300be6a61ae1f3&amp;originationContext=docHeader&amp;contextData=(sc.CustomDigest)&amp;transitionType=Document&amp;needToInjectTerms=False&amp;enableBestPortion=True&amp;docSource=9215f2df364c46cd90476a95a1bde2b7">Amgen Inc. v. F. Hoffman-La Roche Ltd</a></span></h2><ul id="co_documentStatusIcons" class="co_document_indicators"></ul><h3 id="co_docHeaderCitation" title="United States Court of Appeals, Federal Circuit. | September 15, 2009 | 580 F.3d 1340 | 92 U.S.P.Q.2d 1289&nbsp;(Approx. 62 pages)"><span id="courtline">United States Court of Appeals, Federal Circuit.</span><span id="filedate">September 15, 2009</span><span id="cite0">580 F.3d 1340</span><span id="cite1">92 U.S.P.Q.2d 1289</span><em>&nbsp;(Approx. 62 pages)</em></h3><h4 id="co_docHeaderNegativeTreatment"><span id="co_document_compositeHeader_citatorFlag" class="co_citatorFlag"></span></h4></div></div>
		<div class="co_clear"></div>
		<div id="co_docPrimaryTabNavigationContainer" class="co_docTabs">
				<a id="co_iPadKeyCiteMenuToggle">
					Toggle Menu
				</a>
			<ul id="co_docPrimaryTabNavigation" class="co_tabs">










<li id="DocumentTab" class="co_tabLeft co_tabActive co_dropdownTab">
	<h2 class="co_tabRight">
		<a id="coid_DocumentTab_link" class="co_tabLink" href="javascript:void(0);">
			<span>Document</span>
		</a>
				<div class="co_clear"></div> 
	</h2>
	</li>







<li id="riFilingsTab" class="co_tabLeft" countstatus="" categoryenum="riFilings">
	<h2 class="co_tabRight">
		<a id="coid_relatedInfo_riFilings_link" class="co_tabLink" href="/RelatedInformation/Ie59924e3a21711dea82ab9f4ee295c21/riFilings.html?originationContext=documentTab&amp;transitionType=Filings&amp;contextData=(sc.CustomDigest)&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;rulebookMode=false" hiddenhref="/RelatedInformation/Ie59924e3a21711dea82ab9f4ee295c21/riFilings.html?originationContext=documentTab&amp;transitionType=Filings&amp;contextData=(sc.CustomDigest)&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;rulebookMode=false">
			
			<span>
				Filings 
			 (847)</span>
		</a>
		<div class="co_clear"></div> 
	</h2>
</li>







<li id="kcNegativeTreatmentTab" class="co_tabLeft co_tabInactive co_done" countstatus="" categoryenum="kcNegativeTreatment">
	<h2 class="co_tabRight">
		<a id="coid_relatedInfo_kcNegativeTreatment_link" class="co_tabLink" href="javascript:void(0);" hiddenhref="/RelatedInformation/Ie59924e3a21711dea82ab9f4ee295c21/kcNegativeTreatment.html?originationContext=documentTab&amp;transitionType=NegativeTreatment&amp;contextData=(sc.CustomDigest)&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;rulebookMode=false" aria-label="Negative Treatment 
			 (0) unavailable">
			
			<span>
				Negative Treatment 
			 (0)</span>
		</a>
		<div class="co_clear"></div> 
	</h2>
</li>







<li id="kcJudicialHistoryTab" class="co_tabLeft" countstatus="" categoryenum="kcJudicialHistory">
	<h2 class="co_tabRight">
		<a id="coid_relatedInfo_kcJudicialHistory_link" class="co_tabLink" href="/RelatedInformation/Ie59924e3a21711dea82ab9f4ee295c21/kcJudicialHistory.html?originationContext=documentTab&amp;transitionType=History&amp;contextData=(sc.CustomDigest)&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;rulebookMode=false" hiddenhref="/RelatedInformation/Ie59924e3a21711dea82ab9f4ee295c21/kcJudicialHistory.html?originationContext=documentTab&amp;transitionType=History&amp;contextData=(sc.CustomDigest)&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;rulebookMode=false">
			
			<span>
				History 
			 (206)</span>
		</a>
		<div class="co_clear"></div> 
	</h2>
</li>







<li id="kcCitingReferencesTab" class="co_tabLeft co_dropdownTab" countstatus="" categoryenum="kcCitingReferences">
	<h2 class="co_tabRight">
		<a id="coid_relatedInfo_kcCitingReferences_link" class="co_tabLink" href="/RelatedInformation/Ie59924e3a21711dea82ab9f4ee295c21/kcCitingReferences.html?originationContext=documentTab&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;rulebookMode=false" hiddenhref="/RelatedInformation/Ie59924e3a21711dea82ab9f4ee295c21/kcCitingReferences.html?originationContext=documentTab&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;rulebookMode=false">
			
			<span>
				Citing References 
			 (1,448)</span>
		</a>





<span id="co_kcCitingReferencesNavAnchor" class="co_dropdownArrowCollapsed">Navigate Citing References</span>
		<div class="co_clear"></div> 
	</h2>
		<div id="co_kcCitingReferencesNavContent" class="co_dropdownBoxCollapsed" style="display:none;"></div>
</li>







<li id="kcTableOfAuthoritiesTab" class="co_tabLeft" countstatus="" categoryenum="kcTableOfAuthorities">
	<h2 class="co_tabRight">
		<a id="coid_relatedInfo_kcTableOfAuthorities_link" class="co_tabLink" href="/RelatedInformation/Ie59924e3a21711dea82ab9f4ee295c21/kcTableOfAuthorities.html?originationContext=documentTab&amp;transitionType=TableOfAuthorities&amp;contextData=(sc.CustomDigest)&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;rulebookMode=false" hiddenhref="/RelatedInformation/Ie59924e3a21711dea82ab9f4ee295c21/kcTableOfAuthorities.html?originationContext=documentTab&amp;transitionType=TableOfAuthorities&amp;contextData=(sc.CustomDigest)&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;rulebookMode=false">
			
			<span>
				Table of Authorities 
			</span>
		</a>
		<div class="co_clear"></div> 
	</h2>
</li>




<li id="co_powByKCContainer">
	<a id="co_powByKC" href="javascript:void(0)">
		Powered by KeyCite
	</a>
</li>

			</ul>
		</div>
		<div class="co_clear"></div>
		<div id="co_docToolbarContainer" class="">
			<div id="co_docToolbar"><div><ul id="co_docToolbarMenuLeft"><li id="co_docToolbarBackToResults"><div id="co_documentFooterBreadcrumb"><a class="co_tbButton" href="/Search/Results.html?jurisdiction=CTAF&amp;contentType=CUSTOMDIGEST&amp;querySubmissionGuid=i0ad6ad3e0000016314b8705c8686bce0&amp;tocGuid=I4aee2539c6f64c1812a4c2f3395c2607&amp;categoryPageUrl=Home%2FWestKeyNumberSystem&amp;searchId=i0ad6ad3a0000016314b861eab2033b51&amp;collectionSet=w_cs_cd_toc&amp;transitionType=ReturnToList&amp;contextData=%28sc.CustomDigest%29#Ie59924e3a21711dea82ab9f4ee295c21"><span class="icon25 icon_back_arrow btnOffset"></span>Return to list</a></div></li><li id="co_docToolbarDocumentNavigation"><div id="co_documentFooterResultsNavigation" class="co_prevNextNavigation"><button title="Previous Document" id="co_documentFooterResultsNavigationPrevious" class="co_prev co_tbButton">
	                <span class="icon25 icon_prev_arrow">Previous Document</span>
                </button>
                <span class="co_navigationText"><strong>170</strong> of <strong>718 results</strong></span>
                <button title="Next Document" id="co_documentFooterResultsNavigationNext" class="co_next co_tbButton">
                    <span class="icon25 icon_next_arrow">Next Document</span>
                </button></div></li></ul><ul id="co_docToolbarMenuRight"><li id="co_docToolbarMenuRightChildWidget0" class="co_hideState"></li><li id="co_docHeaderSearchGrading"></li><li id="co_docToolbarGoTo"><div class="co_dropdownTabCollapsed"><div class="co_dropdownTab"><a href="javascript:void(0);" class="co_dropdownBoxanchorLabel" role="button">Go to</a><a href="javascript:void(0);" role="button" class="co_dropdownArrowCollapsed">Open Skip to Menu</a></div></div><div id="co_docGoToWidget" class="co_dropdownBoxCollapsed"><div class="co_dropdownBoxContent" id="co_skipTo"><div class="co_dropdownBoxContentRight"><div><div><a href="#co_synopsis">Synopsis</a></div><div><a href="#co_headnoteHeader">West Headnotes</a></div><div><a href="#co_attorneysAndLawFirms">Attorneys and Law Firms</a></div><div><a href="#co_opinion">Opinion</a></div><div><a href="#co_allCitations">All Citations</a></div></div></div></div><div id="co_starPage" class="co_dropdownBoxContent"><div class="co_dropdownBoxContentRight"><label for="co_document_starPage_starPageNavInput">Page #</label><input id="co_document_starPage_starPageNavInput" maxlength="6" size="6" type="text"><span id="co_document_starPage_starPageNavGo" class="co_primaryBtn">Go</span><div id="co_document_starPage_starPageNavError"></div><div class="co_clear"></div></div></div></div></li><li id="co_docToolbarTocNavigation"></li><li id="co_docToolbarTocFlyout"></li><li id="co_docToolbarMenuRightChildWidget5"></li><li id="co_docToolbarMenuRightChildWidget6"></li><li id="co_docToolbarMenuRightChildWidget7" class="co_toolbarSeparator"></li><li id="co_docToolbarSearchWithinDocument"><div id="co_docSearchWithinContainer"><a role="button" href="javascript:void(0);" class="co_dropdownTitle" title="Search text in this document">Search Within this Document</a>
<div id="co_docSearchWithinDropdownContainer">
	<div id="co_docSearchWithinDropdownContainerInner">
		<div id="co_docSearchWithinDropdownContainerInnerContent" class="co_dropdownBoxCollapsed">
			<!-- toggle between co_dropDownBoxCollapsed and co_dropdownBoxExpanded to show/hide -->
			<div class="co_dropdownBoxHeader">
				<span></span>
			</div>
			<div class="co_dropdownBoxContent">
				<div class="co_dropdownBoxContentRight">
					<div id="co_docSearchWithin_input">
						
<div id="co_docSearchWithin_searchInputContainer_withRecentSearch">
	<a id="co_searchLast10Link" class="co_recentSearchesLink" href="javascript:void(0);" title="Recent Searches">
		Last 10 Searches
	</a>
	<div class="co_textarea">
		<textarea id="co_docSearchWithin_searchInput_withRecentSearch" rows="1" autocorrect="off" autocapitalize="off" role="textbox" aria-label="Enter term to search for in current document"></textarea>
	</div>
	<div id="co_documentRecentQueryListBox" class="co_hideState"><ul class="co_searchSuggestionContainer" id="co_documentSearchLast10List"></ul></div>
</div>

						<input id="co_docSearchWithin_searchButton" class="co_secondaryBtn" value="Search" role="button" aria-label="Search Within this Document" type="button">
					</div>
					<div class="co_prevNextNavigation co_hideState">
						<button title="Previous Term" class="co_prev co_tbButton">
							<span class="icon25 icon_prev_arrow">Previous Term</span>
						</button>
						<button title="Next Term" class="co_next co_tbButton">
							<span class="icon25 icon_next_arrow">Next Term</span>
						</button>
						<span class="co_navigationText co_hideState"></span>
					</div>
					<button id="co_docSearchWithin_help" class="co_helpLink">Terms &amp;amp; Connectors</button>
					<button id="co_docSearchWithinCloseButton" class="co_widget_closeIcon">Close</button>
					<div id="co_docSearchWithinMessage"></div>
					<div class="co_clear"></div>
				</div>
				<div id="searchWithinTncContainer" class="co_hideState"><div id="co_search_advancedSearch_tncLegendBox">  <h2 id="co_search_advancedSearch_tncHelpTitle">Connectors and Expanders</h2>  <a id="co_search_advancedSearch_tncHelpLink" href="#" class="co_hideState">Help</a>  <dl id="co_search_advancedSearch_tncLegendList">    <dt>&amp;</dt><dd>AND</dd>    <dt>/s</dt><dd>In same sentence</dd>    <dt>or</dt><dd>OR</dd>    <dt>+s</dt><dd>Preceding within sentence</dd>    <dt>/p</dt><dd>In same paragraph</dd>    <dt>""</dt><dd>Phrase</dd>    <dt>+p</dt><dd>Preceding within paragraph</dd>    <dt>%</dt><dd>But not</dd>    <dt>/n</dt><dd>Within n terms of</dd>    <dt>!</dt><dd>Root expander</dd>    <dt>+n</dt><dd>Preceding within n terms of</dd>    <dt>*</dt><dd>Universal character</dd>    <dt>#</dt><dd>Prefix to turn off plurals and equivalents</dd>  </dl></div></div>
			</div>
			<div class="co_dropdownBoxFooter">
				<span></span>
			</div>
		</div>
	</div>
</div></div></li><li id="co_docToolbarDisplayOptions"><a role="button" id="co_displayOptionsLink" class="co_tbButton" href="javascript:void(0);" title="Display Options"><span class="icon25 icon_text_resize">Display Options</span></a></li><li id="co_docToolbarDeliveryWidget"><div id="deliveryWidget1" class="co_dropDownMenu collapsed"><div class="co_dropDownButton"><a role="button" id="deliveryLink1" title="Email" class="co_tbButton" href="javascript:void(0);"><span class="icon25 icon_email">Email</span></a><a href="javascript:void(0);" class="co_tbButton co_dropDownAnchor" role="button" id="deliveryDropButton1" aria-label="Delivery menu" title="Delivery menu" aria-describedby="navigation1"><span class="icon25 icon_down_blue_arrow"></span></a><span id="navigation1" class="co_accessibilityLabel">Enter to open, tab to navigate, enter to select</span></div><div id="deliveryWidgetMenu1" class="co_dropDownMenuContent" role="document"><ul class="co_dropDownMenuList checkmarks icons" role="listbox" aria-multiselectable="true" aria-hidden="false" aria-expanded="true"><li id="deliveryRow1Email" name="Email" role="presentation" class="checked"><a title="Email" id="deliveryLinkRow1Email" role="option" aria-posinset="1" aria-setsize="3" class="co_deliveryLinkOptions" tabindex="0" aria-selected="true"><span class="icon25 icon_email"></span>Email</a></li><li id="deliveryRow1Print" name="Print" role="presentation"><a title="Print" id="deliveryLinkRow1Print" role="option" aria-posinset="2" aria-setsize="3" class="co_deliveryLinkOptions" tabindex="0" aria-selected="false"><span class="icon25 icon_print"></span>Print</a></li><li id="deliveryRow1Download" name="Download" role="presentation"><a title="Download" id="deliveryLinkRow1Download" role="option" aria-posinset="3" aria-setsize="3" class="co_deliveryLinkOptions" tabindex="0" aria-selected="false"><span class="icon25 icon_download"></span>Download</a></li></ul><div class="co_deliveryWidgetMenuFooter"></div></div><div id="co_deliveryWidget_Message1"></div></div></li><li id="co_docToolbarReadingModeWidget"><a role="button" id="co_fullscreenModeLink" class="co_tbButton" href="javascript:void(0);" title="Fullscreen Mode"><span class="icon25 icon_fullscreen">Fullscreen Mode</span></a></li></ul></div></div> 
			<div class="co_clear"></div>
		</div>
	</div>
</div>

				<div id="coid_website_errorsSummaryPlaceHolder"><div class="co_infoBox failure" style="display: none;"><div class="co_infoBox_container"><div class="co_infoBox_outer"><div class="co_infoBox_inner"><a id="co_website_errorSumarryCloseLink" class="co_infoBox_closeButton">Close</a><div class="co_infoBox_message" tabindex="-1">Sorry, there was an error on this page.<a href="javascript:void(0);" id="co_website_errorSummaryToggleLink">More info</a><a href="javascript:void(0);" id="co_website_errorSummaryToggleLinkLessInfo" style="display: none; margin-left: 6px;">Less info</a><ul class="co_website_errorsSummaryList" style="display: none;"></ul></div></div></div></div></div></div>
				<div id="coid_website_messagePlaceholder"></div>







				<div id="test_hplink"></div>
				<div class="co_scrollWrapper">





							<div id="coid_website_documentWidgetDiv" class=" co_khSpeedReadExpandAll">
<div id="co_chunkNavOne"><div class="co_chunkPagination" id="co_topChunkNav"><ul class="co_navFooter_pagination" id="co_topDocumentChunkNavFooter_pagination"><li><strong>Part:</strong></li><li><a id="co_topPreviousChunkButton" class="co_prev co_tbButton co_disabled" href=""><span class="icon25 icon_prev_arrow">Previous Part</span></a></li><li><label><span class="co_accessibilityLabel">Go To Document Part</span><input id="co_topCurrentChunkStatus" size="1" maxlength="4" type="text"></label> of <strong id="co_topChunkCountStatus">2</strong></li><li><a id="co_topNextChunkButton" class="co_next co_tbButton" href=""><span class="icon25 icon_next_arrow">Next Part</span></a></li></ul><div class="co_clear"></div><div></div></div></div><div id="co_briefItDiv" class="co_excludeAnnotations"><button id="co_briefItButton" class="co_primaryBtn co_floatRight">Brief It</button><div class="undefined"></div></div><div id="co_document" class="co_addFocusCorrection"><div id="co_document_0" class="co_document co_caselawNRS"><input id="co_keyCiteFlagPlaceHolder" type="hidden"><input id="co_document_starPageMetadata" value="{ &quot;citations&quot;: { &quot;Sf679c9a4b2a811de9988d233d23fe599&quot;:&quot;580 F.3d 1340&quot; }, &quot;pubs&quot;: { &quot;Sf679c9a4b2a811de9988d233d23fe599&quot;:&quot;506&quot; } }" alt="metadata" type="hidden"><div><a href="https://1.next.westlaw.com/Link/Document/Blob/I1A0FD0301DD211B2831F8800820C0E34/580_F.3d_1340.pdf?targetType=NRS&amp;originationContext=pagepdflink&amp;transitionType=DocumentImage&amp;uniqueId=c24afad6-ccf7-44e9-ae9f-0ea757500f88&amp;contextData=(sc.CustomDigest)" class="co_blobLink" type="application/pdf"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/v1/co_pdf-icon.gif" class="co_pdfIcon" alt="PDF">​Original Image of 580 F.3d 1340 (PDF)</a></div><div class="co_cites">580 F.3d 1340</div><input id="co_document_paraNumbersSourceCiteMetadata" value="{ &quot;paraNumbersSourceCite&quot;: &quot;580 F.3d 1340&quot;, &quot;publicationNumber&quot;: &quot;506&quot; }" alt="metadata" type="hidden"><div class="co_contentBlock co_briefItState co_courtBlock"><div><div class="co_hAlign2">United States Court of Appeals,</div>Federal Circuit.</div></div><div class="co_title"><div class="co_suit"><div class="co_partyLine">AMGEN INC., Plaintiff–Cross Appellant,</div><div>v.</div><div class="co_partyLine"><a id="co_link_I4aede63cd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Search/Results.html?query=advanced%3a+WCAID(I86B4BFA242B111DD961A0014224D2780)&amp;saveJuris=False&amp;contentType=BUSINESS-INVESTIGATOR&amp;startIndex=1&amp;contextData=(sc.Default)&amp;categoryPageUrl=Home%2fCompanyInvestigator&amp;originationContext=document&amp;transitionType=DocumentItem">F. HOFFMAN–LA ROCHE LTD</a>, Roche Diagnostics GMBH, and Hoffman–LA Roche Inc., Defendants–Appellants.</div></div></div><div class="co_docketDate"><div class="co_contentBlock co_briefItState co_docketBlock"><span>Nos. 2009–1020, 2009–1096.</span></div><div class="co_date"><span>Sept. 15, 2009.</span><span>Rehearing and Rehearing En Banc Denied Dec. 10, 2009.<sup id="co_footnoteReference_B0012019808227_ID0EVH"><a href="#co_footnote_B0012019808227" class="co_footnoteReference">*</a></sup></span></div></div><div class="co_contentBlock co_briefItState co_synopsis"><h2 id="co_synopsis" class="co_printHeading">Synopsis</h2><div><div class="co_paragraph"><div class="co_paragraphText"><strong>Background:</strong> Owner of patents relating to production of erythropoietin (EPO) using recombinant deoxyribonucleic acid (DNA) technology filed declaratory judgment action alleging that competitor's product would infringe patents if imported into United States. Competitor filed counterclaims asserting that patents were invalid and not infringed. Following entry of summary judgment of no invalidity for obviousness, <a id="co_link_I4aede640d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;pubNum=4637&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">581 F.Supp.2d 160,</a> and jury verdict in patentee's favor, the United States District Court for the District of Massachusetts, William G. Young, J., vacated jury's verdict that claim of one patent was infringed under doctrine of equivalents (DOE), but granted patentee declaratory relief and permanently enjoined competitor from marketing its product in United States. Parties filed cross-appeals.</div></div></div><div class="co_contentBlock co_briefItState co_synopsisHolding"><div class="co_paragraph"><div class="co_paragraphText"><strong>Holdings:</strong> The Court of Appeals, <a id="co_link_I4aede644d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0144380101&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Schall</a>, Circuit Judge, held that:</div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F52019808227" class="co_internalLink co_excludeAnnotations co_disableHighlightFeatures">1</a> patents could not receive protection of statutory safe harbor provision;</div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F102019808227" class="co_internalLink co_excludeAnnotations co_disableHighlightFeatures">2</a> patents were not invalid for obviousness-type double patenting; and</div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F152019808227" class="co_internalLink co_excludeAnnotations co_disableHighlightFeatures">3</a> prior clinical study isolating EPO from human urine did not anticipate patent;</div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F212019808227" class="co_internalLink co_excludeAnnotations co_disableHighlightFeatures">4</a> failure to instruct jury that it was possible to anticipate product-by-process claim even if product in prior art was not made by same process did not warrant new trial;</div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F292019808227" class="co_internalLink co_excludeAnnotations co_disableHighlightFeatures">5</a> court's construction of claim did not render claim indefinite;</div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F302019808227" class="co_internalLink co_excludeAnnotations co_disableHighlightFeatures">6</a> source limitations did not render claims indefinite;</div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F352019808227" class="co_internalLink co_excludeAnnotations co_disableHighlightFeatures">7</a> accused product literally infringed patent;</div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F362019808227" class="co_internalLink co_excludeAnnotations co_disableHighlightFeatures">8</a> sue of whether human EPO in accused product was materially changed prior to importation was for jury; and</div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F412019808227" class="co_internalLink co_excludeAnnotations co_disableHighlightFeatures">9</a> patentee failed to present particularized testimony of equivalents.</div></div></div><div class="co_paragraph"><div class="co_paragraphText">Affirmed in part, vacated in part, and remanded.</div></div></div><div id="co_headnotes" class="co_headnotes co_fancyHeadnotes"><h2 id="co_headnoteHeader" class="co_headnoteHeader co_printHeading"><span class="co_headnoteHeaderSpan">West Headnotes (45)</span><a id="co_headnoteExpandCollapseLink" class="co_accLink co_excludeAnnotations co_disableHighlightFeatures" href="javascript:void(0);" role="button">Collapse West Headnotes</a></h2><div class="co_headnotesContentContainer"><div id="co_expandedHeadnotes"><div id="co_headnoteTools"><a id="co_headnotesShowOrHideFancy" href="javascript:void(0);" class="co_fancyHeadnotesShowHide co_excludeAnnotations co_disableHighlightFeatures">Change View</a></div><div class="co_headnoteRow" id="co_anchor_2019808227001"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F12019808227"><span class="co_headnoteNumber" id="co_anchor_headNote_1"><a href="#co_anchor_B12019808227" class="co_internalLink">1</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0E5PAC" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/106/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Courts</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EDCAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/106k96(7)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Particular questions or subject matter</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">In patent infringement actions, Court of Appeals for the Federal Circuit applies standard of review for judgment as matter of law (JMOL) rulings used in relevant regional circuit.</div></div><div id="co_headnoteId_201980822700120150331223520" class="co_headnoteCitedCaseRef"><a id="co_link_ID0ESCAE" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;headnoteId=201980822700120150331223520&amp;originationContext=document&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 1"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">2 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede645d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/106/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">106</a></span><span class="co_headnoteTopicKey">Courts</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede646d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/106II/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">106II</a></span><span class="co_headnoteTopicKey">Establishment, Organization, and Procedure</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede647d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/106II(G)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">106II(G)</a></span><span class="co_headnoteTopicKey">Rules of Decision</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede648d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/106k88/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">106k88</a></span><span class="co_headnoteTopicKey">Previous Decisions as Controlling or as Precedents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede649d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/106k96/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">106k96</a></span><span class="co_headnoteTopicKey">Decisions of United States Courts as Authority in Other United States Courts</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede64ad82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/106k96(7)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">106k96(7)</a></span><span class="co_headnoteTopicKey">Particular questions or subject matter</span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2019808227002"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F22019808227"><span class="co_headnoteNumber" id="co_anchor_headNote_2"><a href="#co_anchor_B22019808227" class="co_internalLink">2</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EEDAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170A/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Federal Civil Procedure</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EWEAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170Ak2142/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Weight and Sufficiency of Evidence</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Under First Circuit law, judgment as matter of law (JMOL) is warranted when, viewing evidence in light most favorable to non-moving party, there is no legally sufficient evidentiary basis for reasonable jury to find for non-moving party.</div></div><div id="co_headnoteId_201980822700220150331223520" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EWFAE" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;headnoteId=201980822700220150331223520&amp;originationContext=document&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 2"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">4 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede64bd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170A/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170A</a></span><span class="co_headnoteTopicKey">Federal Civil Procedure</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede64cd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170AXV/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170AXV</a></span><span class="co_headnoteTopicKey">Trial</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede64dd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170AXV(F)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170AXV(F)</a></span><span class="co_headnoteTopicKey">Taking Case or Question from Jury;  Preverdict Motion for Judgment as Matter of Law</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede64ed82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170AXV(F)2/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170AXV(F)2</a></span><span class="co_headnoteTopicKey">Questions for Jury</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede64fd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170Ak2142/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170Ak2142</a></span><span class="co_headnoteTopicKey">Weight and Sufficiency of Evidence</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede650d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170Ak2142.1/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170Ak2142.1</a></span><span class="co_headnoteTopicKey">In general</span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2019808227003"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F32019808227"><span class="co_headnoteNumber" id="co_anchor_headNote_3"><a href="#co_anchor_B32019808227" class="co_internalLink">3</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EIGAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0E1HAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1965/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Scope, Standard, and Extent of Review</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">In patent infringement action, Court of Appeals reviews court's conclusion on double patenting without deference because double patenting is matter of what is claimed, and therefore is treated like claim construction upon appellate review.</div></div><div id="co_headnoteId_201980822700320150331223520" class="co_headnoteCitedCaseRef"><a id="co_link_ID0E4IAE" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;headnoteId=201980822700320150331223520&amp;originationContext=document&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 3"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">2 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede651d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede652d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII</a></span><span class="co_headnoteTopicKey">Patent Infringement</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede653d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII(C)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII(C)</a></span><span class="co_headnoteTopicKey">Actions</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede654d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII(C)7/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII(C)7</a></span><span class="co_headnoteTopicKey">Appellate Review</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede655d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1965/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1965</a></span><span class="co_headnoteTopicKey">Scope, Standard, and Extent of Review<input id="co_docMarker_0" type="hidden"></span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede656d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1966/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1966</a></span><span class="co_headnoteTopicKey">In general</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k324.5)</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2019808227004"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F42019808227"><span class="co_headnoteNumber" id="co_anchor_headNote_4"><a href="#co_anchor_B42019808227" class="co_internalLink">4</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EPJAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EFLAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k828/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Obvious variant of invention claimed in prior application</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Obviousness-type “double patenting” is judicially created doctrine adopted to prevent claims in separate applications or patents that do not recite same invention, but nonetheless claim inventions so alike that granting both exclusive rights would effectively extend life of patent protection.</div></div><div id="co_headnoteId_201980822700420150331223520" class="co_headnoteCitedCaseRef"><a id="co_link_ID0E1LAE" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;headnoteId=201980822700420150331223520&amp;originationContext=document&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 4"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">10 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede657d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede658d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II</a></span><span class="co_headnoteTopicKey">Patentability and Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede659d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(F)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(F)</a></span><span class="co_headnoteTopicKey">Other Challenges to Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede65ad82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k826/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k826</a></span><span class="co_headnoteTopicKey">Multiple Patents for Same Invention;  Double Patenting</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede65bd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k828/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k828</a></span><span class="co_headnoteTopicKey">Obvious variant of invention claimed in prior application</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k120)</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2019808227005"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F52019808227"><span class="co_headnoteNumber" id="co_anchor_headNote_5"><a href="#co_anchor_B52019808227" class="co_internalLink">5</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EQMAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EGOAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k953/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Continuation or divisional application</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Patents relating to production of erythropoietin (EPO) using recombinant deoxyribonucleic acid (DNA) technology issued exclusively from continuation, rather than divisional, applications, and thus could not receive protection of statutory safe harbor provision shielding divisional application, original application, or any patent issued on either of them from double patenting invalidation, even if continuation applications could have been filed as divisional applications. <a id="co_link_I4aede661d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C.A. § 121</a>.</div></div><div id="co_headnoteId_201980822700520150331223520" class="co_headnoteCitedCaseRef"><a id="co_link_ID0E4OAE" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;headnoteId=201980822700520150331223520&amp;originationContext=document&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 5"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">8 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede65cd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede65dd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291IV/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291IV</a></span><span class="co_headnoteTopicKey">Patent Applications and Proceedings</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede65ed82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291IV(B)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291IV(B)</a></span><span class="co_headnoteTopicKey">Examination</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede65fd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k951/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k951</a></span><span class="co_headnoteTopicKey">Renewal of Application</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede660d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k953/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k953</a></span><span class="co_headnoteTopicKey">Continuation or divisional application</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k120, 291k110)</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2019808227006"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F62019808227"><span class="co_headnoteNumber" id="co_anchor_headNote_6"><a href="#co_anchor_B62019808227" class="co_internalLink">6</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EYPAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EORAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k953/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Continuation or divisional application</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Statutory safe harbor provision shielding divisional application, original application, or any patent issued on either of them from double patenting invalidation does not protect continuation applications or patents descending from only continuation applications. <a id="co_link_I4aede667d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C.A. § 121</a>.</div></div><div id="co_headnoteId_201980822700620150331223520" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EFSAE" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;headnoteId=201980822700620150331223520&amp;originationContext=document&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 6"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">7 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede662d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede663d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291IV/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291IV</a></span><span class="co_headnoteTopicKey">Patent Applications and Proceedings</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede664d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291IV(B)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291IV(B)</a></span><span class="co_headnoteTopicKey">Examination</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede665d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k951/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k951</a></span><span class="co_headnoteTopicKey">Renewal of Application</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede666d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k953/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k953</a></span><span class="co_headnoteTopicKey">Continuation or divisional application</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k120, 291k110)</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2019808227007"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F72019808227"><span class="co_headnoteNumber" id="co_anchor_headNote_7"><a href="#co_anchor_B72019808227" class="co_internalLink">7</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EATAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EWUAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k828/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Obvious variant of invention claimed in prior application</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Party challenging validity of continuation patents under obviousness-type double patenting analysis could not use evidence up to filing date of secondary applications to show lack of patentable distinctiveness, but rather was limited to developments in art occurring up to date of original application. <a id="co_link_I4aede66dd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS120&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C.A. §§ 120</a>, <a id="co_link_I4aede66ed82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">121</a>.</div></div><div id="co_headnoteId_201980822700720150331223520" class="co_headnoteCitedCaseRef"><a id="co_link_ID0ELVAE" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;headnoteId=201980822700720150331223520&amp;originationContext=document&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 7"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">9 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede668d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede669d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II</a></span><span class="co_headnoteTopicKey">Patentability and Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede66ad82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(F)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(F)</a></span><span class="co_headnoteTopicKey">Other Challenges to Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede66bd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k826/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k826</a></span><span class="co_headnoteTopicKey">Multiple Patents for Same Invention;  Double Patenting</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede66cd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k828/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k828</a></span><span class="co_headnoteTopicKey">Obvious variant of invention claimed in prior application</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k120)</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2019808227008"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F82019808227"><span class="co_headnoteNumber" id="co_anchor_headNote_8"><a href="#co_anchor_B82019808227" class="co_internalLink">8</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EOWAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EWXAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k826/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Multiple Patents for Same Invention;  Double Patenting</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Double patenting is not sustainable when product can be fabricated by processes other than that secured by issued process patent.</div></div><div id="co_headnoteId_201980822700820150331223520" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EZYAE" class="co_link co_excludeAnnotations co_disableHighlightFeatures co_hideState" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;headnoteId=201980822700820150331223520&amp;originationContext=document&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 8"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">0 </span>Case that cites this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede66fd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede670d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II</a></span><span class="co_headnoteTopicKey">Patentability and Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede671d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(F)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(F)</a></span><span class="co_headnoteTopicKey">Other Challenges to Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede672d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k826/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k826</a></span><span class="co_headnoteTopicKey">Multiple Patents for Same Invention;  Double Patenting</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede673d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k827/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k827</a></span><span class="co_headnoteTopicKey">In general</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k120)</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2019808227009"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F92019808227"><span class="co_headnoteNumber" id="co_anchor_headNote_9"><a href="#co_anchor_B92019808227" class="co_internalLink">9</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0ELZAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EB2AE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k829/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Claim not patentably distinct from prior claims</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">If patentee relies on alternative processes for making products claimed in product patents up to their filing dates to prove that claims of those patents and claims of process patents are patentably distinct, then party challenging patents' validity pursuant to double patenting doctrine may rely on subsequent developments in art up to filing dates of product patents to prove that any alternative processes put forth by patentee do not render claims of product patents and claims of process patents patentably distinct. <input id="co_docMarker_1" type="hidden"><a id="co_link_I4aede679d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS120&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C.A. §§ 120</a>, <a id="co_link_I4aede67ad82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">121</a>.</div></div><div id="co_headnoteId_201980822700920150331223520" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EW2AE" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;headnoteId=201980822700920150331223520&amp;originationContext=document&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 9"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">1 </span>Case that cites this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede674d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede675d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II</a></span><span class="co_headnoteTopicKey">Patentability and Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede676d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(F)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(F)</a></span><span class="co_headnoteTopicKey">Other Challenges to Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede677d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k826/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k826</a></span><span class="co_headnoteTopicKey">Multiple Patents for Same Invention;  Double Patenting</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede678d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k829/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k829</a></span><span class="co_headnoteTopicKey">Claim not patentably distinct from prior claims</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k120)</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2019808227010"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F102019808227"><span class="co_headnoteNumber" id="co_anchor_headNote_10"><a href="#co_anchor_B102019808227" class="co_internalLink">10</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0E53AE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EU5AE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k832/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Particular products or processes</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Patentable differences existed between prior patent for deoxyribonucleic acid (DNA) sequences encoding erythropoietin (EPO) and process patents relating to production of EPO using recombinant DNA technology, and thus patents were not invalid for obviousness-type double patenting, where, unlike later patents, none of prior patent's claims required actual production of isolatable amounts of in vivo biologically active EPO glycoprotein, and actual production of glycosylated EPO having stated in vivo biological activities would not have been obvious to ordinarily skilled artisan in possession of transfected Chinese hamster ovary (CHO) cells described in prior patent. <a id="co_link_I4aede680d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C.A. § 121</a>.</div></div><div id="co_headnoteId_201980822701020150331223520" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EJ6AE" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;headnoteId=201980822701020150331223520&amp;originationContext=document&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 10"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">13 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede67bd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede67cd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II</a></span><span class="co_headnoteTopicKey">Patentability and Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede67dd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(F)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(F)</a></span><span class="co_headnoteTopicKey">Other Challenges to Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede67ed82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k826/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k826</a></span><span class="co_headnoteTopicKey">Multiple Patents for Same Invention;  Double Patenting</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede67fd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k832/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k832</a></span><span class="co_headnoteTopicKey">Particular products or processes</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k120)</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2019808227011"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F112019808227"><span class="co_headnoteNumber" id="co_anchor_headNote_11"><a href="#co_anchor_B112019808227" class="co_internalLink">11</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EFAAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EXBAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k794/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Degree of proof</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Party challenging patent as obvious has burden to show by clear and convincing evidence that person of ordinary skill in art would have had reason to carry out claimed process, and would have had reasonable expectation of success in doing so. <a id="co_link_I4aede686d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS103&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C.A. § 103</a>.</div></div><div id="co_headnoteId_201980822701120150331223520" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EMCAG" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;headnoteId=201980822701120150331223520&amp;originationContext=document&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 11"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">33 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede681d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede682d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II</a></span><span class="co_headnoteTopicKey">Patentability and Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede683d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(E)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(E)</a></span><span class="co_headnoteTopicKey">Obviousness;  Lack of Invention</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede684d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(E)4/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(E)4</a></span><span class="co_headnoteTopicKey">Evidence and Determination</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede685d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k794/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k794</a></span><span class="co_headnoteTopicKey">Degree of proof</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k36(2))</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2019808227012"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F122019808227"><span class="co_headnoteNumber" id="co_anchor_headNote_12"><a href="#co_anchor_B122019808227" class="co_internalLink">12</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EHDAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0E4EAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1119/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Degree of proof</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Patent is presumed to be valid, and this presumption only can be overcome by clear and convincing evidence to contrary.</div></div><div id="co_headnoteId_201980822701220150331223520" class="co_headnoteCitedCaseRef"><a id="co_link_ID0ESFAG" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;headnoteId=201980822701220150331223520&amp;originationContext=document&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 12"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">1 </span>Case that cites this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede687d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede688d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291IV/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291IV</a></span><span class="co_headnoteTopicKey">Patent Applications and Proceedings</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede689d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291IV(D)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291IV(D)</a></span><span class="co_headnoteTopicKey">Conclusiveness and Effect of Administrative Decisions</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede68ad82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1116/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1116</a></span><span class="co_headnoteTopicKey">Sufficiency of Evidence to Offset Effect of Decision</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede68bd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1119/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1119</a></span><span class="co_headnoteTopicKey">Degree of proof</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k112.5)</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2019808227013"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F132019808227"><span class="co_headnoteNumber" id="co_anchor_headNote_13"><a href="#co_anchor_B132019808227" class="co_internalLink">13</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EEGAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EEIAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k488/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Extent of similarity or difference between prior art and claimed invention in general</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Anticipation generally requires presence in prior art of each and every limitation of claimed invention. <a id="co_link_I4aede692d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RB&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_8b3b0000958a4">35 U.S.C.A. § 102(a)</a>.</div></div><div id="co_headnoteId_201980822701320150331223520" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EZIAG" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;headnoteId=201980822701320150331223520&amp;originationContext=document&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 13"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">28 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede68cd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede68dd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II</a></span><span class="co_headnoteTopicKey">Patentability and Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede68ed82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(C)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(C)</a></span><span class="co_headnoteTopicKey">Novelty;  Anticipation</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede68fd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(C)1/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(C)1</a></span><span class="co_headnoteTopicKey">In General</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede690d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k483/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k483</a></span><span class="co_headnoteTopicKey">Prior Art and Relation of Claimed Invention Thereto</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede691d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k488/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k488</a></span><span class="co_headnoteTopicKey">Extent of similarity or difference between prior art and claimed invention in general</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k72(1))</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2019808227014"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F142019808227"><span class="co_headnoteNumber" id="co_anchor_headNote_14"><a href="#co_anchor_B142019808227" class="co_internalLink">14</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EVJAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0ELLAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k445/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Products or results</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Old product is not patentable even if it is made by new process.</div></div><div id="co_headnoteId_201980822701420150331223520" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EAMAG" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;headnoteId=201980822701420150331223520&amp;originationContext=document&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 14"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">9 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede693d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede694d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II</a></span><span class="co_headnoteTopicKey">Patentability and Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede695d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(B)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(B)</a></span><span class="co_headnoteTopicKey">Eligible Subject Matter</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede696d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k442/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k442</a></span><span class="co_headnoteTopicKey">Classes of Invention or Discovery;  Statutory Subject Matter</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede697d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k445/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k445</a></span><span class="co_headnoteTopicKey">Products or results</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k8)</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2019808227015"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F152019808227"><span class="co_headnoteNumber" id="co_anchor_headNote_15"><a href="#co_anchor_B152019808227" class="co_internalLink">15</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0ESMAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EEOAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k602/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Particular products or processes</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Production of erythropoietin (EPO) purified from mammalian cells grown in culture by recombinant deoxyribonucleic acid (DNA) technology resulted in new product, and thus prior clinical study isolating EPO from human urine did not anticipate patent relating to EPO production using recombinant technology; recombinant EPO had higher molecular weight and different charge than urinary EPO due to differences in carbohydrate composition. <a id="co_link_I4aede69dd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RB&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_8b3b0000958a4">35 U.S.C.A. § 102(a)</a>.</div></div><div id="co_headnoteId_201980822701520150331223520" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EZOAG" class="co_link co_excludeAnnotations co_disableHighlightFeatures co_hideState" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;headnoteId=201980822701520150331223520&amp;originationContext=document&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 15"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">0 </span>Case that cites this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede698d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede699d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II</a></span><span class="co_headnoteTopicKey">Patentability and Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede69ad82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(C)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(C)</a></span><span class="co_headnoteTopicKey">Novelty;  Anticipation</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede69bd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(C)4/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(C)4</a></span><span class="co_headnoteTopicKey">Prior Description in Printed Publication<input id="co_docMarker_2" type="hidden"></span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede69cd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k602/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k602</a></span><span class="co_headnoteTopicKey">Particular products or processes</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k70)</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2019808227016"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F162019808227"><span class="co_headnoteNumber" id="co_anchor_headNote_16"><a href="#co_anchor_B162019808227" class="co_internalLink">16</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EVPAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/106/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Courts</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EZRAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/106k96(7)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Particular questions or subject matter</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">In patent infringement actions, Court of Appeals for the Federal Circuit reviews decisions on motions for new trial under law of relevant regional circuit.</div></div><div id="co_headnoteId_201980822701620150331223520" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EISAG" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;headnoteId=201980822701620150331223520&amp;originationContext=document&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 16"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">4 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede69ed82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/106/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">106</a></span><span class="co_headnoteTopicKey">Courts</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede69fd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/106II/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">106II</a></span><span class="co_headnoteTopicKey">Establishment, Organization, and Procedure</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6a0d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/106II(G)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">106II(G)</a></span><span class="co_headnoteTopicKey">Rules of Decision</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6a1d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/106k88/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">106k88</a></span><span class="co_headnoteTopicKey">Previous Decisions as Controlling or as Precedents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6a2d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/106k96/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">106k96</a></span><span class="co_headnoteTopicKey">Decisions of United States Courts as Authority in Other United States Courts</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6a3d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/106k96(7)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">106k96(7)</a></span><span class="co_headnoteTopicKey">Particular questions or subject matter</span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2019808227017"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F172019808227"><span class="co_headnoteNumber" id="co_anchor_headNote_17"><a href="#co_anchor_B172019808227" class="co_internalLink">17</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0E1SAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170B/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Federal Courts</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0E1UAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170Bk3606/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">New Trial, Rehearing, or Reconsideration</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Under First Circuit law, Court of Appeals reviews district court's denial of motion for new trial for manifest abuse of discretion.</div></div><div id="co_headnoteId_201980822701720150331223520" class="co_headnoteCitedCaseRef"><a id="co_link_ID0E4VAG" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;headnoteId=201980822701720150331223520&amp;originationContext=document&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 17"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">1 </span>Case that cites this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6a4d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170B/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170B</a></span><span class="co_headnoteTopicKey">Federal Courts</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6a5d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170BXVII/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170BXVII</a></span><span class="co_headnoteTopicKey">Courts of Appeals</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6a6d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170BXVII(K)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170BXVII(K)</a></span><span class="co_headnoteTopicKey">Scope and Extent of Review</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6a7d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170BXVII(K)2/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170BXVII(K)2</a></span><span class="co_headnoteTopicKey">Standard of Review</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6a8d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170Bk3576/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170Bk3576</a></span><span class="co_headnoteTopicKey">Procedural Matters</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6a9d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170Bk3606/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170Bk3606</a></span><span class="co_headnoteTopicKey">New Trial, Rehearing, or Reconsideration</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6aad82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170Bk3606(1)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170Bk3606(1)</a></span><span class="co_headnoteTopicKey">In general</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 170Bk825.1)</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2019808227018"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F182019808227"><span class="co_headnoteNumber" id="co_anchor_headNote_18"><a href="#co_anchor_B182019808227" class="co_internalLink">18</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EPWAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EBYAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1965/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Scope, Standard, and Extent of Review</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Court of Appeals reviews legal sufficiency of jury instructions on issue of patent law without deference to district court.</div></div><div id="co_headnoteId_201980822701820150331223520" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EEZAG" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;headnoteId=201980822701820150331223520&amp;originationContext=document&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 18"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">1 </span>Case that cites this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6abd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6acd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII</a></span><span class="co_headnoteTopicKey">Patent Infringement</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6add82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII(C)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII(C)</a></span><span class="co_headnoteTopicKey">Actions</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6aed82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII(C)7/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII(C)7</a></span><span class="co_headnoteTopicKey">Appellate Review</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6afd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1965/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1965</a></span><span class="co_headnoteTopicKey">Scope, Standard, and Extent of Review</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6b0d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1966/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1966</a></span><span class="co_headnoteTopicKey">In general</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k324.5)</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2019808227019"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F192019808227"><span class="co_headnoteNumber" id="co_anchor_headNote_19"><a href="#co_anchor_B192019808227" class="co_internalLink">19</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EWZAG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170B/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Federal Courts</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EW2AG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170Bk3703/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Instructions</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Jury verdict will be set aside, based on erroneous jury instructions, if party seeking to set aside verdict can establish that those instructions were legally erroneous, and that errors had prejudicial effect.</div></div><div id="co_headnoteId_201980822701920150331223520" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EZ3AG" class="co_link co_excludeAnnotations co_disableHighlightFeatures co_hideState" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;headnoteId=201980822701920150331223520&amp;originationContext=document&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 19"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">0 </span>Case that cites this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6b1d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170B/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170B</a></span><span class="co_headnoteTopicKey">Federal Courts</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6b2d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170BXVII/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170BXVII</a></span><span class="co_headnoteTopicKey">Courts of Appeals</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6b3d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170BXVII(K)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170BXVII(K)</a></span><span class="co_headnoteTopicKey">Scope and Extent of Review</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6b4d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170BXVII(K)4/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170BXVII(K)4</a></span><span class="co_headnoteTopicKey">Harmless and Reversible Error</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6b5d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170Bk3686/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170Bk3686</a></span><span class="co_headnoteTopicKey">Particular Errors as Harmless or Prejudicial</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6b6d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170Bk3703/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170Bk3703</a></span><span class="co_headnoteTopicKey">Instructions</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6b7d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170Bk3703(1)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170Bk3703(1)</a></span><span class="co_headnoteTopicKey">In general</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 170Bk908.1)</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2019808227020"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F202019808227"><span class="co_headnoteNumber" id="co_anchor_headNote_20"><a href="#co_anchor_B202019808227" class="co_internalLink">20</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EL4AG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170B/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Federal Courts</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EL6AG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170Bk3703/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Instructions</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Party seeking to alter judgment based on erroneous jury instructions must establish that: (1) it made proper and timely objection to jury instructions, (2) those instructions were legally erroneous, (3) errors had prejudicial effect, and (4) it requested alternative instructions that would have remedied error.</div></div><div id="co_headnoteId_201980822702020150331223520" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EOABG" class="co_link co_excludeAnnotations co_disableHighlightFeatures co_hideState" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;headnoteId=201980822702020150331223520&amp;originationContext=document&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 20"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">0 </span>Case that cites this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6b8d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170B/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170B</a></span><span class="co_headnoteTopicKey">Federal Courts</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6b9d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170BXVII/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170BXVII</a></span><span class="co_headnoteTopicKey">Courts of Appeals</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6bad82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170BXVII(K)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170BXVII(K)</a></span><span class="co_headnoteTopicKey">Scope and Extent of Review</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6bbd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170BXVII(K)4/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170BXVII(K)4</a></span><span class="co_headnoteTopicKey">Harmless and Reversible Error</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6bcd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170Bk3686/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170Bk3686</a></span><span class="co_headnoteTopicKey">Particular Errors as Harmless or Prejudicial</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6bdd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170Bk3703/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170Bk3703</a></span><span class="co_headnoteTopicKey">Instructions</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6bed82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170Bk3703(1)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170Bk3703(1)</a></span><span class="co_headnoteTopicKey">In general</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 170Bk908.1)</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2019808227021"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F212019808227"><span class="co_headnoteNumber" id="co_anchor_headNote_21"><a href="#co_anchor_B212019808227" class="co_internalLink">21</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EGBBG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EGDBG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1942/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">New trial;  amendment</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">District court's failure to instruct jury in patent infringement action that it was possible to anticipate product-by-process claim even if product in prior art was not made by same process was not prejudicial error warranting new trial, even though district court effectively took away from jury question of whether asserted claims of patent for production of erythropoietin (EPO) purified from mammalian host cell by recombinant deoxyribonucleic acid (DNA) technology recited old product made by new process, where court's instruction was legally correct, and reasonable jury could not have found that recombinant EPO described in asserted claims was old product. <a id="co_link_I4aede6c5d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RB&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_8b3b0000958a4">35 U.S.C.A. § 102(a)</a>.</div></div><div id="co_headnoteId_201980822702120150331223520" class="co_headnoteCitedCaseRef"><a id="co_link_ID0E2DBG" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;headnoteId=201980822702120150331223520&amp;originationContext=document&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 21"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">1 </span>Case that cites this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6bfd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6c0d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII</a></span><span class="co_headnoteTopicKey">Patent Infringement</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6c1d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII(C)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII(C)</a></span><span class="co_headnoteTopicKey">Actions</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6c2d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII(C)6/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII(C)6</a></span><span class="co_headnoteTopicKey">Judgment</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6c3d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1939/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1939</a></span><span class="co_headnoteTopicKey">Relief from Judgment</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6c4d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1942/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1942</a></span><span class="co_headnoteTopicKey">New trial;  amendment</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k323.3)</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2019808227022"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F222019808227"><span class="co_headnoteNumber" id="co_anchor_headNote_22"><a href="#co_anchor_B222019808227" class="co_internalLink">22</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EXEBG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EXGBG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k488/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Extent of similarity or difference between prior art and claimed invention in general</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Product-by-process claim can be anticipated by prior art product that does not adhere to claim's process limitation. <input id="co_docMarker_3" type="hidden"><a id="co_link_I4aede6ccd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RB&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_8b3b0000958a4">35 U.S.C.A. § 102(a)</a>.</div></div><div id="co_headnoteId_201980822702220150331223520" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EMHBG" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;headnoteId=201980822702220150331223520&amp;originationContext=document&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 22"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">9 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6c6d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6c7d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II</a></span><span class="co_headnoteTopicKey">Patentability and Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6c8d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(C)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(C)</a></span><span class="co_headnoteTopicKey">Novelty;  Anticipation</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6c9d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(C)1/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(C)1</a></span><span class="co_headnoteTopicKey">In General</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6cad82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k483/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k483</a></span><span class="co_headnoteTopicKey">Prior Art and Relation of Claimed Invention Thereto</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6cbd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k488/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k488</a></span><span class="co_headnoteTopicKey">Extent of similarity or difference between prior art and claimed invention in general</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k72(1))</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2019808227023"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F232019808227"><span class="co_headnoteNumber" id="co_anchor_headNote_23"><a href="#co_anchor_B232019808227" class="co_internalLink">23</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EIIBG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0E5JBG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1555/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">In general;  comparison with patent claims</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Process terms in product-by-process claims serve as limitations in determining infringement.</div></div><div id="co_headnoteId_201980822702320150331223520" class="co_headnoteCitedCaseRef"><a id="co_link_ID0ETKBG" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;headnoteId=201980822702320150331223520&amp;originationContext=document&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 23"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">2 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6cdd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6ced82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII</a></span><span class="co_headnoteTopicKey">Patent Infringement</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6cfd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII(A)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII(A)</a></span><span class="co_headnoteTopicKey">In General</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6d0d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1554/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1554</a></span><span class="co_headnoteTopicKey">Substantial Identity of Subject Matter</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6d1d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1555/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1555</a></span><span class="co_headnoteTopicKey">In general;  comparison with patent claims</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k226.6)</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2019808227024"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F242019808227"><span class="co_headnoteNumber" id="co_anchor_headNote_24"><a href="#co_anchor_B242019808227" class="co_internalLink">24</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EFLBG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0E2MBG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1555/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">In general;  comparison with patent claims</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Product-by-process claim is not infringed by product made by process other than that recited in claim.</div></div><div id="co_headnoteId_201980822702420150331223520" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EQNBG" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;headnoteId=201980822702420150331223520&amp;originationContext=document&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 24"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">16 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6d2d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6d3d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII</a></span><span class="co_headnoteTopicKey">Patent Infringement</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6d4d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII(A)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII(A)</a></span><span class="co_headnoteTopicKey">In General</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6d5d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1554/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1554</a></span><span class="co_headnoteTopicKey">Substantial Identity of Subject Matter</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6d6d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1555/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1555</a></span><span class="co_headnoteTopicKey">In general;  comparison with patent claims</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k226.6)</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2019808227025"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F252019808227"><span class="co_headnoteNumber" id="co_anchor_headNote_25"><a href="#co_anchor_B252019808227" class="co_internalLink">25</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0ECOBG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0ECQBG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k488/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Extent of similarity or difference between prior art and claimed invention in general</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Patent is invalid if product made by process recited in product-by-process claim is anticipated by or obvious from prior art products, even if those prior art products are made by different processes.</div></div><div id="co_headnoteId_201980822702520150331223520" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EXQBG" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;headnoteId=201980822702520150331223520&amp;originationContext=document&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 25"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">18 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6d7d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6d8d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II</a></span><span class="co_headnoteTopicKey">Patentability and Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6d9d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(C)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(C)</a></span><span class="co_headnoteTopicKey">Novelty;  Anticipation</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6dad82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(C)1/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(C)1</a></span><span class="co_headnoteTopicKey">In General</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6dbd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k483/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k483</a></span><span class="co_headnoteTopicKey">Prior Art and Relation of Claimed Invention Thereto</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6dcd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k488/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k488</a></span><span class="co_headnoteTopicKey">Extent of similarity or difference between prior art and claimed invention in general</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k72(1))</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2019808227026"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F262019808227"><span class="co_headnoteNumber" id="co_anchor_headNote_26"><a href="#co_anchor_B262019808227" class="co_internalLink">26</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EJRBG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0E6SBG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1638/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Genes and genetic technology</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">In order for patentee to establish that competitor's EPO product infringed on its patents relating to production of erythropoietin (EPO) using recombinant deoxyribonucleic acid (DNA) technology, it was not necessary for patentee to show that competitor's product possessed novel structure that distinguished recombinant EPO from urinary EPO described in prior art, even though court required source limitations to impart novel structure onto EPO for validity purposes. <a id="co_link_I4aede6e2d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS102&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RB&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_8b3b0000958a4">35 U.S.C.A. § 102(a)</a>.</div></div><div id="co_headnoteId_201980822702620150331223520" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EUTBG" class="co_link co_excludeAnnotations co_disableHighlightFeatures co_hideState" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;headnoteId=201980822702620150331223520&amp;originationContext=document&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 26"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">0 </span>Case that cites this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6ddd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6ded82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII</a></span><span class="co_headnoteTopicKey">Patent Infringement</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6dfd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII(B)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII(B)</a></span><span class="co_headnoteTopicKey">Particular Fields of Invention</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6e0d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1636/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1636</a></span><span class="co_headnoteTopicKey">Biological Subject Matter;  Biotechnology</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6e1d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1638/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1638</a></span><span class="co_headnoteTopicKey">Genes and genetic technology</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k250)</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2019808227027"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F272019808227"><span class="co_headnoteNumber" id="co_anchor_headNote_27"><a href="#co_anchor_B272019808227" class="co_internalLink">27</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EQUBG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EGWBG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k824/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Questions of law or fact</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Patent's indefiniteness is question of law. <a id="co_link_I4aede6e8d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS112&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C.A. § 112</a>.</div></div><div id="co_headnoteId_201980822702720150331223520" class="co_headnoteCitedCaseRef"><a id="co_link_ID0E2WBG" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;headnoteId=201980822702720150331223520&amp;originationContext=document&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 27"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">10 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6e3d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6e4d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II</a></span><span class="co_headnoteTopicKey">Patentability and Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6e5d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(F)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(F)</a></span><span class="co_headnoteTopicKey">Other Challenges to Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6e6d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k815/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k815</a></span><span class="co_headnoteTopicKey">Ambiguity, Uncertainty, or Indefiniteness</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6e7d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k824/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k824</a></span><span class="co_headnoteTopicKey">Questions of law or fact</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k314(5))</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2019808227028"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F282019808227"><span class="co_headnoteNumber" id="co_anchor_headNote_28"><a href="#co_anchor_B282019808227" class="co_internalLink">28</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EWXBG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0E5YBG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k815/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Ambiguity, Uncertainty, or Indefiniteness</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">If patent claim fails to reasonably apprise one skilled in art of claim's boundaries when read in light of specification, then claim is invalid for indefiniteness.</div></div><div id="co_headnoteId_201980822702820150331223520" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EB1BG" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;headnoteId=201980822702820150331223520&amp;originationContext=document&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 28"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">3 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6e9d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6ead82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II</a></span><span class="co_headnoteTopicKey">Patentability and Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6ebd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(F)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(F)</a></span><span class="co_headnoteTopicKey">Other Challenges to Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6ecd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k815/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k815</a></span><span class="co_headnoteTopicKey">Ambiguity, Uncertainty, or Indefiniteness</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6edd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k816/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k816</a></span><span class="co_headnoteTopicKey">In general</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k101(6))</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2019808227029"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F292019808227"><span class="co_headnoteNumber" id="co_anchor_headNote_29"><a href="#co_anchor_B292019808227" class="co_internalLink">29</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0ET1BG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EJ3BG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k822/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Particular products or processes</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Court's construction of claim in patent for production of erythropoietin (EPO) purified by recombinant deoxyribonucleic acid (DNA) technology as describing protein having “amino acid sequence of human” EPO did not render claim indefinite, even though no one knew amino acid sequence of human EPO at time of invention, where specification defined human EPO as having same amino acid sequence as naturally occurring EPO and being produced by process described in example, and ordinarily skilled artisan would have understood claim's boundaries. <input id="co_docMarker_4" type="hidden"><a id="co_link_I4aede6f3d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS112&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C.A. § 112</a>.</div></div><div id="co_headnoteId_201980822702920150331223520" class="co_headnoteCitedCaseRef"><a id="co_link_ID0E53BG" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;headnoteId=201980822702920150331223520&amp;originationContext=document&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 29"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">1 </span>Case that cites this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6eed82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6efd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II</a></span><span class="co_headnoteTopicKey">Patentability and Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6f0d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(F)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(F)</a></span><span class="co_headnoteTopicKey">Other Challenges to Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6f1d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k815/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k815</a></span><span class="co_headnoteTopicKey">Ambiguity, Uncertainty, or Indefiniteness</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6f2d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k822/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k822</a></span><span class="co_headnoteTopicKey">Particular products or processes</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k101(6))</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2019808227030"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F302019808227"><span class="co_headnoteNumber" id="co_anchor_headNote_30"><a href="#co_anchor_B302019808227" class="co_internalLink">30</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EZ4BG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EP6BG" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k822/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Particular products or processes</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Source limitations did not render indefinite asserted claims of patents relating to production of erythropoietin (EPO) using recombinant deoxyribonucleic acid (DNA) technology, even though asserted claims were found not to be anticipated by urinary EPO on ground that recombinant EPO and urinary EPO were structurally and functionally distinct, and those structural and functional distinctions were not stated on claims' face, where court construed source as limitation of asserted claims and found that source imparted structural and functional features not possessed by EPO purified from urine. <a id="co_link_I4aede6f9d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS112&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C.A. § 112</a>.</div></div><div id="co_headnoteId_201980822703020150331223520" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EFAAI" class="co_link co_excludeAnnotations co_disableHighlightFeatures co_hideState" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;headnoteId=201980822703020150331223520&amp;originationContext=document&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 30"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">0 </span>Case that cites this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6f4d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6f5d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II</a></span><span class="co_headnoteTopicKey">Patentability and Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6f6d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(F)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(F)</a></span><span class="co_headnoteTopicKey">Other Challenges to Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6f7d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k815/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k815</a></span><span class="co_headnoteTopicKey">Ambiguity, Uncertainty, or Indefiniteness</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6f8d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k822/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k822</a></span><span class="co_headnoteTopicKey">Particular products or processes</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k101(6))</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2019808227031"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F312019808227" tabindex="0"><span class="co_headnoteNumber" id="co_anchor_headNote_31"><a href="#co_anchor_B312019808227" class="co_internalLink">31</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EFBAI" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0E2CAI" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k445/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Products or results</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Findings of fact that go to question of validity of product-by-process claims do not automatically become part of claim construction.</div></div><div id="co_headnoteId_201980822703120150331223520" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EQDAI" class="co_link co_excludeAnnotations co_disableHighlightFeatures co_hideState" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;headnoteId=201980822703120150331223520&amp;originationContext=document&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 31"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">0 </span>Case that cites this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6fad82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6fbd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II</a></span><span class="co_headnoteTopicKey">Patentability and Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6fcd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(B)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(B)</a></span><span class="co_headnoteTopicKey">Eligible Subject Matter</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6fdd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k442/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k442</a></span><span class="co_headnoteTopicKey">Classes of Invention or Discovery;  Statutory Subject Matter</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6fed82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k445/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k445</a></span><span class="co_headnoteTopicKey">Products or results</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k101(11))</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2019808227032"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F322019808227"><span class="co_headnoteNumber" id="co_anchor_headNote_32"><a href="#co_anchor_B322019808227" class="co_internalLink">32</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0ECEAI" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EUFAI" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1848/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Questions of law or fact</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Patent infringement is question of fact.</div></div><div id="co_headnoteId_201980822703220150331223520" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EJGAI" class="co_link co_excludeAnnotations co_disableHighlightFeatures co_hideState" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;headnoteId=201980822703220150331223520&amp;originationContext=document&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 32"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">0 </span>Case that cites this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede6ffd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede700d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII</a></span><span class="co_headnoteTopicKey">Patent Infringement</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede701d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII(C)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII(C)</a></span><span class="co_headnoteTopicKey">Actions</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede702d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII(C)4/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII(C)4</a></span><span class="co_headnoteTopicKey">Trial, Hearing, and Determination</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede703d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1848/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1848</a></span><span class="co_headnoteTopicKey">Questions of law or fact</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k314(5))</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2019808227033"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F332019808227"><span class="co_headnoteNumber" id="co_anchor_headNote_33"><a href="#co_anchor_B332019808227" class="co_internalLink">33</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0E2GAI" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0ERIAI" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1555/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">In general;  comparison with patent claims</a></span></div><div class="co_secondaryHeadnoteNodes"> <span class="co_hiddenKeyText"><strong><a id="co_link_ID0EGJAI" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0E3KAI" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1574/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Substitution of Equivalents</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">To prove patent infringement, patentee must show that accused product embodies all limitations of claim either literally or by doctrine of equivalents (DOE).</div></div><div id="co_headnoteId_201980822703320150331223520" class="co_headnoteCitedCaseRef"><a id="co_link_ID0E6LAI" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;headnoteId=201980822703320150331223520&amp;originationContext=document&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 33"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">39 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede704d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede705d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII</a></span><span class="co_headnoteTopicKey">Patent Infringement</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede706d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII(A)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII(A)</a></span><span class="co_headnoteTopicKey">In General</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede707d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1554/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1554</a></span><span class="co_headnoteTopicKey">Substantial Identity of Subject Matter</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede708d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1555/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1555</a></span><span class="co_headnoteTopicKey">In general;  comparison with patent claims</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k226.6)</span></span></div></div></div></div></div><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede709d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede70ad82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII</a></span><span class="co_headnoteTopicKey">Patent Infringement</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede70bd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII(A)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII(A)</a></span><span class="co_headnoteTopicKey">In General</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede70cd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1568/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1568</a></span><span class="co_headnoteTopicKey">Patents for Machines, Products, or Devices</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede70dd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1574/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1574</a></span><span class="co_headnoteTopicKey">Substitution of Equivalents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede70ed82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1574(1)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1574(1)</a></span><span class="co_headnoteTopicKey">In general</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k237)</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2019808227034"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F342019808227"><span class="co_headnoteNumber" id="co_anchor_headNote_34"><a href="#co_anchor_B342019808227" class="co_internalLink">34</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0ERMAI" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EHOAI" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1555/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">In general;  comparison with patent claims</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">If any claim limitation is absent from accused device, there is no literal patent infringement as matter of law.</div></div><div id="co_headnoteId_201980822703420150331223520" class="co_headnoteCitedCaseRef"><a id="co_link_ID0E3OAI" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;headnoteId=201980822703420150331223520&amp;originationContext=document&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 34"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">20 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede70fd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede710d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII</a></span><span class="co_headnoteTopicKey">Patent Infringement</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede711d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII(A)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII(A)</a></span><span class="co_headnoteTopicKey">In General</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede712d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1554/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1554</a></span><span class="co_headnoteTopicKey">Substantial Identity of Subject Matter</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede713d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1555/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1555</a></span><span class="co_headnoteTopicKey">In general;  comparison with patent claims</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k226.6)</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2019808227035"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F352019808227"><span class="co_headnoteNumber" id="co_anchor_headNote_35"><a href="#co_anchor_B352019808227" class="co_internalLink">35</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EOPAI" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EWQAI" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1636/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Biological Subject Matter;  Biotechnology</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Accused product comprised human erythropoietin (EPO), and thus literally infringed patent relating to production of human EPO purified from mammalian cells grown in culture, even though accused product was not produced and purified from mammalian cells, and had hydrogen atom removed from human EPO, where accused product comprised protein having same amino acid sequence as human EPO, patent specifications contemplated attachment of additional molecules, and epoetin beta used as starting ingredient for accused product was produced in and purified from mammalian cells grown in culture.</div></div><div id="co_headnoteId_201980822703520150331223520" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EZRAI" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;headnoteId=201980822703520150331223520&amp;originationContext=document&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 35"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">1 </span>Case that cites this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede714d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede715d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII</a></span><span class="co_headnoteTopicKey">Patent Infringement</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede716d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII(B)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII(B)</a></span><span class="co_headnoteTopicKey">Particular Fields of Invention</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede717d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1636/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1636</a></span><span class="co_headnoteTopicKey">Biological Subject Matter;  Biotechnology</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede718d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1637/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1637<input id="co_docMarker_5" type="hidden"></a></span><span class="co_headnoteTopicKey">In general</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k250)</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2019808227036"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F362019808227"><span class="co_headnoteNumber" id="co_anchor_headNote_36"><a href="#co_anchor_B362019808227" class="co_internalLink">36</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0ELSAI" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0E4TAI" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1848/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Questions of law or fact</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Issue of whether human erythropoietin (EPO) in accused product was materially changed by pegylation prior to importation, such that importation of accused product infringed patents relating to EPO production using recombinant deoxyribonucleic acid (DNA) technology, was for jury in patent infringement action, despite alleged infringer's contention that accused product possessed different structures and properties than patented EPO, and was suitable for administration to patients, where there was evidence that accused product contained EPO, that structure of EPO remained intact, that accused product bound to EPO receptor, and that accused product retained its claimed ability to increase production of reticulocytes and red blood cells. <a id="co_link_I4aede71ed82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS271&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RB&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_16f4000091d86">35 U.S.C.A. § 271(g)</a>.</div></div><div id="co_headnoteId_201980822703620150331223520" class="co_headnoteCitedCaseRef"><a id="co_link_ID0ESUAI" class="co_link co_excludeAnnotations co_disableHighlightFeatures co_hideState" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;headnoteId=201980822703620150331223520&amp;originationContext=document&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 36"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">0 </span>Case that cites this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede719d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede71ad82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII</a></span><span class="co_headnoteTopicKey">Patent Infringement</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede71bd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII(C)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII(C)</a></span><span class="co_headnoteTopicKey">Actions</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede71cd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII(C)4/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII(C)4</a></span><span class="co_headnoteTopicKey">Trial, Hearing, and Determination</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede71dd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1848/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1848</a></span><span class="co_headnoteTopicKey">Questions of law or fact</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k314(5))</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2019808227037"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F372019808227"><span class="co_headnoteNumber" id="co_anchor_headNote_37"><a href="#co_anchor_B372019808227" class="co_internalLink">37</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EOVAI" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EOXAI" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1942/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">New trial;  amendment</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Alleged infringer was not entitled to new trial in action alleging infringement of patents relating to human erythropoietin (EPO) production using recombinant deoxyribonucleic acid (DNA) technology due to fact that court instructed jury that it could consider whether accused product would function if not made by patented process, where accused product's biological function was relevant consideration in assessing whether pegylation was material change, and court effectively instructed jury that it could consider whether accused product's biological function depended on its EPO component produced according to patented process.</div></div><div id="co_headnoteId_201980822703720150331223520" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EDYAI" class="co_link co_excludeAnnotations co_disableHighlightFeatures co_hideState" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;headnoteId=201980822703720150331223520&amp;originationContext=document&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 37"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">0 </span>Case that cites this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede71fd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede720d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII</a></span><span class="co_headnoteTopicKey">Patent Infringement</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede721d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII(C)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII(C)</a></span><span class="co_headnoteTopicKey">Actions</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede722d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII(C)6/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII(C)6</a></span><span class="co_headnoteTopicKey">Judgment</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede723d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1939/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1939</a></span><span class="co_headnoteTopicKey">Relief from Judgment</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede724d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1942/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1942</a></span><span class="co_headnoteTopicKey">New trial;  amendment</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k323.3)</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2019808227038"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F382019808227"><span class="co_headnoteNumber" id="co_anchor_headNote_38"><a href="#co_anchor_B382019808227" class="co_internalLink">38</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EVYAI" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EL1AI" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1574/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Substitution of Equivalents</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Accused device that does not literally infringe patent claim may still infringe under doctrine of equivalents if each limitation of claim is met in accused device either literally or equivalently.</div></div><div id="co_headnoteId_201980822703820150331223520" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EO2AI" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;headnoteId=201980822703820150331223520&amp;originationContext=document&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 38"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">48 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede725d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede726d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII</a></span><span class="co_headnoteTopicKey">Patent Infringement</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede727d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII(A)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII(A)</a></span><span class="co_headnoteTopicKey">In General</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede728d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1568/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1568</a></span><span class="co_headnoteTopicKey">Patents for Machines, Products, or Devices</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede729d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1574/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1574</a></span><span class="co_headnoteTopicKey">Substitution of Equivalents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede72ad82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1574(1)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1574(1)</a></span><span class="co_headnoteTopicKey">In general</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k237)</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2019808227039"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F392019808227"><span class="co_headnoteNumber" id="co_anchor_headNote_39"><a href="#co_anchor_B392019808227" class="co_internalLink">39</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EA3AI" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EW4AI" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1574/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Substitution of Equivalents</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Element in accused product is “equivalent” to patent claim limitation if differences between them are insubstantial to one of ordinary skill in art.</div></div><div id="co_headnoteId_201980822703920150331223520" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EZ5AI" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;headnoteId=201980822703920150331223520&amp;originationContext=document&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 39"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">15 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede72bd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede72cd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII</a></span><span class="co_headnoteTopicKey">Patent Infringement</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede72dd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII(A)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII(A)</a></span><span class="co_headnoteTopicKey">In General</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede72ed82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1568/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1568</a></span><span class="co_headnoteTopicKey">Patents for Machines, Products, or Devices</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede72fd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1574/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1574</a></span><span class="co_headnoteTopicKey">Substitution of Equivalents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede730d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1574(1)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1574(1)</a></span><span class="co_headnoteTopicKey">In general</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k237)</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2019808227040"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F402019808227"><span class="co_headnoteNumber" id="co_anchor_headNote_40"><a href="#co_anchor_B402019808227" class="co_internalLink">40</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EU6AI" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EKBBI" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1574/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Substitution of Equivalents</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">To support finding of infringement under doctrine of equivalents, patentee must present, on limitation-by-limitation basis, particularized testimony and linking argument as to insubstantiality of differences between claimed invention and accused product, or with respect to function, way, result test.</div></div><div id="co_headnoteId_201980822704020150331223520" class="co_headnoteCitedCaseRef"><a id="co_link_ID0ENCBI" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;headnoteId=201980822704020150331223520&amp;originationContext=document&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 40"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">17 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede731d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede732d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII</a></span><span class="co_headnoteTopicKey">Patent Infringement</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede733d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII(A)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII(A)</a></span><span class="co_headnoteTopicKey">In General</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede734d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1568/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1568</a></span><span class="co_headnoteTopicKey">Patents for Machines, Products, or Devices</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede735d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1574/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1574</a></span><span class="co_headnoteTopicKey">Substitution of Equivalents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede736d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1574(1)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1574(1)</a></span><span class="co_headnoteTopicKey">In general</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k237)</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2019808227041"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F412019808227"><span class="co_headnoteNumber" id="co_anchor_headNote_41"><a href="#co_anchor_B412019808227" class="co_internalLink">41</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0E6CBI" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EVEBI" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1638/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Genes and genetic technology</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Patentee's expert's statements relating to literal infringement of process claims in patents relating to human erythropoietin (EPO) production using recombinant deoxyribonucleic acid (DNA) technology did not constitute particularized testimony of equivalents of therapeutic efficacy limitation in patentee's pharmaceutical composition claim, where expert report lacked limitation-by-limitation analysis.<input id="co_docMarker_6" type="hidden"></div></div><div id="co_headnoteId_201980822704120150331223520" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EKFBI" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;headnoteId=201980822704120150331223520&amp;originationContext=document&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 41"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">4 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede737d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede738d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII</a></span><span class="co_headnoteTopicKey">Patent Infringement</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede739d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII(B)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII(B)</a></span><span class="co_headnoteTopicKey">Particular Fields of Invention</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede73ad82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1636/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1636</a></span><span class="co_headnoteTopicKey">Biological Subject Matter;  Biotechnology</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede73bd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1638/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1638</a></span><span class="co_headnoteTopicKey">Genes and genetic technology</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k230)</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2019808227042"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F422019808227"><span class="co_headnoteNumber" id="co_anchor_headNote_42"><a href="#co_anchor_B422019808227" class="co_internalLink">42</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0E3FBI" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EOHBI" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1848/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Questions of law or fact</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Issue of whether accused product infringed patent claim covering process of producing erythropoietin (EPO) from cultured vertebrate cells that produce human EPO in excess of 100 U of EPO per 10 <sup>6</sup> cells in 48 hours as determined by radioimmunoassay (RIA) was for jury, even though patentee's expert relied on enzyme-linked immunoabsorbent assay (ELISA) data in alleged infringer's Food and Drug Administration (FDA) submissions to arrive at his conclusion that accused product was made by vertebrate cells that produced approximately 1,500 units of EPO per 10 <sup>6</sup> cells in 48 hours, where expert testified that RIA and ELISA yielded very similar, if not identical, results, and comparison test indicated that production of accused product met patent's production-rate limitation.</div></div><div id="co_headnoteId_201980822704220150331223520" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EDIBI" class="co_link co_excludeAnnotations co_disableHighlightFeatures co_hideState" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;headnoteId=201980822704220150331223520&amp;originationContext=document&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 42"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">0 </span>Case that cites this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede73cd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede73dd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII</a></span><span class="co_headnoteTopicKey">Patent Infringement</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede73ed82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII(C)/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII(C)</a></span><span class="co_headnoteTopicKey">Actions</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede73fd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII(C)4/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII(C)4</a></span><span class="co_headnoteTopicKey">Trial, Hearing, and Determination</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede740d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1848/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1848</a></span><span class="co_headnoteTopicKey">Questions of law or fact</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k314(5))</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2019808227501"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_2019808227"><span class="co_headnoteNumber" id="co_anchor_headNote_43">43</span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0E1IBI" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EYJBI" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k2091/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">In general;  utility</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText"><a id="co_link_I4aede744d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1987255753&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0ef6725072dd11d7b0409d11d16b6b13&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">US Patent 4,703,008</a>, <a id="co_link_I4aede745d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1995342658&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I6eeb62d0722711d7ba84e3942a4b620d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">US Patent 5,441,868</a>, <a id="co_link_I4aede746d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">US Patent 5,618,698</a>, <a id="co_link_I4aede747d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998398894&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I9866fae0724311d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">US Patent 5,756,349</a>. Cited.</div></div><div id="co_headnoteId_201980822750120150331223520" class="co_headnoteCitedCaseRef"><a id="co_link_ID0ENKBI" class="co_link co_excludeAnnotations co_disableHighlightFeatures co_hideState" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;headnoteId=201980822750120150331223520&amp;originationContext=document&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 43"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">0 </span>Case that cites this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede741d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede742d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291X/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291X</a></span><span class="co_headnoteTopicKey">Patents Enumerated</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede743d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k2091/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k2091</a></span><span class="co_headnoteTopicKey">In general;  utility</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k328(2))</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2019808227502"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_2019808227_0"><span class="co_headnoteNumber" id="co_anchor_headNote_44">44</span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EBMBI" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0E6MBI" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k2091/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">In general;  utility</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText"><a id="co_link_I4aede74bd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1996374737&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I18611aa072d011d7ba84e3942a4b620d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">US Patent 5,547,933</a>. Not Infringed.</div></div><div id="co_headnoteId_201980822750220150331223520" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EUNBI" class="co_link co_excludeAnnotations co_disableHighlightFeatures co_hideState" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;headnoteId=201980822750220150331223520&amp;originationContext=document&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 44"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">0 </span>Case that cites this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede748d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede749d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291X/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291X</a></span><span class="co_headnoteTopicKey">Patents Enumerated</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede74ad82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k2091/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k2091</a></span><span class="co_headnoteTopicKey">In general;  utility</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k328(2))</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2019808227503"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_2019808227_1"><span class="co_headnoteNumber" id="co_anchor_headNote_45">45</span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0ENOBI" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0ELPBI" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k2091/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">In general;  utility</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText"><a id="co_link_I4aede74fd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999386170&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I804ca47072e611d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">US Patent 5,955,422</a>. Infringed.</div></div><div id="co_headnoteId_201980822750320150331223520" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EAQBI" class="co_link co_excludeAnnotations co_disableHighlightFeatures co_hideState" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;headnoteId=201980822750320150331223520&amp;originationContext=document&amp;docSource=9215f2df364c46cd90476a95a1bde2b7&amp;rank=170&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 45"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">0 </span>Case that cites this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede74cd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede74dd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291X/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291X</a></span><span class="co_headnoteTopicKey">Patents Enumerated</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I4aede74ed82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k2091/View.html?docGuid=Ie59924e3a21711dea82ab9f4ee295c21&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k2091</a></span><span class="co_headnoteTopicKey">In general;  utility</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k328(2))</span></span></div></div></div></div></div></div><div class="co_clear"></div></div></div></div><div> </div></div><a id="co_headnotesEnd"></a><h2 class="co_attorneyBlockLabel co_printHeading co_briefItState" id="co_attorneysAndLawFirms">Attorneys and Law Firms</h2><div class="co_contentBlock co_briefItState co_attorneyBlock"><div> <span class="co_starPage" id="co_pp_sp_506_1345"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sf679c9a4b2a811de9988d233d23fe599&quot;, &quot;pageNumber&quot;: &quot;1345&quot; }" alt="metadata" type="hidden">*1345</span> <a id="co_link_I4aede750d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0342110801&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Lloyd R. Day, Jr.</a>, Day Casebeer Madrid &amp; Batchelder LLP, of Cupertino, CA, argued for plaintiff-cross appellant. With him on the brief were <a id="co_link_I4aede751d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0356594601&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">David M. Madrid</a>, <a id="co_link_I4aede752d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0126625701&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Linda A. Sasaki–Baxley</a> and <a id="co_link_I4aede753d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0380583801&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Jonathan D. Loeb</a>. of counsel on the brief were <a id="co_link_I4aede754d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0102280101&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Stuart L. Watt</a>, <a id="co_link_I4aede755d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0232556501&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Wendy A. Whiteford</a> and <a id="co_link_I4aede756d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0319274501&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Erica S. Olson</a>, Amgen Inc., of Thousand Oaks, CA; <a id="co_link_I4aede757d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0111337101&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Cecilia H. Gonzalez</a> and <a id="co_link_I4aede758d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0316682301&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Margaret D. MacDonald</a>, Howrey LLP, of Washington, DC. Of counsel was <a id="co_link_I4aede759d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0253280301&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Christian E. Mammen</a>, Day Casebeer Madrid &amp; Batchelder LLP, of Cupertino, CA.</div><div><a id="co_link_I4aede75ad82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0251979601&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Leora Ben–Ami</a>, Kaye Scholer LLP, of New York, NY, argued for defendants-appellants. With her on the brief were <a id="co_link_I4aede75bd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0142262801&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Thomas F. Fleming</a>, <a id="co_link_I4aede75cd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0158463901&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patricia A. Carson</a>, <a id="co_link_I4aede75dd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0342987301&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Christopher T. Jagoe, Sr.</a> and Howard S. Suh. Of counsel on the brief were <a id="co_link_I4aede75ed82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0195202101&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Lee Carl Bromberg</a>, <a id="co_link_I4aede75fd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0151000301&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Timothy M. Murphy</a> and <a id="co_link_I4aee0bc0d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0138535801&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Julia Huston</a>, Bromberg &amp; Sunstein LLP, of Boston, MA. Of counsel were <a id="co_link_I4aee0bc1d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0363062601&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Daniel Forchheimer</a>, <a id="co_link_I4aee0bc2d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0366977301&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Matthew McFarlane</a>, and <a id="co_link_I4aee0bc3d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0321333401&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Krista M. Rycroft</a>, Kaye Scholer LLP, of New York, NY; and <a id="co_link_I4aee0bc4d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0377741401&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Kimberly J. Seluga</a>, <a id="co_link_I4aee0bc5d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0377741801&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Nicole Rizzo Smith</a> and <a id="co_link_I4aee0bc6d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0362986001&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Keith E. Toms</a>, Bromberg &amp; Sunstein LLP, of Boston, MA.</div></div><div class="co_contentBlock co_briefItState co_panelBlock"><div>Before <a id="co_link_I4aee0bc7d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0146644601&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">MAYER</a>, <a id="co_link_I4aee0bc8d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0127928601&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">CLEVENGER</a>, and <a id="co_link_I4aee0bc9d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0144380101&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">SCHALL</a>, Circuit Judges.</div></div><div class="co_contentBlock co_briefItState co_opinionBlock"><h2 id="co_opinion" class="co_printHeading">Opinion</h2><div class="co_docDelivery_dottedLine"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/co_docDelivery_dottedLine.png" alt=""></div><div class="co_contentBlock x_opinionBlockBody"><div class="co_contentBlock x_opinionLead"><div class="co_contentBlock x_leadAuthorLineBlock"><div class="co_contentBlock x_leadAuthorLine"><a id="co_link_I4aee0bcad82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0144380101&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">SCHALL</a>, Circuit Judge.</div></div><div class="co_contentBlock x_opinionBody"><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I17113af7d82d11e498db8b09b4f043e0"><div class="co_paragraph"><div class="co_paragraphText">This is a patent case. Amgen Inc. (“Amgen”) is the owner of  <span class="co_starPage" id="co_pp_sp_506_1346"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sf679c9a4b2a811de9988d233d23fe599&quot;, &quot;pageNumber&quot;: &quot;1346&quot; }" alt="metadata" type="hidden">*1346</span> <a id="co_link_I4aee0bcbd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1995342658&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I6eeb62d0722711d7ba84e3942a4b620d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">U.S. Patent Nos. 5,441,868 (“the ′868 patent”)</a>, <a id="co_link_I4aee0bccd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1996374737&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I18611aa072d011d7ba84e3942a4b620d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">5,547,933 (“the ′933 patent”)</a>, <a id="co_link_I4aee0bcdd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">5,618,698 (“the ′698 patent”)</a>, <a id="co_link_I4aee0bced82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998398894&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I9866fae0724311d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">5,756,349 (“the ′349 patent”)</a>, and <a id="co_link_I4aee0bcfd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999386170&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I804ca47072e611d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">5,955,422 (“the ′422 patent”)</a>. The patents relate to the production of the protein erythropoietin (“EPO”) using recombinant deoxyribonucleic acid (“DNA”) technology. All five patents share a common specification and descend from Application No. 06/675,298 (“the ′298 application”), which issued as now-expired <a id="co_link_I4aee0bd0d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1987255753&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0ef6725072dd11d7b0409d11d16b6b13&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">U.S. Patent No. 4,703,008 (“the ′008 patent”)</a>.</div></div><div class="co_paragraph"><div class="co_paragraphText">In November of 2005, Amgen brought a declaratory judgment action against F. Hoffman–La Roche Ltd, Roche Diagnostics GMBH, and Hoffman–La Roche Inc.<input id="co_docMarker_7" type="hidden"> (“Roche”) in the United States District Court for the District of Massachusetts, alleging that Roche's product, MIRCERA®, would infringe Amgen's five patents if imported into the United States. Roche responded with affirmative defenses and counterclaims that Amgen's asserted patents were invalid and not infringed. In October of 2008, following rulings of summary judgment and judgment as a matter of law (“JMOL”), and a jury trial, the court entered judgment that the ′868, ′933, ′698, and ′<a id="co_link_I4aee0bd1d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999386170&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I804ca47072e611d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">422 patents</a> were infringed and not invalid, and that the ′<a id="co_link_I4aee0bd2d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998398894&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I9866fae0724311d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">349 patent</a> was neither invalid nor infringed. <em>Amgen, Inc. v. F. Hoffman–La Roche Ltd.,</em> No. 05–12237–WGY, slip op. at 1–2 (D.Mass. Oct. 17, 2008) (“<em>Final Judgment</em> ”). Accordingly, the court granted Amgen declaratory relief and permanently enjoined Roche from marketing MIRCERA® in the United States. <em>Id.</em></div></div><div class="co_paragraph"><div class="co_paragraphText">Roche appeals from several rulings of the court. Specifically, Roche challenges the court's rulings that none of the claims-in-suit were invalid for obviousness-type double patenting, <a id="co_link_I4aee0bd5d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;pubNum=0004637&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_4637_173&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_4637_173"><em>Amgen, Inc. v. F. Hoffman–La Roche Ltd.,</em> 581 F.Supp.2d 160, 173, 186, 192 (D.Mass.2008)</a>; and that claim 1 of the ′<a id="co_link_I4aee0bd6d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999386170&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I804ca47072e611d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"> 422 patent</a> was neither anticipated nor indefinite and infringed, <a id="co_link_I4aee0bd7d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>id.</em> at 194, 198, 204.</a> Roche also challenges the court's rulings sustaining the jury's verdict that claims 3, 7, and 8 of the ′<a id="co_link_I4aee0bd8d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1996374737&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I18611aa072d011d7ba84e3942a4b620d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">933 patent</a> were neither anticipated nor indefinite; and that claims 3, 7, and 8 of the ′<a id="co_link_I4aee0bd9d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1996374737&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I18611aa072d011d7ba84e3942a4b620d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">933 patent</a>, claims 1 and 2 of the ′<a id="co_link_I4aee0bdad82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1995342658&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I6eeb62d0722711d7ba84e3942a4b620d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">868 patent</a>, and claims 6–9 of the ′<a id="co_link_I4aee0bdbd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">698 patent</a> were literally infringed.</div></div><div class="co_paragraph"><div class="co_paragraphText">Amgen cross-appeals from the court's rulings that claim 7 of the ′<a id="co_link_I4aee0bdcd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998398894&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I9866fae0724311d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">349 patent</a> and claims 9, 11, and 14 of the ′<a id="co_link_I4aee0bddd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1996374737&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I18611aa072d011d7ba84e3942a4b620d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">933 patent</a> were not infringed. Amgen also cross-appeals from the court's ruling vacating the jury's verdict that claim 12 of the ′<a id="co_link_I4aee0bded82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1996374737&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I18611aa072d011d7ba84e3942a4b620d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">933 patent</a> was infringed under the doctrine of equivalents (“DOE”). <a id="co_link_I4aee0bdfd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 205.</a></div></div><div class="co_paragraph"><div class="co_paragraphText">We vacate the court's grant of summary judgment and of JMOL to Amgen of no invalidity for obviousness-type double patenting of claims 3, 7, and 8 of the ′<a id="co_link_I4aee0be0d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1996374737&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I18611aa072d011d7ba84e3942a4b620d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"> 933 patent</a>; claim 1 of the ′<a id="co_link_I4aee0be1d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999386170&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I804ca47072e611d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">422 patent</a>; and claim 7 of the ′<a id="co_link_I4aee0be2d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998398894&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I9866fae0724311d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"> 349 patent</a>. We therefore remand to the district court for an obviousness-type double patenting analysis of those claims in light of this opinion. We also vacate the court's grant of JMOL to Roche of non-infringement of claim 7 of the ′<a id="co_link_I4aee0be3d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998398894&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I9866fae0724311d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">349 patent</a> and remand to the district for a new trial on infringement of that claim. We affirm the court's judgment in all other respects.</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I17113af8d82d11e498db8b09b4f043e0"><div class="co_headtext co_hAlign2"><span class="co_smallCaps">BACKGROUND</span></div><div class="co_headtext co_hAlign2"><span class="co_smallCaps">I</span></div><div class="co_paragraph"><div class="co_paragraphText">As noted, the patents at issue relate to the production of EPO using <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=mproc&amp;entityId=Iaa1b6aec475411db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_Iaa1b6aec475411db9765f9243f53508a">recombinant DNA technology</a>. EPO, which is a naturally occurring protein (or polypeptide), stimulates the production of red blood cells through a process called erythropoiesis. <a id="co_link_I4aee0be5d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;pubNum=4637&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_4637_168&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_4637_168"><em>Amgen,</em> 581 F.Supp.2d at 168.</a> The production of EPO is useful in treating <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=disease&amp;entityId=Icb1f90cf475411db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_Icb1f90cf475411db9765f9243f53508a">blood disorders</a> characterized by a low hematocrit, which is a low ratio of red blood cells to total blood cells. <a id="co_link_I4aee0be7d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> One such <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=disease&amp;entityId=Icb1f90cf475411db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_Icb1f90cf475411db9765f9243f53508a_0">blood disorder</a> is <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=disease&amp;entityId=Ib2202ec4475411db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_Ib2202ec4475411db9765f9243f53508a">anemia</a>. In a clinical study  <span class="co_starPage" id="co_pp_sp_506_1347"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sf679c9a4b2a811de9988d233d23fe599&quot;, &quot;pageNumber&quot;: &quot;1347&quot; }" alt="metadata" type="hidden">*1347</span> performed in 1979–80, Dr. Eugene Goldwasser attempted to treat anemic patients with EPO isolated from human urine. <a id="co_link_I4aee0bead82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 168.</a> He had limited success, however, because the EPO recovered from urine was low-yield, of high impurity, and unstable. <a id="co_link_I4aee0bebd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 168–69.</a></div></div><div class="co_paragraph"><div class="co_paragraphText">Rather than attempting to obtain EPO from natural sources such as human urine, a team of Amgen researchers led by Dr. Fu–Kuen Lin identified a means of producing usable amounts of EPO via recombinant DNA technology. <a id="co_link_I4aee0becd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 169.</a> The common specification of Amgen's patents describes the production of recombinant EPO. <input id="co_docMarker_8" type="hidden">To produce EPO, Dr. Lin made an expression vector carrying the human EPO DNA sequence he had discovered. <em>See</em> ′<a id="co_link_I4aee0bedd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999386170&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I804ca47072e611d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">422 patent</a> col. 11 ll.1–10. An expression vector is a circular piece of DNA that is inserted into a host cell to produce a protein. <a id="co_link_I4aee0beed82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999386170&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> col.2 ll.36–54; figs.2 &amp; 3. He then injected, or transfected, host Chinese hamster ovary (“CHO”) cells with the expression vector. <a id="co_link_I4aee0befd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999386170&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> col. 11 ll.5–10</div></div><div class="co_paragraph"><div class="co_paragraphText">The transfected CHO cells use the EPO DNA sequence to form a protein with the 166 amino acid sequence of EPO shown in Figure 6 of the common specification of the patents. <a id="co_link_I4aee0bf0d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999386170&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> fig.6. Prior to secretion of EPO from the cell, the final amino acid, or the C-terminal amino acid, of the 166 amino acid sequence is cleaved off, leaving a 165 amino acid protein. <a id="co_link_I4aee0bf1d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;pubNum=4637&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_4637_170&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_4637_170"><em>Amgen,</em> 581 F.Supp.2d at 170.</a> Also prior to secretion, carbohydrates are attached to certain sites on EPO in a process called glycosylation, which results in a glycoprotein. <em>Id.</em> Thus, Dr. Lin's transfected CHO cells ultimately yield a glycoprotein with the 165 amino acid sequence of human EPO. <a id="co_link_I4aee0bf3d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> Recombinant EPO produced in this manner can bind to the EPO receptor and stimulate erythropoiesis. <a id="co_link_I4aee0bf4d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 169.</a></div></div><div class="co_paragraph"><div class="co_paragraphText">On November 30, 1984, Amgen submitted to the United States Patent and Trademark Office (“PTO”) the ′298 application, from which Amgen's five patents descend. <a id="co_link_I4aee0bf5d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 180.</a> The ′298 application originally contained claims drawn to, inter alia, DNA sequences, host cells, processes of producing polypeptides, polypeptides, and pharmaceutical compositions. <a id="co_link_I4aee0bf6d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> In 1986, the PTO subjected Amgen's ′298 application to a restriction requirement, which identified claims drawn to DNA, cells, polypeptides, and pharmaceutical compositions as each directed to patentably distinct subject matter. <a id="co_link_I4aee0bf7d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> The PTO examiner stated that, under <a id="co_link_I4aee0bf8d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C. § 121</a>, restriction to one of the following inventions was required:</div><div class="co_paragraph co_indentLeft1 co_indentHanging1"><div class="co_paragraphText">I. Claims 1–13, 16, 39–41, 47–54, and 59, drawn to polypeptide, classified in Class 260, subclass 112.</div></div><div class="co_paragraph co_indentLeft1 co_indentHanging1"><div class="co_paragraphText">II. Claims 14, 15, 17–36, 58, and 61–72, drawn to DNA, classified in Class 536, subclass 27.</div></div><div class="co_paragraph co_indentLeft1 co_indentHanging1"><div class="co_paragraphText">III. Claims 37–38, drawn to plasmid, classified in Class 435, subclass 317.</div></div><div class="co_paragraph co_indentLeft1 co_indentHanging1"><div class="co_paragraphText">IV. Claims 42–46, drawn to cells, classified in Class 435, subclass 240.</div></div><div class="co_paragraph co_indentLeft1 co_indentHanging1"><div class="co_paragraphText">V. Claims 55–57, drawn to pharmaceutical composition, classified in Class 435, subclass 177.</div></div><div class="co_paragraph co_indentLeft1 co_indentHanging1"><div class="co_paragraphText">VI. Claim 60, drawn to assay, classified in Class 435, subclass 6.<sup id="co_footnoteReference_B00112019808227_ID0EQOCI"><a href="#co_footnote_B00112019808227" class="co_footnoteReference">1</a></sup></div></div></div><div class="co_paragraph"><div class="co_paragraphText co_flush"><a id="co_link_I4aee0bfad82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> In response, Amgen elected to prosecute Group II claims in the ′298 application, <span class="co_starPage" id="co_pp_sp_506_1348"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sf679c9a4b2a811de9988d233d23fe599&quot;, &quot;pageNumber&quot;: &quot;1348&quot; }" alt="metadata" type="hidden">*1348</span>  which were drawn to DNA and host cells. <a id="co_link_I4aee0bfbd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> Ultimately, the ′298 application issued on October 27, 1987, as the now-expired ′<a id="co_link_I4aee0bfcd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1987255753&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0ef6725072dd11d7b0409d11d16b6b13&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">008 patent</a> entitled “DNA Sequences Encoding Erythropoietin.” The ′<a id="co_link_I4aee0bfdd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1987255753&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0ef6725072dd11d7b0409d11d16b6b13&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"> 008 patent</a> claimed DNA sequences encoding EPO and host cells transformed or transfected with those DNA sequences. <a id="co_link_I4aee0bfed82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1987255753&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0ef6725072dd11d7b0409d11d16b6b13&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">′008 patent</a> col.40 ll.17–68.</div></div><div class="co_paragraph"><div class="co_paragraphText">On October 23, 1987, subsequent to the restriction requirement but before the ′<a id="co_link_I4aee0bffd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1987255753&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0ef6725072dd11d7b0409d11d16b6b13&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">008 patent</a> issued, Amgen prosecuted the claims withdrawn from the ′298 application in continuation application 07/113,178 (“the ′178 application”) and continuation application 07/113,179 (“the ′179 application”). <a id="co_link_I4aee0c00d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;pubNum=4637&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_4637_180&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_4637_180"><em>Amgen,</em> 581 F.Supp.2d at 180.</a> After a series of intervening continuation applications and interferences, the ′<a id="co_link_I4aee0c01d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1996374737&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I18611aa072d011d7ba84e3942a4b620d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">933 patent</a> eventually emerged from the ′178 application, while the ′422, ′349, ′868, and ′<a id="co_link_I4aee0c02d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">698 patents</a> eventually emerged from the ′ 179 application. As a result, all five patents-in-suit (<a id="co_link_I4aee0c03d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1996374737&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I18611aa072d011d7ba84e3942a4b620d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">'933</a>, ′422, ′349, ′ 868, and ′698) claim priority to the ′298 application, share a common specification, and have the title “Production of Erythropoietin” or “Production of Recombinant Erythropoietin.”<input id="co_docMarker_9" type="hidden"></div></div><div class="co_paragraph"><div class="co_paragraphText">In broad <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=disease&amp;entityId=Iaa9b49b2475411db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_Iaa9b49b2475411db9765f9243f53508a">strokes</a>, the ′<a id="co_link_I4aee0c05d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1996374737&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I18611aa072d011d7ba84e3942a4b620d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">933 patent</a> claims recombinant EPO, a pharmaceutical composition comprising recombinant EPO, and methods of treating <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=mproc&amp;entityId=Iadf549e6475411db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_Iadf549e6475411db9765f9243f53508a">kidney dialysis</a> patients by administering pharmaceutical compositions comprising recombinant EPO. ′<a id="co_link_I4aee0c07d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1996374737&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I18611aa072d011d7ba84e3942a4b620d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">933 patent</a> col.38 l.17–col.40 l.11. The ′<a id="co_link_I4aee0c08d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999386170&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I804ca47072e611d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">422 patent</a> claims a pharmaceutical composition comprising recombinant EPO. ′<a id="co_link_I4aee0c09d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999386170&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I804ca47072e611d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">422 patent</a> col.38 l.37–41. Because the ′933 and ′<a id="co_link_I4aee0c0ad82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999386170&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I804ca47072e611d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">422 patents</a> both cover recombinant EPO and pharmaceutical compositions thereof, the parties refer to them collectively as the “product patents.” The ′<a id="co_link_I4aee0c0bd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998398894&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I9866fae0724311d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">349 patent</a> claims the process of producing recombinant EPO in vertebrate cells capable of producing EPO at a specific rate. <a id="co_link_I4aee0c0cd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998398894&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I9866fae0724311d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">′349 patent</a> col.38 ll.34–36. The ′<a id="co_link_I4aee0c0dd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1995342658&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I6eeb62d0722711d7ba84e3942a4b620d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">868 patent</a> claims the process of producing recombinant EPO in mammalian cells, ′<a id="co_link_I4aee0c0ed82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1995342658&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I6eeb62d0722711d7ba84e3942a4b620d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">868 patent</a> col.38 ll.24–37, while the ′<a id="co_link_I4aee0c0fd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">698 patent</a> claims the process of producing recombinant EPO in cells comprised of amplified DNA encoding EPO, ′<a id="co_link_I4aee0c10d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"> 698 patent</a> col.38 ll.50–65. Because the ′868 and ′<a id="co_link_I4aee0c11d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">698 patents</a> both cover processes of producing recombinant EPO, the parties refer to them collectively as the “process patents.”</div></div><div class="co_paragraph"><div class="co_paragraphText">Based on these patents, Amgen has developed two erythropoiesis-stimulating agent (“ESA”) drugs, <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I39f2860d475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I39f2860d475111db9765f9243f53508a">EPOGEN</a>® and <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I37eaa86d475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I37eaa86d475111db9765f9243f53508a">Aranesp</a>®, to treat <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=disease&amp;entityId=Ib2202ec4475411db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_Ib2202ec4475411db9765f9243f53508a_0">anemia</a> and anemia-related diseases. <a id="co_link_I4aee0c15d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;pubNum=4637&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_4637_171&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_4637_171"><em>Amgen,</em> 581 F.Supp.2d at 171.</a> The key difference between these drugs is how frequently patients must take them. <em>Id.</em> The Food and Drug Administration (“FDA”) has approved <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I39f2860d475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I39f2860d475111db9765f9243f53508a_0">EPOGEN</a> for weekly dosing and <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I37eaa86d475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I37eaa86d475111db9765f9243f53508a_0">Aranesp</a> for bi-weekly dosing to anemic patients. <a id="co_link_I4aee0c19d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a></div></div><div class="co_paragraph"><div class="co_paragraphText">Roche sought to introduce into the United States market its own ESA drug, MIRCERA®, which it manufactures overseas. <a id="co_link_I4aee0c1ad82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 172.</a> The active ingredient of MIRCERA® is continuous erythropoietin receptor activator (“CERA”). CERA is formed via a chemical reaction that bonds <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=gdrug&amp;entityId=Iffb45d416c7111e18b05fdf15589d8e8&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_Iffb45d416c7111e18b05fdf15589d8e8">polyethylene glycol</a> (“PEG”) to recombinant EPO produced by CHO cells. <a id="co_link_I4aee0c1cd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> The attachment of one PEG molecule to EPO, also known as pegylation of EPO, results in the displacement of a single hydrogen atom from the amino acid lysine or from the beginning amino acid (i.e., the N-terminus) of EPO. <a id="co_link_I4aee0c1dd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> Pegylation of a therapeutic protein, such as EPO, can expand the drug's life in the body and reduce levels of toxicity, allowing for extended dosing intervals. <a id="co_link_I4aee0c1ed82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> As a result, MIRCERA® has received FDA approval for once-monthly dosing to anemic patients. <a id="co_link_I4aee0c1fd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a></div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I17113af9d82d11e498db8b09b4f043e0"><div class="co_headtext co_hAlign2"><span class="co_smallCaps">II</span></div><div class="co_paragraph"><div class="co_paragraphText">Amgen sought a declaratory judgment that, if imported into the United States, MIRCERA® would infringe the ′933, ′422,  <span class="co_starPage" id="co_pp_sp_506_1349"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sf679c9a4b2a811de9988d233d23fe599&quot;, &quot;pageNumber&quot;: &quot;1349&quot; }" alt="metadata" type="hidden">*1349</span> ′868, ′698, and ′<a id="co_link_I4aee0c20d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998398894&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I9866fae0724311d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">349 patents</a>. Specifically, Amgen alleged infringement of claims 3, 7–9, 11, 12, and 14 of the ′<a id="co_link_I4aee0c21d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1996374737&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I18611aa072d011d7ba84e3942a4b620d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">933 patent</a>, claim 1 of the ′<a id="co_link_I4aee0c22d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999386170&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I804ca47072e611d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">422 patent</a>, claim 7 of the ′<a id="co_link_I4aee0c23d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998398894&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I9866fae0724311d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"> 349 patent</a>, claims 1–2 of the ′<a id="co_link_I4aee0c24d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1995342658&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I6eeb62d0722711d7ba84e3942a4b620d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">868 patent</a>, and claims 6–9 of the ′<a id="co_link_I4aee0c25d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">698 patent</a>. Roche responded with affirmative defenses and counterclaims that Amgen's asserted patents were invalid and not infringed.</div></div><div class="co_paragraph"><div class="co_paragraphText">After discovery, the district court granted Amgen summary judgment of no obviousness-type double patenting of any of the asserted claims in the ′933, ′ 422, and ′<a id="co_link_I4aee0c26d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998398894&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I9866fae0724311d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">349 patents</a> over the claims in the ′<a id="co_link_I4aee0c27d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1987255753&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0ef6725072dd11d7b0409d11d16b6b13&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">008 patent</a> based on the protection from such challenge afforded by <a id="co_link_I4aee0c28d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C. § 121</a>. <a id="co_link_I4aee0c29d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;pubNum=4637&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_4637_173&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_4637_173"><em>Amgen,</em> 581 F.Supp.2d at 173.</a> Over cross-motions for summary judgment, the district court also granted Amgen summary judgment that claim 1 of the ′<a id="co_link_I4aee0c2ad82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999386170&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I804ca47072e611d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">422 patent</a> was infringed. <a id="co_link_I4aee0c2bd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 167, 204.</a> The parties tried the remaining infringement and invalidity claims to a jury. After Roche presented its case-in-chief to the jury, the court granted Amgen JMOL that claim 1 of the ′<a id="co_link_I4aee0c2cd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999386170&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I804ca47072e611d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">422 patent<input id="co_docMarker_10" type="hidden"></a> was not anticipated. <a id="co_link_I4aee0c2dd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 198.</a> After conducting hearings outside the presence of the jury and reviewing the trial record, the court granted Amgen JMOL of no obviousness-type double patenting of (1) the asserted claims in the ′933, ′422, and ′<a id="co_link_I4aee0c2ed82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998398894&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I9866fae0724311d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">349 patents</a> over the claims in the ′868 and ′<a id="co_link_I4aee0c2fd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">698 patents</a>, <a id="co_link_I4aee0c30d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;pubNum=0004637&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_4637_192&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_4637_192"><em>id.</em> at 192</a>, and (2) the asserted claims in the ′868 and ′<a id="co_link_I4aee0c31d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">698 patents</a> over the claims in the ′<a id="co_link_I4aee0c32d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1987255753&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0ef6725072dd11d7b0409d11d16b6b13&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">008 patent</a>, <a id="co_link_I4aee0c33d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>id.</em> at 186.</a> The court also granted Roche JMOL that claims 9, 11, and 14 of the ′<a id="co_link_I4aee0c34d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1996374737&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I18611aa072d011d7ba84e3942a4b620d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">933 patent</a> and claim 7 of the ′<a id="co_link_I4aee0c35d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998398894&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I9866fae0724311d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">349 patent</a> were not infringed.</div></div><div class="co_paragraph"><div class="co_paragraphText">On October 23, 2007, the jury rendered a verdict in favor of Amgen, upholding the validity of all the claims-in-suit. The jury found that Roche literally infringed claims 3, 7, and 8 of the ′<a id="co_link_I4aee0c36d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1996374737&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I18611aa072d011d7ba84e3942a4b620d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">933 patent</a>; claims 1 and 2 of the ′<a id="co_link_I4aee0c37d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1995342658&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I6eeb62d0722711d7ba84e3942a4b620d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"> 868 patent</a>; and claims 6–9 of the ′<a id="co_link_I4aee0c38d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">698 patent</a>. Over Roche's motions for renewed JMOL and a new trial, the court sustained these jury findings. The jury also found that claim 12 of the ′<a id="co_link_I4aee0c39d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1996374737&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I18611aa072d011d7ba84e3942a4b620d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">933 patent</a> was infringed under the DOE. Granting Roche's motion for renewed JMOL relating to claim 12 of the ′<a id="co_link_I4aee0c3ad82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1996374737&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I18611aa072d011d7ba84e3942a4b620d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"> 933 patent</a>, the court vacated the jury verdict of infringement and entered judgment of non-infringement as to that claim. <a id="co_link_I4aee0c3bd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 205.</a> Subsequently, the court granted Amgen a declaratory judgment and a permanent injunction, enjoining Roche from marketing MIRCERA® in the United States. <em>Final Judgment,</em> slip op. at 1–2. Roche appeals the described rulings and findings in favor of Amgen, while Amgen cross-appeals the described rulings in favor of Roche. We have jurisdiction pursuant to <a id="co_link_I4aee0c3cd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=28USCAS1295&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RB&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_7b9b000044381">28 U.S.C. § 1295(a)(1)</a>.</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I17113afad82d11e498db8b09b4f043e0"><div class="co_headtext co_hAlign2"><span class="co_smallCaps">DISCUSSION</span></div><div class="co_paragraph"><div class="co_paragraphText">In this appeal, we are presented with issues involving obviousness-type double patenting, anticipation, indefiniteness, and infringement relating to the ′933, ′422, ′349, ′868, and ′<a id="co_link_I4aee0c3dd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">698 patents</a>.</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I17113afbd82d11e498db8b09b4f043e0"><div class="co_headtext co_hAlign2"><span class="co_smallCaps">I</span></div><div class="co_headtext co_hAlign2">Obviousness–Type Double Patenting</div><div class="co_paragraph"><div class="co_paragraphText">For purposes of explaining its rulings relating to obviousness-type double patenting, the district court grouped the ′933, ′422, and ′<a id="co_link_I4aee0c3ed82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998398894&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I9866fae0724311d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">349 patents</a>, and the ′868 and ′<a id="co_link_I4aee0c3fd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">698 patents</a> separately. We shall do the same.</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I17113afcd82d11e498db8b09b4f043e0"><div class="co_headtext co_hAlign2"><span class="co_smallCaps">A</span></div><div class="co_paragraph"><div class="co_paragraphText">The court granted Amgen summary judgment of no obviousness-type double patenting of the asserted claims of the ′933, ′422, and ′<a id="co_link_I4aee0c40d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998398894&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I9866fae0724311d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">349 patents</a> over the claims of the ′<a id="co_link_I4aee0c41d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1987255753&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0ef6725072dd11d7b0409d11d16b6b13&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">008 patent</a>.<sup id="co_footnoteReference_B00222019808227_ID0EXMDI"><a href="#co_footnote_B00222019808227" class="co_footnoteReference">2</a></sup>  <span class="co_starPage" id="co_pp_sp_506_1350"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sf679c9a4b2a811de9988d233d23fe599&quot;, &quot;pageNumber&quot;: &quot;1350&quot; }" alt="metadata" type="hidden">*1350</span> <a id="co_link_I4aee0c42d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;pubNum=4637&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_4637_179&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_4637_179"><em>Amgen,</em> 581 F.Supp.2d at 179.</a> The court also granted Amgen JMOL of no obviousness-type double patenting of the asserted claims of the ′933, ′422, and ′<a id="co_link_I4aee0c43d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998398894&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I9866fae0724311d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">349 patents</a> over the claims of the ′868 and ′<a id="co_link_I4aee0c44d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">698 patents</a>.<sup id="co_footnoteReference_B00332019808227_ID0EEODI"><a href="#co_footnote_B00332019808227" class="co_footnoteReference">3</a></sup> <a id="co_link_I4aee0c45d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 192.</a> The court arrived at these rulings after concluding that the ′933, ′422, and ′<a id="co_link_I4aee0c46d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998398894&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I9866fae0724311d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">349 patents</a> were shielded from double patenting by <a id="co_link_I4aee0c47d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C. § 121</a>. <a id="co_link_I4aee0c48d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a></div></div><div class="co_paragraph"><div class="co_paragraphText"><a id="co_link_I4aee0c58d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Section 121</a>, entitled “Divisional applications,” provides in its third sentence:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText"><blockquote><div>A patent issuing on an application with respect to which a requirement for restriction under this section has been made, or on an application filed as a result of such a requirement, shall not be used as a reference either in the Patent and Trademark Office or in the courts against a divisional application or against the original application or any patent issued on either of them, if the divisional application is filed before the issuance of the patent on the other application.</div></blockquote></div></div><div class="co_paragraphText co_flush"><a id="co_link_I4aee0c59d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C. § 121</a>. The third sentence of <a id="co_link_I4aee0c5ad82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 121</a> is a safe harbor provision that protects a divisional application, the original application, or any patent issued on either of them from validity challenges based on a patent issuing on an application subjected to a restriction requirement or on an application filed as a result of a restriction requirement. In effect, the third sentence of <input id="co_docMarker_11" type="hidden"><a id="co_link_I4aee0c5bd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 121</a> shields patents that issue on applications filed as a result of a restriction requirement from double patenting invalidation. <em>See </em><a id="co_link_I4aee0c5cd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1996240058&amp;pubNum=0000506&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1568&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1568"><em>Applied Materials, Inc. v. Advanced Semiconductor Materials America, Inc.,</em> 98 F.3d 1563, 1568 (Fed.Cir.1996)</a> (“[W]hen two or more patents result from a PTO restriction requirement, whereby aspects of the original application must be divided into separate applications, <a id="co_link_I4aee0c5dd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 121</a> insulates the ensuing patents from the charge of double patenting.”).</div></div><div class="co_paragraph"><div class="co_paragraphText">The court concluded that the ′933, ′422, and ′<a id="co_link_I4aee0c5ed82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998398894&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I9866fae0724311d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">349 patents</a> were entitled to the <a id="co_link_I4aee0c5fd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 121</a> safe harbor because they had descended from the ′178 and ′179 applications, both of which had been filed in response to a PTO-imposed restriction requirement. The court observed that “[a]fter the PTO imposed the 1986 restriction requirement,” Amgen “filed two divisional applications, the ′ 178 and ′179, which ultimately issued as the ′933, ′422, and ′<a id="co_link_I4aee0c60d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998398894&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I9866fae0724311d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">349 patents</a>.” <a id="co_link_I4aee0c61d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;pubNum=4637&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_4637_179&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_4637_179"><em>Amgen,</em> 581 F.Supp.2d at 179.</a> The court found that the “undisputed evidence show[ed] that both the ′178 and ′179 applications were filed as a result of the PTO's 1986 restriction requirement.” <em>Id.</em> Thus, the court deemed the ′933, ′422, and ′<a id="co_link_I4aee0c63d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998398894&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I9866fae0724311d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">349 patents</a> immune from a charge of obviousness-type double patenting over the ′008, ′868, and ′<a id="co_link_I4aee0c64d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">698 patents</a>. <a id="co_link_I4aee0c65d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 182, 192.</a></div></div><div class="co_paragraph"><div class="co_paragraphText">On appeal, Roche contends that the district court erroneously determined that <a id="co_link_I4aee0c66d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 121</a>'s safe harbor insulates the ′933 and ′<a id="co_link_I4aee0c67d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999386170&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I804ca47072e611d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">422 patents</a> from obviousness-type double patenting invalidation over the ′008, ′868, and ′<a id="co_link_I4aee0c68d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">698 patents</a>. Roche's Br. 34. Roche's main contention is that <a id="co_link_I4aee0c69d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 121</a> cannot shield the ′933 and ′<a id="co_link_I4aee0c6ad82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999386170&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I804ca47072e611d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">422 patents</a> because they issued from solely continuation applications to which <a id="co_link_I4aee0c6bd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 121</a> is inapplicable.  <span class="co_starPage" id="co_pp_sp_506_1351"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sf679c9a4b2a811de9988d233d23fe599&quot;, &quot;pageNumber&quot;: &quot;1351&quot; }" alt="metadata" type="hidden">*1351</span> <a id="co_link_I4aee0c6cd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999386170&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> Roche contends that <a id="co_link_I4aee0c6dd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 121</a> applies exclusively to divisional applications and patents issuing therefrom. Roche emphasizes that the statute, entitled “Divisional applications,” requires on its face that the later patent must issue from “a divisional application” or the “original application.” <a id="co_link_I4aee0c6ed82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999386170&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 35.</a> Because the ′933 and ′<a id="co_link_I4aee0c6fd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999386170&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I804ca47072e611d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">422 patents</a> issued from the ′178 and ′179 continuation applications, Roche contends they are not entitled to the <a id="co_link_I4aee0c70d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 121</a> safe harbor. <a id="co_link_I4aee0c71d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999386170&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 36.</a></div></div><div class="co_paragraph"><div class="co_paragraphText">Amgen argues that the district court correctly held that <a id="co_link_I4aee0c72d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 121</a> protects the asserted claims of the ′933 and ′<a id="co_link_I4aee0c73d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999386170&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I804ca47072e611d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">422 patents</a> from obviousness-type double patenting invalidation over the claims of the ′008, ′868, and ′<a id="co_link_I4aee0c74d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">698 patents</a>. Amgen's Br. 39. Amgen relies on our decisions in <a id="co_link_I4aee0c75d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1996240058&amp;pubNum=0000506&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1568&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1568"><em>Applied Materials, Inc. v. Advanced Semiconductor Materials Am., Inc.,</em> 98 F.3d 1563, 1568 (Fed.Cir.1996)</a>, and <a id="co_link_I4aee0c76d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1991110113&amp;pubNum=0000350&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Symbol Technologies, Inc. v. Opticon, Inc.,</em> 935 F.2d 1569 (Fed.Cir.1991)</a>, for the proposition that patents that issue directly from continuation applications, as the ′933 and ′<a id="co_link_I4aee0c77d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999386170&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I804ca47072e611d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">422 patents</a> did, are eligible for <a id="co_link_I4aee0c78d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 121</a> protection so long as the other requirements of <a id="co_link_I4aee0c79d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 121</a> are met. <a id="co_link_I4aee0c7ad82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999386170&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 41.</a> In Amgen's view, the only <a id="co_link_I4aee0c7bd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 121</a> requirement at issue is the “divisional application” requirement, and Amgen contends that the ′178 and ′179 applications meet that requirement. <a id="co_link_I4aee0c7cd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999386170&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> Amgen urges the court to look to an application's substance—not its designation—to determine whether it qualifies as a divisional application under <a id="co_link_I4aee0c7dd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 121</a>'s safe harbor. <a id="co_link_I4aee0c7ed82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999386170&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 42.</a> In support of this approach, Amgen relies on the definition of “divisional application” in § 201.06 of the Manual of Patent Examining Procedure (“MPEP”), which provides:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText"><blockquote><div>A later application for an independent or distinct invention, carved out of a pending application and disclosing and claiming only subject matter disclosed in the earlier or parent application, is known as a divisional application or “division.”<input id="co_docMarker_12" type="hidden"></div></blockquote></div></div><div class="co_paragraphText co_flush"><a id="co_link_I4aee0c7fd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;pubNum=1015320&amp;cite=MPEPs201.06&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=TS&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">MPEP § 201.06 (8th ed., July 2008 rev.)</a>. According to Amgen, the ′178 and ′179 applications were later applications, which were (1) carved out of a pending application (the ′298 application), (2) contained claims to distinct and independent inventions, and (3) disclosed and claimed only subject matter disclosed in the earlier or parent application. Amgen's Br. 41. Thus, Amgen argues, because the ′178 and ′179 applications, from which the ′933 and ′<a id="co_link_I4aee0c80d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999386170&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I804ca47072e611d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">422 patents</a> descend, conform to the PTO's definition of a “divisional application” in <a id="co_link_I4aee0c81d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;pubNum=1015320&amp;cite=MPEPs201.06&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=TS&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">MPEP § 201.06</a>, the ′933 and ′<a id="co_link_I4aee0c82d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999386170&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I804ca47072e611d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">422 patents</a> are entitled to the <a id="co_link_I4aee0c83d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 121</a> safe harbor. <a id="co_link_I4aee0c84d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999386170&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a></div></div><div class="co_paragraph"><div class="co_paragraphText">Amgen also noted at oral argument that Roche did not contest the no obviousness-type double patenting ruling relating to the ′<a id="co_link_I4aee0c85d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998398894&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I9866fae0724311d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">349 patent</a> in its reply brief, even though Amgen cross-appealed the court's ruling that the ′<a id="co_link_I4aee0c86d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998398894&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I9866fae0724311d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"> 349 patent</a> was not infringed by MIRCERA®. <em>See</em> Oral Arg. 33:10–35, June 4, 2009, <em>available at</em> http://oralarguments.cafc.uscourts.gov/ searchscript.asp (search case no.2009–1020). Amgen urges us to treat Roche's omission as waiver. <em>Id.</em></div></div><div class="co_paragraph"><div class="co_paragraphText">We address this last point of Amgen's first. Amgen correctly points out that Roche did not challenge the <a id="co_link_I4aee0c88d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 121</a> protection afforded to the ′<a id="co_link_I4aee0c89d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998398894&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I9866fae0724311d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">349 patent</a> in its reply brief. When questioned at oral argument about this omission, counsel for Roche stated, “We won on non-infringement, so you can't appeal when you win.” Oral Arg. 37:00–27. While a challenge to the no invalidity ruling of the ′<a id="co_link_I4aee0c8ad82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998398894&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I9866fae0724311d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">349 patent</a> would have been a proper response to Amgen's cross-appeal of the non-infringement ruling of the ′<a id="co_link_I4aee0c8bd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998398894&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I9866fae0724311d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">349 patent</a>, we do not deem Roche's failure to raise this alternative ground for affirmance as waiver in this case. <em>See </em><a id="co_link_I4aee0c8cd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2009302849&amp;pubNum=0000506&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1240&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1240"><em>Independence Park Apartments v. United States,</em> 449 F.3d 1235, 1240 (Fed.Cir.2006)</a> (explaining that appellees are in  <span class="co_starPage" id="co_pp_sp_506_1352"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sf679c9a4b2a811de9988d233d23fe599&quot;, &quot;pageNumber&quot;: &quot;1352&quot; }" alt="metadata" type="hidden">*1352</span> the position of defending a favorable judgment and, under certain circumstances, may not be “required to raise all possible alternative grounds for affirmance to avoid waiving any of those grounds”); <em>cf. </em> <a id="co_link_I4aee0c8dd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2007091564&amp;pubNum=0000506&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1251&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1251"><em>Harris Corp. v. Ericsson Inc.,</em> 417 F.3d 1241, 1251 (Fed.Cir.2005)</a> (“An appellate court retains case-by-case discretion over whether to apply waiver.”). Therefore, given our ruling on infringement of the ′<a id="co_link_I4aee0c8ed82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998398894&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I9866fae0724311d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">349 patent</a>, <em>see <a id="co_link_I4aee0c8fd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998398894&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">infra</a></em> Part V.B, we will rule on whether the ′<a id="co_link_I4aee0c90d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998398894&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I9866fae0724311d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">349 patent</a> is entitled to the <a id="co_link_I4aee0c91d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 121</a> safe harbor.</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I17113afdd82d11e498db8b09b4f043e0"><div class="co_headtext co_hAlign2"><span class="co_smallCaps">B</span></div><div class="co_paragraph"><div class="co_paragraphText">We review a district court's grant of summary judgment without deference. <em>See </em><a id="co_link_I4aee0c92d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2012754722&amp;pubNum=0000506&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1015&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1015"><em>In re Metoprolol Succinate Patent Litig.,</em> 494 F.3d 1011, 1015 (Fed.Cir.2007)</a>. Summary judgment is appropriate if there are no genuine issues of material fact so that the moving party is entitled to judgment as a matter of law. <em>See</em> <a id="co_link_I4aee0c93d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000600&amp;cite=USFRCPR56&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RB&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_4b24000003ba5">Fed.R.Civ.P. 56(c)</a>. In other words, the court properly grants summary judgment if no reasonable jury could return a verdict for the non-moving party. <em>See </em><a id="co_link_I4aee0c94d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1986132674&amp;pubNum=0000708&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Anderson v. Liberty Lobby, Inc.,</em> 477 U.S. 242, 248, 106 S.Ct. 2505, 91 L.Ed.2d 202 (1986)</a>. In assessing the evidence, we draw all reasonable inferences in favor of the non-moving party. <a id="co_link_I4aee0c95d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2013222987&amp;pubNum=0000506&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1378&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1378"><em>BMC Res., Inc. v. Paymentech, L.P.,</em> 498 F.3d 1373, 1378 (Fed.Cir.2007)</a>.</div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F12019808227" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF1">1</a><a id="co_anchor_B12019808227"></a><a href="#co_anchor_F22019808227" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF2">2</a><a id="co_anchor_B22019808227"></a> We apply the standard of review for JMOL rulings used in the relevant regional circuit. <a id="co_link_I4aee0c96d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2018960329&amp;pubNum=0000506&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1329&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1329"><em>DePuy Spine, Inc. v. Medtronic Sofamor Danek, Inc.,</em> 567 F.3d 1314, 1329 (Fed.Cir.2009)</a>. In this case, that is the First Circuit. In the First Circuit, a district court's grant of JMOL is reviewed without deference. <em>Id.</em> (applying First Circuit law). Under First Circuit law, JMOL is warranted when, viewing the evidence in the light most favorable to the non-moving party, “there is no legally sufficient evidentiary basis for a reasonable jury to find for the [non-moving] party.”<input id="co_docMarker_13" type="hidden"> <a id="co_link_I4aee0c98d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2003545300&amp;pubNum=0000506&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_50&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_50"><em>Guilloty Perez v. Pierluisi,</em> 339 F.3d 43, 50 (1st Cir.2003)</a> (quotation marks omitted).</div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F32019808227" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF3">3</a><a id="co_anchor_B32019808227"></a><a href="#co_anchor_F42019808227" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF4">4</a><a id="co_anchor_B42019808227"></a> We review a court's conclusion on double patenting without deference because “double patenting is a matter of what is claimed, and therefore is treated like claim construction upon appellate review.” <a id="co_link_I4aee0c99d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999244324&amp;pubNum=0000506&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1326&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1326"><em>Georgia–Pacific Corp. v. U.S. Gypsum Co.,</em> 195 F.3d 1322, 1326 (Fed.Cir.1999)</a>. “[Obviousness-type] double patenting is a judicially created doctrine adopted to prevent claims in separate applications or patents that do not recite the ‘same’ invention, but nonetheless claim inventions so alike that granting both exclusive rights would effectively extend the life of patent protection.” <a id="co_link_I4aee0c9ad82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2007917386&amp;pubNum=0000506&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1373&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1373"><em>Perricone v. Medicis Pharm. Corp.,</em> 432 F.3d 1368, 1373 (Fed.Cir.2005)</a>.</div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F52019808227" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF5">5</a><a id="co_anchor_B52019808227"></a> We conclude that, because the ′178 and ′179 applications were filed as continuation—rather than divisional—applications, the ′933, ′422, and ′<a id="co_link_I4aee0c9bd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998398894&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I9866fae0724311d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">349 patents</a> do not receive the benefit of <a id="co_link_I4aee0c9cd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 121</a>. We reach this conclusion in light of our opinion in <a id="co_link_I4aee0c9dd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2015427244&amp;pubNum=0000506&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Pfizer, Inc. v. Teva Pharmaceuticals USA, Inc.,</em> 518 F.3d 1353 (Fed.Cir.2008)</a>. The <em>Pfizer</em> decision addressed whether a patent that issued from a continuation-in-part application—rather than a divisional application—could receive the protection of the <a id="co_link_I4aee0c9fd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 121</a> safe harbor. <a id="co_link_I4aee0ca0d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2015427244&amp;pubNum=506&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1358&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1358">518 F.3d at 1358–62.</a> Looking first to the statute, the court observed that <a id="co_link_I4aee0ca1d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 121</a> on its face refers to “divisional application[s].” <a id="co_link_I4aee0ca2d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2015427244&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 1360.</a> Turning to the legislative history, the court observed that a House Report also referred specifically to “divisional application[s].” <a id="co_link_I4aee0ca3d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2015427244&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> Notably absent from the legislative history, in the court's view, was a suggestion “that the safe-harbor provision was, or needed to be, directed at anything but divisional applications.” <a id="co_link_I4aee0ca4d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2015427244&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 1361.</a> From there, the court “conclude[d] that the protection afforded by <a id="co_link_I4aee0ca5d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">section 121</a> to applications (or patents issued therefrom) filed as a result of a restriction requirement <span class="co_starPage" id="co_pp_sp_506_1353"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sf679c9a4b2a811de9988d233d23fe599&quot;, &quot;pageNumber&quot;: &quot;1353&quot; }" alt="metadata" type="hidden">*1353</span>  is limited to divisional applications.” <a id="co_link_I4aee0ca6d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2015427244&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 1362.</a> Accordingly, the court decided that the <a id="co_link_I4aee0ca7d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 121</a> safe harbor did not apply to the patent before it, which issued from a continuation-in-part application. <a id="co_link_I4aee0ca8d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2015427244&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a></div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F62019808227" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF6">6</a><a id="co_anchor_B62019808227"></a> We are persuaded by the reasoning in <em>Pfizer</em> that the <a id="co_link_I4aee0caad82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 121</a> safe harbor provision does not protect continuation applications or patents descending from only continuation applications. The statute on its face applies only to divisional applications,<sup id="co_footnoteReference_B00442019808227_ID0EX3AK"><a href="#co_footnote_B00442019808227" class="co_footnoteReference">4</a></sup> and a continuation application, like a continuation-in-part application, is not a divisional application. <em>See </em><a id="co_link_I4aee0cabd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1990144478&amp;pubNum=0000350&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_350_688&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_688"><em>Gerber Garment Tech., Inc. v. Lectra Sys., Inc.,</em> 916 F.2d 683, 688 (Fed.Cir.1990)</a> (“To gain the benefits of <a id="co_link_I4aee0cacd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Section 121</a> there outlined, [the patentee] must have brought its case within the purview of the statute, i.e., it must have limited the claims in its <em>divisional application</em> to the non-elected invention or inventions.” (emphasis added)). We recognize that, unlike a continuation-in-part application, a continuation application can satisfy the definition of a “divisional application” in <a id="co_link_I4aee0cadd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;pubNum=1015320&amp;cite=MPEPs201.06&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=TS&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">MPEP § 201.06</a>. That is because a continuation-in-part application adds subject matter not disclosed in the earlier application, <em>see</em> <a id="co_link_I4aee0caed82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;pubNum=1015320&amp;cite=MPEPs201.08&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=TS&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">MPEP § 201.08</a>, whereas continuation and divisional applications are limited to subject matter disclosed in the earlier application, <em>see</em> <a id="co_link_I4aee0cafd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;pubNum=1015320&amp;cite=MPEPs201.06&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=TS&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">MPEP §§ 201.06</a>, <a id="co_link_I4aee0cb0d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;pubNum=1015320&amp;cite=MPEPs201.07&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=TS&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">201.07</a>. This distinction, however, does not justify departing from a strict application of the plain language of <a id="co_link_I4aee0cb1d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 121</a>, which affords its benefits to “divisional application[s].” <em>See</em> <a id="co_link_I4aee0cb2d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C. § 121</a> (sheltering from attack “a <em>divisional application</em> or <input id="co_docMarker_14" type="hidden">... the original application or any patent issued on either of them, if the <em>divisional application</em> is filed before the issuance of the patent on the other application” (emphases added)); <em>see also </em><a id="co_link_I4aee0cb3d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2003867260&amp;pubNum=0000506&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1382&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1382"><em>Geneva Pharm., Inc. v. GlaxoSmithKline PLC,</em> 349 F.3d 1373, 1382 (Fed.Cir.2003)</a> (“Given the potential windfall [a] patent term extension could provide to a patentee, this court applies a strict test for application of <a id="co_link_I4aee0cb4d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 121</a>.” (footnote omitted)).</div></div><div class="co_paragraph"><div class="co_paragraphText">Our conclusion that the <a id="co_link_I4aee0cb8d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 121</a> safe harbor protects patents descending from divisional applications, but not from continuation applications exclusively, is consistent with our decisions in <em>Applied Materials</em> and in <em>Symbol Technologies.</em> In both of those cases, we affirmed <a id="co_link_I4aee0cbbd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 121</a> protection of patents which issued directly from continuation applications. <em>See </em><a id="co_link_I4aee0cbcd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1996240058&amp;pubNum=506&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1568&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1568"><em>Applied Materials,</em> 98 F.3d at 1568–69;</a> <a id="co_link_I4aee0cbdd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1991110113&amp;pubNum=350&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_350_1579&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_1579"><em>Symbol Technologies,</em> 935 F.2d at 1579–81.</a> In both cases, however, the continuation applications, from which the protected patents issued, descended from divisional applications that were filed as a result of restriction <span class="co_starPage" id="co_pp_sp_506_1354"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sf679c9a4b2a811de9988d233d23fe599&quot;, &quot;pageNumber&quot;: &quot;1354&quot; }" alt="metadata" type="hidden">*1354</span>  requirements. <em>See </em><a id="co_link_I4aee0cbed82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1996240058&amp;pubNum=506&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1568&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1568"><em>Applied Materials,</em> 98 F.3d at 1568;</a> <a id="co_link_I4aee0cbfd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1991110113&amp;pubNum=350&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_350_1580&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_1580"><em>Symbol Technologies,</em> 935 F.2d at 1580.</a> Our decisions in <em>Applied Materials</em> and <em>Symbol Technologies</em> thus establish that a patent need not have issued directly from a divisional application to receive <a id="co_link_I4aee0cc2d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 121</a> protection. In other words, intervening continuation applications do not render a patent ineligible for <a id="co_link_I4aee0cc3d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 121</a> protection so long as they descended from a divisional application filed as a result of a restriction requirement. Unlike the patents at issue in <em>Applied Materials</em> and <em>Symbol Technologies,</em> the ′933, ′422, and ′<a id="co_link_I4aee0cc6d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998398894&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I9866fae0724311d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">349 patents</a> issued from continuation applications, which descended from continuation applications exclusively, and not from divisional applications. Thus, <em>Applied Materials</em> and <em>Symbol Technologies</em> are of no help to Amgen's position that the ′933, ′ 422, and ′<a id="co_link_I4aee0cc9d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998398894&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I9866fae0724311d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">349 patents</a> deserve <a id="co_link_I4aee0ccad82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 121</a> protection.</div></div><div class="co_paragraph"><div class="co_paragraphText">Furthermore, Amgen has not presented us with any persuasive reason as to why we should deem the ′178 and ′179 continuation applications divisional applications for purposes of <a id="co_link_I4aee0ccbd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 121</a>. Amgen does not dispute that it denominated the ′178 and ′179 applications continuations, that it checked the continuation application box on the submitted form, or that its applications met the PTO's definition of a continuation application in <a id="co_link_I4aee0cccd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;pubNum=1015320&amp;cite=MPEPs201.07&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=TS&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">MPEP § 201.07</a>. <em>See</em> Amgen's Br. 38, 42. Instead, Amgen argues that, because the ′178 and ′179 continuation applications could have been filed as divisional applications, we should treat them as such for purposes of <a id="co_link_I4aee0ccdd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 121</a>. While this argument convinced the district court to regard the ′178 and ′179 continuation applications as divisional applications, we are not likewise convinced. We decline to construe “divisional application” in <a id="co_link_I4aee0cced82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 121</a> to encompass Amgen's properly filed, properly designated continuation applications.</div></div><div class="co_paragraph"><div class="co_paragraphText">Because the ′178 and ′179 applications were filed as continuation applications instead of divisional applications, we hold that the ′933, ′422, and ′<a id="co_link_I4aee0ccfd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998398894&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I9866fae0724311d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">349 patents</a> do not receive the protections afforded by <a id="co_link_I4aee0cd0d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 121</a>'s safe harbor. As a result, we vacate the grant of summary judgment and of JMOL of no obviousness-type double patenting of the ′933, ′422, and ′<a id="co_link_I4aee0cd1d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998398894&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I9866fae0724311d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">349 patents</a> and remand to the district court the question of whether the asserted claims of those patents are invalid for obviousness-type double patenting over the claims of the ′008, ′868, and ′<a id="co_link_I4aee0cd2d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">698 patents</a>.<sup id="co_footnoteReference_B00552019808227_ID0EJOBK"><a href="#co_footnote_B00552019808227" class="co_footnoteReference">5</a></sup></div></div><div class="co_paragraph"><div class="co_paragraphText">In this context, we now address Roche's contention that a new time frame for obviousness-type double patenting should apply in the district court on remand when it considers the validity of the ′933, ′422, and ′<input id="co_docMarker_15" type="hidden"><a id="co_link_I4aee0cd8d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998398894&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I9866fae0724311d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">349 patents</a>, and in our review of the district court's decision on the validity of the ′868 and ′<a id="co_link_I4aee0cd9d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">698 patents</a>. Roche finds support for the new time frame in our recent decision in <a id="co_link_I4aee0cdad82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2018580593&amp;pubNum=0000506&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Takeda Pharmaceutical Co. v. Doll,</em> 561 F.3d 1372 (Fed.Cir.2009)</a>, which post-dates the district court's decision in this case.</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I17113afed82d11e498db8b09b4f043e0"><div class="co_headtext co_hAlign2"><span class="co_smallCaps">C</span></div><div class="co_paragraph"><div class="co_paragraphText"><em>Takeda</em> presented the situation where a patent applicant sought to overcome a double patenting rejection of a process patent over a product patent by presenting post-invention evidence of alternative processes of making the product. <a id="co_link_I4aee0cdcd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2018580593&amp;pubNum=506&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1375&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1375">561 F.3d at 1375–76.</a> In 1974, Takeda Pharmaceutical Co.  <span class="co_starPage" id="co_pp_sp_506_1355"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sf679c9a4b2a811de9988d233d23fe599&quot;, &quot;pageNumber&quot;: &quot;1355&quot; }" alt="metadata" type="hidden">*1355</span>  (“Takeda”) filed a Japanese patent application disclosing a product (cephem compounds) and the process for making the product. <a id="co_link_I4aee0cddd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2018580593&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 1373.</a> Takeda obtained a patent on the product in 1981, and a patent on the process in 1996, both of which claimed priority to the 1974 application. <a id="co_link_I4aee0cded82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2018580593&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 1373–74.</a> During reexamination of the process patent, the PTO examiner rejected the claims of the process patent as patentably indistinct over the claims of the product patent, and, therefore, invalid for double patenting, a ruling which the Board of Patent Appeals and Interferences affirmed. <a id="co_link_I4aee0cdfd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2018580593&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 1374.</a> The District Court for the District of Columbia disagreed, however, based primarily on <a id="co_link_I4aee0ce0d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;pubNum=1015320&amp;cite=MPEPs806.05(f)&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=TS&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">MPEP § 806.05(f)</a>, which provides that process and product claims are patentably distinct if “the product as claimed can be made by another materially different process.” <a id="co_link_I4aee0ce1d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2013258368&amp;pubNum=0004637&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_4637_96&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_4637_96"><em>Takeda Pharm. Co. v. Dudas,</em> 511 F.Supp.2d 81, 96 (D.D.C.2007)</a>, <em>vacated, </em><a id="co_link_I4aee0ce2d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2018580593&amp;pubNum=506&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1378&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1378"><em>Takeda,</em> 561 F.3d at 1378.</a> The district court held that, because viable, alternative processes for making the product existed in 2002 and 2005, the process and product were patentably distinct, and, therefore, not invalid for obviousness-type double patenting. <a id="co_link_I4aee0ce3d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2013258368&amp;pubNum=0004637&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_4637_97&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_4637_97"><em>Takeda,</em> 511 F.Supp.2d at 97</a>.</div></div><div class="co_paragraph"><div class="co_paragraphText">The question on appeal to this court in <em>Takeda</em> was whether, when an issued patent claims a product and discloses, but does not claim, a process for making that product, the patentee, when later seeking a patent on the disclosed process, may present evidence of <em>post-invention,</em> alternative processes that produce the patented product, in order to show that the process and product are patentably distinct. <a id="co_link_I4aee0ce5d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2018580593&amp;pubNum=506&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1375&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1375">561 F.3d at 1375–76.</a><sup id="co_footnoteReference_B00662019808227_ID0EPYBK"><a href="#co_footnote_B00662019808227" class="co_footnoteReference">6</a></sup> The answer was a qualified yes. We concluded that “the relevant time frame for determining whether a product and process are ‘patentably distinct’ should be at the filing date of the secondary application,” which is the later application for the process. <a id="co_link_I4aee0ce6d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2018580593&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 1377.</a> We reasoned that “[t]he secondary application ... actually <em>triggers</em> the potential of an ‘unjustified extension of patent term,’ ” which is one of the “policies underlying the double patenting doctrine.” <a id="co_link_I4aee0ce7d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2018580593&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> That is because the patentee “essentially avers that the product and process are ‘patentably distinct’ ” upon filing of the secondary application. <a id="co_link_I4aee0ce8d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2018580593&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> Accordingly, Takeda could “rely on subsequent developments in the art up to January 8, 1990, the filing date of the secondary application, in order to show a patentable distinction between the [product and process for making the product].” <a id="co_link_I4aee0ce9d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2018580593&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 1378.</a> We thus held that Takeda could rely on alternative processes that were in existence prior to January 8, 1990, the date of the application for the process patent. <a id="co_link_I4aee0cead82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2018580593&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> It could not, however, rely on processes that came into existence after January 8, 1990, which eliminated processes existing in 2002 and 2005, which did not exist before January 8, 1990. <a id="co_link_I4aee0cebd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2018580593&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> Since the parties disputed whether alternative processes existed prior to the filing of the process patent, we remanded to the district court for a final obviousness-type double patenting decision.<input id="co_docMarker_16" type="hidden"> <a id="co_link_I4aee0cecd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2018580593&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a></div></div><div class="co_paragraph"><div class="co_paragraphText">Roche contends that <em>Takeda</em> changed the time frame for an obviousness-type double patenting analysis. Roche's Resp. Ct. Req. 1. Roche hones in on the language in the <em>Takeda</em> opinion stating that “the relevant time frame for determining  <span class="co_starPage" id="co_pp_sp_506_1356"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sf679c9a4b2a811de9988d233d23fe599&quot;, &quot;pageNumber&quot;: &quot;1356&quot; }" alt="metadata" type="hidden">*1356</span> whether a product and process are ‘patentably distinct’ should be at the filing date of the secondary application.” <em>Id.</em> at 2 (quoting <a id="co_link_I4aee0cf1d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2018580593&amp;pubNum=506&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1377&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1377"><em>Takeda,</em> 561 F.3d at 1377).</a> Given this language, Roche argues that it should be able to rely on evidence up to the filing date of “secondary application[s]” to show a lack of patentable distinctiveness in this case. <em>Id.</em> Roche contends that interpreting <a id="co_link_I4aee0cf3d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2018580593&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Takeda</em>'s</a> holding so that only patentees can take advantage of post-invention developments to show a patentable distinction is manifestly unfair. <em>Id.</em> at 4. In Roche's view, if the patentee is to benefit from art that arises after the invention date, then an accused infringer is likewise benefitted. <em>Id.</em> In other words, Roche contends, <em>Takeda</em> must be a two-way street, benefitting the patentee and patent challenger alike. Thus, Roche argues that evidence arising up to the time of filing of the “secondary application[s]” (June 7, 1995, for the ′<a id="co_link_I4aee0cf5d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1996374737&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I18611aa072d011d7ba84e3942a4b620d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">933 patent</a>; August 2, 1993, for the ′<a id="co_link_I4aee0cf6d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999386170&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I804ca47072e611d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">422 patent</a>; and June 6, 1995, for the ′<a id="co_link_I4aee0cf7d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998398894&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I9866fae0724311d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">349 patent</a>) should be considered (1) by the district court on remand in its obviousness-type double patenting analysis of the claims of the ′ 933, ′422, and ′<a id="co_link_I4aee0cf8d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998398894&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I9866fae0724311d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">349 patents</a> over the claims of the ′008, ′868, and ′<a id="co_link_I4aee0cf9d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"> 698 patents</a>, and (2) by this court in its review of the obviousness-type double patenting analysis of the ′868 and ′<a id="co_link_I4aee0cfad82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">698 patents</a> over the ′<a id="co_link_I4aee0cfbd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1987255753&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0ef6725072dd11d7b0409d11d16b6b13&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">008 patent</a>.</div></div><div class="co_paragraph"><div class="co_paragraphText">Amgen responds that <em>Takeda</em> did not change the time frame of the obviousness-type double patenting inquiry in all cases. Amgen's Resp. Ct. Req. 1. Amgen reads <em>Takeda</em> to only allow the patentee an opportunity to rely on post-invention evidence. <em>Id.</em> Under this reading, <em>Takeda</em> permits Amgen to show post-invention developments in the art that confirm patentable distinctiveness. <em>Id.</em> at 2. Amgen contends that, if <a id="co_link_I4aee0cffd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 121</a> does not shield the ′933, ′422, and ′<a id="co_link_I4aee0d00d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998398894&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I9866fae0724311d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">349 patents</a> from obviousness-type double patenting invalidation, then <em>Takeda</em> permits Amgen to present evidence of alternative processes for making the products claimed in the ′933, ′422, and ′<a id="co_link_I4aee0d02d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998398894&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I9866fae0724311d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">349 patents</a> up to the filing dates of those patents. <a id="co_link_I4aee0d03d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998398894&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 5.</a> In short, Amgen contends, <em>Takeda</em> is a one-way street, benefitting only the patentee.</div></div><div class="co_paragraph"><div class="co_paragraphText">Roche's view that <em>Takeda</em> changed the time frame of the obviousness-type double patenting inquiry in all cases collides with <a id="co_link_I4aee0d06d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS120&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C. § 120</a>. <a id="co_link_I4aee0d07d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS120&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Section 120</a>, entitled “Benefit of earlier filing date in the United States,” recites in pertinent part:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText"><blockquote><div>An application for patent for an invention disclosed in the manner provided by the first paragraph of <a id="co_link_I4aee0d08d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS112&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">section 112</a> of this title in an application previously filed in the United States, ... which is filed by an inventor or inventors named in the previously filed <em>application shall have the same effect,</em> as to such invention, <em>as though filed on the date of the prior application,</em> if filed before the patenting or abandonment of or termination of proceedings on the first application or on an application similarly entitled to the benefit of the filing date of the first application and if it contains or is amended to contain a specific reference to the earlier filed application.</div></blockquote></div></div><div class="co_paragraphText co_flush"><a id="co_link_I4aee0d09d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS120&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C. § 120</a> (emphases added). In short, <a id="co_link_I4aee0d0ad82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS120&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 120</a> provides that a qualifying “application for patent for an invention ... shall have the same effect ... as though filed on the date of the prior application.”<input id="co_docMarker_17" type="hidden"> This court has “repeatedly recognized [the] principle” that the “plain and unambiguous meaning of <a id="co_link_I4aee0d0bd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS120&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">section 120</a> is that any application fulfilling the requirements therein ‘shall have the same effect’ as if filed on the date of the application upon which it claims priority.” <a id="co_link_I4aee0d0cd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1994185855&amp;pubNum=0000506&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_556&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_556"><em>Transco Prods. Inc. v. Performance Contracting, Inc.,</em> 38 F.3d 551, 556 (Fed.Cir.1994)</a>. “The ‘effect’ described in <a id="co_link_I4aee0d0dd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS120&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">section 120</a> is the benefit of the earlier filing date—i.e., the benefit for purposes of priority and <a id="co_link_I4aee0d0ed82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS112&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">section 112</a>....”  <span class="co_starPage" id="co_pp_sp_506_1357"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sf679c9a4b2a811de9988d233d23fe599&quot;, &quot;pageNumber&quot;: &quot;1357&quot; }" alt="metadata" type="hidden">*1357</span> <a id="co_link_I4aee0d0fd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2016786083&amp;pubNum=0000506&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1342&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1342"><em>Cooper Techs. Co. v. Dudas,</em> 536 F.3d 1330, 1342 (Fed.Cir.2008)</a>. Thus, <a id="co_link_I4aee0d10d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS120&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 120</a> requires continuation applications to receive, at the very least, the benefits provided by the earlier filing date.</div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F72019808227" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF7">7</a><a id="co_anchor_B72019808227"></a> We cannot read <em>Takeda</em> in the manner for which Roche advocates without violating the plain language of <a id="co_link_I4aee0d12d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS120&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C. § 120</a>. <a id="co_link_I4aee0d13d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS120&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Section 120</a> requires that all five of Amgen's asserted patents (<a id="co_link_I4aee0d14d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1996374737&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I18611aa072d011d7ba84e3942a4b620d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">'933</a>, ′422, ′349, ′868, and ′698) benefit from the effect of having been filed on the filing date of the ′298 application, which is November 30, 1984. That means that Amgen's patents cannot be invalidated based on art arising after November 30, 1984. Consequently, we must reject Roche's contention that it should be able to show patentable indistinctiveness by relying on evidence up to the filing date of “secondary application[s].” Therefore, on remand, Roche may not rely on developments in the art subsequent to November 30, 1984, but prior to the filing dates of the ′<a id="co_link_I4aee0d15d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1996374737&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I18611aa072d011d7ba84e3942a4b620d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">933 patent</a> (June 7, 1995), ′<a id="co_link_I4aee0d16d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999386170&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I804ca47072e611d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">422 patent</a> (August 2, 1993), and ′<a id="co_link_I4aee0d17d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998398894&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I9866fae0724311d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">349 patent</a> (June 6, 1995), to show that that the ′933, ′422, and ′<a id="co_link_I4aee0d18d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998398894&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I9866fae0724311d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">349 patents</a> are patentably indistinct over the ′<a id="co_link_I4aee0d19d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1987255753&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0ef6725072dd11d7b0409d11d16b6b13&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">008 patent</a>.</div></div><div class="co_paragraph"><div class="co_paragraphText">The question of impairment of a patentee's rights under <a id="co_link_I4aee0d1ad82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS120&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 120</a>, as applied to foreign applicants via <a id="co_link_I4aee0d1bd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS119&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C. § 119</a>, did not arise in <em>Takeda.</em><sup id="co_footnoteReference_B00772019808227_ID0E2SCK"><a href="#co_footnote_B00772019808227" class="co_footnoteReference">7</a></sup> Rather, the <em>Takeda</em> decision conferred upon the patentee an additional benefit outside the mandate of <a id="co_link_I4aee0d1ed82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS120&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 120</a>. Nevertheless, the <em>Takeda</em> court understood the interrelationship between <a id="co_link_I4aee0d20d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS120&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 120</a> and the timing rule it created. It recognized that the rule it crafted could “provide the patentee with the best of both worlds: the applicant can use the filing date as a shield, enjoying the earlier priority date in order to avoid prior art, <em>and</em> rely on later-developed alternative processes as a sword to defeat double patenting challenges.” <a id="co_link_I4aee0d21d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2018580593&amp;pubNum=506&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1377&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1377"><em>Takeda,</em> 561 F.3d at 1377.</a> Because of <a id="co_link_I4aee0d22d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS120&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 120</a>, we read <em>Takeda</em> to stand for the limited proposition that an applicant can only rely on subsequent developments in the art up to the filing date of the “secondary application” in order to show that alternative processes to make the product render the product and the process for making that product patentably distinct.</div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F82019808227" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF8">8</a><a id="co_anchor_B82019808227"></a><a href="#co_anchor_F92019808227" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF9">9</a><a id="co_anchor_B92019808227"></a> The claims of the ′933 and ′422 product patents, which we hold are not protected by the <a id="co_link_I4aee0d2ad82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 121</a> safe harbor, are related to the claims of the ′868 and ′698 process patents, although not in precisely the same way the claims of the product and process patents were related in <em>Takeda.</em> That is to say, the ′933 and ′<a id="co_link_I4aee0d2cd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999386170&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I804ca47072e611d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">422 patents</a> claim products which are made by processes claimed in the ′868 and ′<a id="co_link_I4aee0d2dd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">698 patents</a>. The ′<a id="co_link_I4aee0d2ed82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1998398894&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I9866fae0724311d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">349 patent</a> differs, however, from the ′933 and ′<a id="co_link_I4aee0d2fd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999386170&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I804ca47072e611d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">422 patents</a> in its relationship to the ′868 and ′<a id="co_link_I4aee0d30d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">698 patents</a> because it, like the ′868 and ′<a id="co_link_I4aee0d31d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">698 patents</a>, claims a process of producing recombinant EPO. The relationship between the ′933 and ′ 422, but not the ′349, claims and the ′868 and ′698 claims implicates the principle applied in <a id="co_link_I4aee0d32d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2018580593&amp;pubNum=506&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1375&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1375"><em>Takeda,</em> 561 F.3d at 1375,</a> that “double patenting is not sustainable when the product can be fabricated by processes other than that secured by the issued process patent.”<input id="co_docMarker_18" type="hidden">  <span class="co_starPage" id="co_pp_sp_506_1358"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sf679c9a4b2a811de9988d233d23fe599&quot;, &quot;pageNumber&quot;: &quot;1358&quot; }" alt="metadata" type="hidden">*1358</span> <a id="co_link_I4aee0d33d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1935129806&amp;pubNum=0000350&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_350_109&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_109"><em>In re Cady,</em> 22 C.C.P.A. 1190, 77 F.2d 106, 109 (1935)</a> (quotation marks omitted); <em>see also</em> <a id="co_link_I4aee0d34d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;pubNum=1015320&amp;cite=MPEPs806.05(f)&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=TS&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">MPEP § 806.05(f)</a>. On remand, <em>Takeda</em> will permit Amgen, if it wishes to do so, to rely on alternative processes for making the products claimed in the ′933 and ′<a id="co_link_I4aee0d36d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999386170&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I804ca47072e611d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"> 422 patents</a> up to their filing dates to prove that the claims of those patents and the claims of the ′868 and ′<a id="co_link_I4aee0d37d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">698 patents</a> are patentably distinct.<sup id="co_footnoteReference_B00882019808227_ID0EC5CK"><a href="#co_footnote_B00882019808227" class="co_footnoteReference">8</a></sup> If Amgen pursues that course, Roche will be free to rely on subsequent developments in the art up to the filing dates of the ′933 and ′<a id="co_link_I4aee0d38d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999386170&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I804ca47072e611d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"> 422 patents</a> to prove that any alternative processes put forth by Amgen do not render the claims of the ′933 and ′<a id="co_link_I4aee0d39d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999386170&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I804ca47072e611d7a07084608af77b15&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">422 patents</a> and the claims of the ′ 868 and ′<a id="co_link_I4aee0d3ad82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">698 patents patent</a>ably distinct. In other words, <em>Takeda</em> is a two-way street within its own confines.</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_I17113affd82d11e498db8b09b4f043e0"><div class="co_headtext co_hAlign2"><span class="co_smallCaps">D</span></div><div class="co_paragraph"><div class="co_paragraphText">Turning now to the process patents, the court granted Amgen JMOL that claims 1 and 2 of the ′<a id="co_link_I4aee0d41d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1995342658&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I6eeb62d0722711d7ba84e3942a4b620d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">868 patent</a> and claims 6–9 of the ′<a id="co_link_I4aee0d42d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">698 patent</a> are not invalid for obviousness-type double patenting over claim 27 of the ′<a id="co_link_I4aee0d43d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1987255753&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0ef6725072dd11d7b0409d11d16b6b13&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">008 patent</a>. <a id="co_link_I4aee0d44d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;pubNum=4637&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_4637_186&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_4637_186"><em>Amgen,</em> 581 F.Supp.2d at 186.</a> Since the parties had agreed that the <a id="co_link_I4aee0d45d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS121&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 121</a> safe harbor did not apply to these claims, the court engaged in an obviousness-type double patenting analysis. <a id="co_link_I4aee0d46d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 182–83.</a> The court first construed the claims in the ′008, ′868, and ′<a id="co_link_I4aee0d47d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">698 patents</a> and then determined that there were patentable differences. <a id="co_link_I4aee0d48d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a></div></div><div class="co_paragraph"><div class="co_paragraphText">The relevant claim of the ′008 reference patent is claim 27, which depends from claims 7, 8, 11, and 23–25. Those claims recite as follows:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText">7. A purified and isolated DNA sequence consisting essentially of a DNA sequence encoding a polypeptide having an amino acid sequence sufficiently duplicative of that of erythropoietin to allow possession of the biological property of causing bone marrow cells to increase production of <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=mproc&amp;entityId=Ib521ae85475411db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_Ib521ae85475411db9765f9243f53508a">reticulocytes</a> and red blood cells, and to increase <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=mproc&amp;entityId=Ibe736563475411db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_Ibe736563475411db9765f9243f53508a">hemoglobin</a> synthesis or iron uptake.</div></div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText">8. A cDNA sequence according to claim 7.</div></div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText">11. A genomic DNA sequence according to claim 7.</div></div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText">23. A procaryotic or eucaryotic host cell transformed or transfected with a DNA sequence according to claim 7, 8, or 11 in a manner allowing the host cell to express said polypeptide.</div></div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText">24. A transformed or transfected host cell according to claim 23 which host cell is capable of glycosylating said polypeptide.</div></div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText">25. A transformed or transfected mammalian host cell according to claim 24.</div></div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText">27. A transformed or transfected CHO cell according to claim 25.</div></div><div class="co_paragraphText co_flush">′<a id="co_link_I4aee0d4bd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1987255753&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0ef6725072dd11d7b0409d11d16b6b13&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">008 patent</a> col.40 ll.18–25, 30, 56–64, 67–68. In short, claim 27 recites a CHO cell—a mammalian cell capable of glycosylating EPO—transfected with a DNA sequence encoding a polypeptide having an amino acid sequence sufficiently duplicative of that of EPO to allow possession of the stated biological properties.</div></div><div class="co_paragraph"><div class="co_paragraphText">The asserted claims of the ′<a id="co_link_I4aee0d4cd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1995342658&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I6eeb62d0722711d7ba84e3942a4b620d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">868 patent</a> are independent claim 1 and dependent claim 2, which recite as follows:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText">1. A process for the production of a glycosylated erythropoietin polypeptide having the in vivo biological property of causing bone marrow cells to increase production of <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=mproc&amp;entityId=Ib521ae85475411db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_Ib521ae85475411db9765f9243f53508a_0">reticulocytes</a> and red blood cells comprising the steps of:</div></div><div class="co_paragraph co_indentLeft2"><div class="co_paragraphText"> <span class="co_starPage" id="co_pp_sp_506_1359"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sf679c9a4b2a811de9988d233d23fe599&quot;, &quot;pageNumber&quot;: &quot;1359&quot; }" alt="metadata" type="hidden">*1359</span> (a) growing, under suitable nutrient conditions, mammalian host cells transformed or transfected with an isolated DNA sequence encoding human erythropoietin; and</div></div><div class="co_paragraph co_indentLeft2"><div class="co_paragraphText">(b) isolating said glycosylated erythropoietin polypeptide therefrom.</div></div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText">2. The process according to claim 1 wherein said host cells are CHO cells.</div></div><div class="co_paragraphText co_flush">′<a id="co_link_I4aee0d4ed82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1995342658&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I6eeb62d0722711d7ba84e3942a4b620d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">868 patent</a> col.40 ll.24–37. In short, claims 1 and 2 cover a process of producing EPO that involves (a) growing mammalian (CHO in claim 2) cells transfected with DNA encoding EPO and (b) isolating from those cells glycosylated EPO having the stated biological properties in vivo (i.e., in live animals).<input id="co_docMarker_19" type="hidden"></div></div><div class="co_paragraph"><div class="co_paragraphText">The asserted claims of the ′<a id="co_link_I4aee0d4fd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">698 patent</a> are independent claim 6 and dependent claims 7–9, which recite as follows:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText">6. A process for the production of a glycosylated erythropoietin polypeptide having the in vivo biological property of causing bone marrow cells to increase production of <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=mproc&amp;entityId=Ib521ae85475411db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_Ib521ae85475411db9765f9243f53508a_1">reticulocytes</a> and red blood cells comprising the steps of:</div></div><div class="co_paragraph co_indentLeft2"><div class="co_paragraphText">a) growing, under suitable nutrient conditions, vertebrate cells comprising amplified DNA encoding the mature erythropoietin amino acid sequence of FIG. 6; and</div></div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText">b) isolating said glycosylated erythropoietin polypeptide expressed by said cells.</div></div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText">7. The process of claim 6 wherein said vertebrate cells further comprise amplified marker gene DNA.</div></div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText">8. The process of claim 7 wherein said amplified marker gene DNA is Dihydrofolate reductase (DHFR) gene DNA.</div></div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText">9. The process according to claims 2, 4 and 6 wherein said cells are mammalian cells.</div></div><div class="co_paragraphText co_flush">′<a id="co_link_I4aee0d51d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">698 patent</a> col.38 ll.50–64. Claims 6–9 of the ′<a id="co_link_I4aee0d52d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">698 patent</a> are similar to claims 1 and 2 of the ′<a id="co_link_I4aee0d53d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1995342658&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I6eeb62d0722711d7ba84e3942a4b620d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">868 patent</a>, but with an additional limitation that the host cells comprise amplified DNA (which includes a marker gene in claim 7 that is DHFR in claim 8).</div></div><div class="co_paragraph"><div class="co_paragraphText">The district court determined that the asserted claims in the ′868 and ′<a id="co_link_I4aee0d54d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">698 patents</a> were patentably distinct from claim 27 of the ′<a id="co_link_I4aee0d55d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1987255753&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0ef6725072dd11d7b0409d11d16b6b13&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">008 patent</a>. The court identified the following differences between the asserted claims of the ′ 868 and ′<a id="co_link_I4aee0d56d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1987255753&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0ef6725072dd11d7b0409d11d16b6b13&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">008 patents</a>:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText"><blockquote><div>“Unlike the asserted claims of the ′<a id="co_link_I4aee0d57d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1995342658&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I6eeb62d0722711d7ba84e3942a4b620d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">868 patent</a>, none of the ′008 claims require: (1) that the recited host cell actually express any EPO polypeptide; (2) that the recited host cell actually express a glycosylated EPO polypeptide; (3) that the host cell be capable of producing an isolatable amount of a glycosylated EPO polypeptide; and (4) that any glycosylated EPO isolated from cells grown in culture have the stated in vivo function.”</div></blockquote></div></div><div class="co_paragraphText co_flush"><a id="co_link_I4aee0d58d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;pubNum=0004637&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_4637_184&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_4637_184"><em>Amgen,</em> 581 F.Supp.2d at 184</a> (quoting Pl's Mem. Supp. No Obviousness–Type Double Patenting [Doc. 1310] at 41). Citing the declaration testimony of Amgen's expert, Dr. Harvey F. Lodish, the court deduced that “[s]imply having the starting material (which is reflected in the ′<a id="co_link_I4aee0d59d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1987255753&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0ef6725072dd11d7b0409d11d16b6b13&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">008 patent</a>) and knowing that, in theory, it can be used to create proteins is not the equivalent of having an actual process that successfully does so.” <a id="co_link_I4aee0d5ad82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;pubNum=4637&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_4637_184&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_4637_184"><em>Amgen,</em> 581 F.Supp.2d at 184.</a> For similar reasons, the court concluded that claims 6–9 of the ′<a id="co_link_I4aee0d5bd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"> 698 patent</a> were also patentably distinct over the claims of the ′<a id="co_link_I4aee0d5cd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1987255753&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0ef6725072dd11d7b0409d11d16b6b13&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">008 patent</a>. <a id="co_link_I4aee0d5dd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 186.</a> It determined that “[t]o be able to produce [a glycosylated, in vivo biologically active EPO product] from cells containing multiple copies of EPO DNA would have been novel to one skilled in the art at the time of the invention (even if the skilled artisan had possession of the product claimed in the ′<a id="co_link_I4aee0d5ed82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1987255753&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0ef6725072dd11d7b0409d11d16b6b13&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">008 patent</a>).” <a id="co_link_I4aee0d5fd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> The court also noted that the “PTO found the ′868 and ′698 claims patentably distinct from those in the ′<a id="co_link_I4aee0d60d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1987255753&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0ef6725072dd11d7b0409d11d16b6b13&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"> 008 patent</a>.” <a id="co_link_I4aee0d61d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> From there, the court concluded: “The credible evidence shows, and  <span class="co_starPage" id="co_pp_sp_506_1360"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sf679c9a4b2a811de9988d233d23fe599&quot;, &quot;pageNumber&quot;: &quot;1360&quot; }" alt="metadata" type="hidden">*1360</span> the Court so finds, that each invention claimed in the ′868 and ′698 asserted claims is patentably distinct from each invention claimed in the ′<a id="co_link_I4aee0d62d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1987255753&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0ef6725072dd11d7b0409d11d16b6b13&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">008 patent</a>.” <a id="co_link_I4aee0d63d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a></div></div><div class="co_paragraph"><div class="co_paragraphText">On appeal, Roche contends that claims 1 and 2 of the ′<a id="co_link_I4aee0d64d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1995342658&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I6eeb62d0722711d7ba84e3942a4b620d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">868 patent</a> and claims 6–9 of the ′<a id="co_link_I4aee0d65d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">698 patent</a> are obvious over claim 27 of the ′<a id="co_link_I4aee0d66d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1987255753&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0ef6725072dd11d7b0409d11d16b6b13&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">008 patent</a>. Roche's Br. 28. Roche characterizes claim 27 of the ′<a id="co_link_I4aee0d67d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1987255753&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0ef6725072dd11d7b0409d11d16b6b13&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">008 patent</a> as drawn to host cells capable of expressing a glycosylated EPO polypeptide that “allow[s] possession” of in vivo biological EPO activity. <a id="co_link_I4aee0d68d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> In turn, it characterizes claims 1 and 2 of the ′<a id="co_link_I4aee0d69d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1995342658&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I6eeb62d0722711d7ba84e3942a4b620d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">868 patent<input id="co_docMarker_20" type="hidden"></a> and claims 6–9 of the ′<a id="co_link_I4aee0d6ad82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"> 698 patent</a> as drawn to processes for producing in host cells EPO “having” that stated activity. <a id="co_link_I4aee0d6bd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> Roche argues that this difference—“having” rather than “allow[ing] possession” of the stated activity—is not a patentable distinction. <a id="co_link_I4aee0d6cd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> In Roche's view, “having” in vivo activity is obvious if the originally claimed host cells “allow possession” of such activity. <a id="co_link_I4aee0d6dd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017203599&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a></div></div><div class="co_paragraph"><div class="co_paragraphText">Roche also argues that claim 27 of the ′<a id="co_link_I4aee0d6ed82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1987255753&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0ef6725072dd11d7b0409d11d16b6b13&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">008 patent</a> created a reasonable expectation that an ordinarily skilled artisan could successfully practice the processes described in the asserted claims of the ′868 and ′<a id="co_link_I4aee0d6fd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">698 patents</a>. <a id="co_link_I4aee0d70d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 31.</a> Claim 27 of the ′<a id="co_link_I4aee0d71d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1987255753&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0ef6725072dd11d7b0409d11d16b6b13&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">008 patent</a> evidences on its face a reasonable expectation of success, according to Roche, because it “allow[s] possession” of biologically active EPO—the invention recited in the asserted claims of the ′868 and ′<a id="co_link_I4aee80f0d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">698 patents</a>. Roche's Reply Br. 8. In addition, Roche argues that Dr. Lodish's testimony demonstrates that an ordinarily skilled artisan would have had a reasonable expectation of success of producing biologically active EPO in CHO cells. <a id="co_link_I4aee80f1d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> Specifically, Roche highlights Dr. Lodish's testimony that a person of ordinary skill in the art could use claim 27's host cells to express a functional protein “without any difficulty.” <a id="co_link_I4aee80f2d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> (quoting Trial Tr. vol. 2, 109, Oct. 4, 2007). Lastly, Roche points to Dr. Lin's admission that he expected that the claim 27 host cells would have in vivo activity. <a id="co_link_I4aee80f3d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 9–11 (citing Trial Tr. vol 12, 1884, Sept. 27, 2007)</a>.</div></div><div class="co_paragraph"><div class="co_paragraphText">Amgen responds that claim 27 of the ′<a id="co_link_I4aee80f4d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1987255753&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0ef6725072dd11d7b0409d11d16b6b13&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">008 patent</a> does not render obvious claims 1 and 2 of the ′<a id="co_link_I4aee80f5d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1995342658&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I6eeb62d0722711d7ba84e3942a4b620d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">868 patent</a> or claims 6–9 of the ′<a id="co_link_I4aee80f6d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">698 patent</a>. Amgen's Br. 25. Amgen argues that, contrary to Roche's contention, the host cells recited in claim 27 of the ′<a id="co_link_I4aee80f7d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1987255753&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0ef6725072dd11d7b0409d11d16b6b13&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">008 patent</a> do not inevitably produce the biologically active EPO required by the asserted claims of the ′868 and ′<a id="co_link_I4aee80f8d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">698 patents</a>. <a id="co_link_I4aee80f9d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> Amgen emphasizes that it is not the host cells that “allow possession of” the stated biological activities; rather, it is the amino acid sequence encoded by the DNA recited in claim 27. <a id="co_link_I4aee80fad82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 28.</a> This distinction is critical, in Amgen's view, because there is a vast difference between a CHO cell equipped to produce a polypeptide whose amino acid sequence may permit possession of certain biological activity, and a process that produces a human glycoprotein that actually possesses that activity. <a id="co_link_I4aee80fbd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 29.</a> In other words, Amgen argues that while an EPO polypeptide sequence might be necessary, it alone would not be sufficient to produce an EPO product with the stated biological activities. <a id="co_link_I4aee80fcd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a></div></div><div class="co_paragraph"><div class="co_paragraphText">Amgen also argues that an ordinarily skilled artisan in 1983–84 would not have reasonably expected the host cells in claim 27 of the ′<a id="co_link_I4aee80fdd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1987255753&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0ef6725072dd11d7b0409d11d16b6b13&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">008 patent</a> to produce the isolatable, biologically active EPO required by the asserted claims of the ′868 and ′<a id="co_link_I4aee80fed82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">698 patents</a>. <a id="co_link_I4aee80ffd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 32.</a> According to Amgen, before 1984, it was not known whether any recombinant cell—including non-human CHO cells—could be engineered to produce a human EPO glycoprotein with in vivo biological activity. <a id="co_link_I4aee8100d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> Amgen points out that Dr. Lodish testified at trial that, before 1984, no one had successfully produced any recombinant human glycoprotein <span class="co_starPage" id="co_pp_sp_506_1361"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sf679c9a4b2a811de9988d233d23fe599&quot;, &quot;pageNumber&quot;: &quot;1361&quot; }" alt="metadata" type="hidden">*1361</span>  where the carbohydrate structures were required for biological activity. <a id="co_link_I4aee8101d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 33</a> (citing Trial Tr. vol. 2, 83, 102–103, Oct. 4, 2007). As a result, Amgen contends, skilled artisans could not have reasonably expected CHO cells to produce a biologically active EPO glycoprotein. <a id="co_link_I4aee8102d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a></div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F102019808227" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF10">10</a><a id="co_anchor_B102019808227"></a> We agree with the district court that claims 1 and 2 of the ′<input id="co_docMarker_21" type="hidden"><a id="co_link_I4aee8103d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1995342658&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I6eeb62d0722711d7ba84e3942a4b620d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">868 patent</a> and claims 6–9 of the ′<a id="co_link_I4aee8104d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">698 patent</a> are not invalid for obviousness-type double patenting over claim 27 of the ′<a id="co_link_I4aee8105d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1987255753&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0ef6725072dd11d7b0409d11d16b6b13&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">008 patent</a>. The obviousness-type double patenting analysis entails two steps: (1) construction of the claims in the earlier patent and the claim in the later patent to identify any differences, and (2) determination of whether the differences in subject matter between the claims render the claims patentably distinct. <em>See </em><a id="co_link_I4aee8106d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2001454897&amp;pubNum=0000506&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_968&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_968"><em>Eli Lilly &amp; Co. v. Barr Labs., Inc.,</em> 251 F.3d 955, 968 (Fed.Cir.2001)</a>. Accordingly, we begin our obviousness-type double patenting analysis, as the district court's analysis began, by construing the claims and identifying any differences. As mentioned, claim 27 of the ′<a id="co_link_I4aee8107d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1987255753&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0ef6725072dd11d7b0409d11d16b6b13&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">008 patent</a> recites a CHO cell—a mammalian cell capable of glycosylating EPO—transfected with a DNA sequence encoding a polypeptide having an amino acid sequence sufficiently duplicative of that of EPO to allow possession of the stated biological properties. Claims 1 and 2 of the ′<a id="co_link_I4aee8108d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1995342658&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I6eeb62d0722711d7ba84e3942a4b620d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">868 patent</a> and claims 6–9 of the ′<a id="co_link_I4aee8109d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">698 patent</a> recite processes of producing EPO that involve (a) growing mammalian cells transfected with DNA encoding EPO and (b) isolating from those cells glycosylated EPO having the stated biological properties.</div></div><div class="co_paragraph"><div class="co_paragraphText">In essence, claim 27 of the ′<a id="co_link_I4aee810ad82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1987255753&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0ef6725072dd11d7b0409d11d16b6b13&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">008 patent</a> recites the starting materials necessary to execute the processes recited in the asserted claims of the ′868 and ′<a id="co_link_I4aee810bd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">698 patents</a>. The cells described in claim 27 are “capable of glycosylating” EPO and are transfected with DNA encoding a polypeptide “having an amino acid sequence sufficiently duplicative of that of erythropoietin to allow possession” of the stated biological activities. Neither of these limitations in claim 27, however, requires that the cells actually produce isolatable amounts of glycosylated EPO having the stated in vivo bioactivity. In contrast, the asserted claims of the ′868 and ′<a id="co_link_I4aee810cd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">698 patents</a> do require actual production of isolatable amounts of the in vivo biologically active EPO glycoprotein. In addition to possessing the transfected CHO cells recited in claim 27 of the ′<a id="co_link_I4aee810dd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1987255753&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0ef6725072dd11d7b0409d11d16b6b13&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">008 patent</a>, an ordinarily skilled artisan practicing the asserted claims of the ′868 and ′<a id="co_link_I4aee810ed82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">698 patents</a> would need to grow those cells and isolate from them glycosylated EPO having the stated in vivo biological properties. Thus, the main difference between claim 27 of the ′<a id="co_link_I4aee810fd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1987255753&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0ef6725072dd11d7b0409d11d16b6b13&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">008 patent</a> and the asserted claims of the ′868 and ′<a id="co_link_I4aee8110d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">698 patents</a> is the actual production of isolatable glycosylated EPO having the stated in vivo biological activities.</div></div><div class="co_paragraph"><div class="co_paragraphText">Next, we must determine whether this difference renders claims 1 and 2 of the ′<a id="co_link_I4aee8111d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1995342658&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I6eeb62d0722711d7ba84e3942a4b620d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">868 patent</a> and claims 6–9 of the ′<a id="co_link_I4aee8112d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">698 patent patent</a>ably distinct over claim 27 of the ′<a id="co_link_I4aee8113d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1987255753&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0ef6725072dd11d7b0409d11d16b6b13&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">008 patent</a>. In so doing, we ask whether the identified difference renders the claims of the ′868 and ′<a id="co_link_I4aee8114d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">698 patents</a> non-obvious to a person of ordinary skill in the art in light of the prior art. <em>See </em><a id="co_link_I4aee8115d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1986123917&amp;pubNum=0000350&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_350_1580&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_1580"><em>In re Kaplan,</em> 789 F.2d 1574, 1580 (Fed.Cir.1986)</a>. This part of the obviousness-type double patenting analysis is analogous to an obviousness analysis under <a id="co_link_I4aee8116d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS103&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C. § 103</a>, except that the ′<a id="co_link_I4aee8117d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1987255753&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0ef6725072dd11d7b0409d11d16b6b13&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">008 patent</a> is not considered prior art. <em>See </em><a id="co_link_I4aee8118d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1985118268&amp;pubNum=0000350&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_350_892&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_892"><em>In re Longi,</em> 759 F.2d 887, 892 n. 4 (Fed.Cir.1985)</a> (“[A] double patenting of the obviousness type rejection is analogous to [a failure to meet] the non-obviousness requirement of <a id="co_link_I4aee8119d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS103&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C. § 103</a>, except that the patent principally underlying the double patenting rejection is not considered prior art.” (quotation marks omitted)).</div></div><div class="co_paragraph"><div class="co_paragraphText"> <span class="co_starPage" id="co_pp_sp_506_1362"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sf679c9a4b2a811de9988d233d23fe599&quot;, &quot;pageNumber&quot;: &quot;1362&quot; }" alt="metadata" type="hidden">*1362</span> <a href="#co_anchor_F112019808227" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF11">11</a><a id="co_anchor_B112019808227"></a> An obviousness determination requires that a skilled artisan would have perceived a reasonable expectation of success in making the invention in light of the prior art.<input id="co_docMarker_22" type="hidden"> <em>See </em><a id="co_link_I4aee811ad82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2018532882&amp;pubNum=0000506&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1360&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1360"><em>In re Kubin,</em> 561 F.3d 1351, 1360 (Fed.Cir.2009)</a> (“[S]tated in the familiar terms of this court's longstanding case law, the record shows that a skilled artisan would have had a resoundingly ‘reasonable expectation of success' in deriving the claimed invention in light of the teachings of the prior art.”); <a id="co_link_I4aee811bd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1988103052&amp;pubNum=0000350&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_350_904&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_904"><em>In re O'Farrell,</em> 853 F.2d 894, 904 (Fed.Cir.1988)</a> (“For obviousness under <a id="co_link_I4aee811cd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS103&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">§ 103</a>, all that is required is a reasonable expectation of success.”); <em>see also </em><a id="co_link_I4aee811dd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1985118268&amp;pubNum=0000350&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_350_896&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_896"><em>Longi,</em> 759 F.2d at 896–97</a> (holding that a patent application was properly rejected for obviousness-type double patenting where the prior art references indicated a reasonable expectation of success). At trial, Roche had the burden of showing by clear and convincing evidence that a person of ordinary skill in the art in possession of the transfected CHO cells would have had a reasonable expectation of success in producing a recoverable amount of in vivo biologically active EPO. <em>See </em><a id="co_link_I4aee811ed82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2012652319&amp;pubNum=0000506&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1360&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1360"><em>PharmaStem Therapeutics, Inc. v. Viacell, Inc.,</em> 491 F.3d 1342, 1360 (Fed.Cir.2007)</a> (“[T]he burden falls on the patent challenger to show by clear and convincing evidence that a person of ordinary skill in the art would have had reason to ... carry out the claimed process, and would have had a reasonable expectation of success in doing so.”). Whether an ordinarily skilled artisan would have reasonably expected success in practicing the asserted claims of the ′868 and ′<a id="co_link_I4aee811fd82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">698 patents</a> is measured as of the date of the inventions described in those patents.<sup id="co_footnoteReference_B00992019808227_ID0EVSEK"><a href="#co_footnote_B00992019808227" class="co_footnoteReference">9</a></sup> <em>See </em><a id="co_link_I4aee8120d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2000531625&amp;pubNum=0000506&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=RP&amp;fi=co_pp_sp_506_1326&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1326"><em>Life Techs., Inc. v. Clontech Labs., Inc.,</em> 224 F.3d 1320, 1326 (Fed.Cir.2000)</a> (measuring reasonable expectation of success from the perspective of a person of ordinary skill in the art at the time the invention was made).</div></div><div class="co_paragraph"><div class="co_paragraphText">In our view, the identified difference between the asserted claims of the ′868 and ′<a id="co_link_I4aee8126d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">698 patents</a> and claim 27 of the ′<a id="co_link_I4aee8127d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1987255753&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0ef6725072dd11d7b0409d11d16b6b13&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">008 patent</a> renders the claims patentably distinct. We conclude that the actual production of glycosylated EPO having the stated in vivo biological activities would not have been obvious to an ordinarily skilled artisan in possession of the transfected CHO cells described in claim 27. That is because one of ordinary skill in the art would not have reasonably expected to successfully produce isolatable quantities of glycosylated EPO having the stated biological activities in transfected CHO cells. Put most simply, CHO cells transfected with the EPO DNA sequence and the production of recombinant, in vivo biologically active EPO glycoprotein are patentably distinct inventions.</div></div><div class="co_paragraph"><div class="co_paragraphText">We reach this conclusion in light of Dr. Lodish's declarations and testimony at trial, which demonstrate that an ordinarily skilled artisan would not have reasonably expected success in producing recombinant, in vivo biologically active EPO in CHO cells. According to Dr. Lodish, there are at least two reasons why, prior to Dr. Lin's inventions, a person of ordinary skill in the art would not have had a reasonable expectation of practicing the asserted claims of the ′868 and ′<a id="co_link_I4aee8128d82d11e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997305524&amp;pubNum=0004074&amp;originatingDoc=Ie59924e3a21711dea82ab9f4ee295c21&amp;refType=PA&amp;docFamilyGuid=I0f83f2b0744511d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">698 patents</a>: (1) an ordinarily skilled artisan would not have known which, if any, host cells would produce EPO with the carbohydrate structures necessary for its in vivo function; and (2) no one had successfully  <span class="co_starPage" id="co_pp_sp_506_1363"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sf679c9a4b2a811de9988d233d23fe599&quot;, &quot;pageNumber&quot;: &quot;1363&quot; }" alt="metadata" type="hidden">*1363</span> produced any recombinant glycoprotein with in vivo bioactivity where the carbohydrate structures were important for biological activity.<sup id="co_footnoteReference_B010102019808227_ID0ELXEK"><a href="#co_footnote_B010102019808227" class="co_footnoteReference">10</a></sup> Trial Tr. vol. 2, 83, 102–04, Oct. 4, 2007. As a result, Dr. Lodish testified, an ordinarily skilled artisan would have had “great uncertainty in the ability to make recombinant EPO with carbohydrate chains for in vivo biological activity.”<input id="co_docMarker_23" type="hidden"> Trial Tr. vol. 2, 96, Oct. 4, 2007. According to this testimony and declarations to the same effect, we conclude, like the district court concluded, that a person of ordinary skill in the art would not have reasonably expected to successfully isolate from transfected CHO cells recombinant EPO glycoprotein having the stated biological activities.</div></div></div></div></div></div></div></div><input class="co_chunkNumber" value="0" type="hidden"></div><input id="co_document_metaInfo_Ie59924e3a21711dea82ab9f4ee295c21" value="{&quot;FirstLineCite&quot;:null,&quot;PU&quot;:null,&quot;accessControl&quot;:null,&quot;accessionNumber&quot;:&quot;&quot;,&quot;acquirerCompany&quot;:null,&quot;activeDate&quot;:null,&quot;additionalLinks&quot;:null,&quot;agreementDisplayDate&quot;:null,&quot;announcementDate&quot;:null,&quot;articleTitle&quot;:null,&quot;borrower&quot;:null,&quot;caseRequired&quot;:null,&quot;ciCompany&quot;:null,&quot;cicOfficer&quot;:null,&quot;cipOfficer&quot;:null,&quot;cite&quot;:&quot;580 F.3d 1340&quot;,&quot;citeAbbreviation&quot;:null,&quot;citePrimary&quot;:null,&quot;city&quot;:null,&quot;collection&quot;:&quot;w_cs_fed1&quot;,&quot;compoundTitle&quot;:null,&quot;containerId&quot;:null,&quot;containerType&quot;:null,&quot;contentType&quot;:&quot;Cases&quot;,&quot;contentTypeId&quot;:&quot;1&quot;,&quot;correlationIds&quot;:null,&quot;country&quot;:null,&quot;countryDocumentCountry&quot;:null,&quot;countryDocumentGuid&quot;:null,&quot;court&quot;:&quot;C.A.Fed. (Mass.)&quot;,&quot;courtDocumentType&quot;:null,&quot;courtNumber&quot;:&quot;4229&quot;,&quot;courtYear&quot;:&quot;C.A.Fed. (Mass.),2009.&quot;,&quot;date&quot;:&quot;September 15, 2009&quot;,&quot;dateFile&quot;:&quot;September 15, 2009&quot;,&quot;dealDate&quot;:null,&quot;dealTrackPublishDate&quot;:null,&quot;dealType&quot;:null,&quot;dealValue&quot;:null,&quot;description&quot;:null,&quot;docFamilyGuid&quot;:&quot;Ie59924e4a21711dea82ab9f4ee295c21&quot;,&quot;docGuid&quot;:&quot;Ie59924e3a21711dea82ab9f4ee295c21&quot;,&quot;docLink&quot;:&quot;https://1.next.westlaw.com/Document/Ie59924e3a21711dea82ab9f4ee295c21/View/FullText.html?originationContext=document&amp;contextData=(sc.CustomDigest)&amp;needToInjectTerms=False&quot;,&quot;documentTitle&quot;:null,&quot;edgarFileNumber&quot;:null,&quot;entityId&quot;:null,&quot;expertType&quot;:null,&quot;fileName&quot;:null,&quot;fileNumber&quot;:&quot;&quot;,&quot;fileSize&quot;:0,&quot;fileType&quot;:null,&quot;filerCik&quot;:null,&quot;filerName&quot;:null,&quot;filingDate&quot;:null,&quot;filingYear&quot;:null,&quot;firmName&quot;:null,&quot;formNumber&quot;:null,&quot;formSubType&quot;:null,&quot;formType&quot;:null,&quot;formTypeDisplay&quot;:null,&quot;formVolume&quot;:null,&quot;functionalCite&quot;:&quot;580 F.3d 1340&quot;,&quot;fundFirmCompoundTitle&quot;:null,&quot;fundLocation&quot;:null,&quot;fundName&quot;:null,&quot;fundTargetSize&quot;:null,&quot;fundType&quot;:null,&quot;fundYear&quot;:null,&quot;fundraisingStatus&quot;:null,&quot;getTocData&quot;:false,&quot;hasDraftingNotes&quot;:null,&quot;hasVideoContent&quot;:null,&quot;impersonationKey&quot;:null,&quot;inlineKeyCiteFlagsIncluded&quot;:false,&quot;inlineKeyCiteFlagsResolutionStatus&quot;:null,&quot;insiderName&quot;:null,&quot;ip_assignmentsAction&quot;:null,&quot;ip_citeParallel&quot;:null,&quot;ip_derwentPublishedDate&quot;:null,&quot;ip_docket&quot;:null,&quot;ip_documentDate&quot;:&quot;September 15, 2009&quot;,&quot;ip_issuedDate&quot;:null,&quot;ip_litAlertAttorney&quot;:null,&quot;ip_patStatCode&quot;:null,&quot;ip_patentOwner&quot;:null,&quot;ip_publishedDate&quot;:null,&quot;ip_shortTitle&quot;:null,&quot;isDisplayMiniReport&quot;:false,&quot;isGatewayDocument&quot;:false,&quot;isLargeDocument&quot;:false,&quot;isPersistedContent&quot;:false,&quot;isPublicRecordsBlockedByPermissibleUse&quot;:false,&quot;isPublicRecordsBlockedBySocialSecurityAdmin&quot;:false,&quot;isPublicRecordsDocument&quot;:false,&quot;isRefsAndAnnos&quot;:false,&quot;isRegChangeDocument&quot;:false,&quot;isSearchable&quot;:null,&quot;isSecureContent&quot;:false,&quot;issueDate&quot;:null,&quot;issuerName&quot;:null,&quot;jobDescription&quot;:null,&quot;judge&quot;:&quot;SCHALL, Circuit Judge.&quot;,&quot;jurisAbbrev&quot;:null,&quot;jurisdiction&quot;:&quot;MA&quot;,&quot;jurisdictionFacet&quot;:&quot;Federal|**|Cts. of Appeals|**|Federal Cir.&quot;,&quot;jurisdictionText&quot;:&quot;Massachusetts&quot;,&quot;knos&quot;:null,&quot;lastRoundExitComb&quot;:null,&quot;legacyId&quot;:&quot;2019808227&quot;,&quot;letterType&quot;:null,&quot;locationOfIncorporation&quot;:null,&quot;maxOfferingPrice&quot;:null,&quot;natureOfTransaction&quot;:null,&quot;newsImageHrefLarge&quot;:null,&quot;newsImageHrefSmall&quot;:null,&quot;normalizedDocType&quot;:null,&quot;normalizedFormType&quot;:null,&quot;offeringType&quot;:null,&quot;organizationName&quot;:null,&quot;originatingDoc&quot;:null,&quot;pageCount&quot;:null,&quot;persistedDocGuid&quot;:null,&quot;plcFirmStyleAvailable&quot;:false,&quot;plcResourceName&quot;:&quot;&quot;,&quot;portfolioCompanyLocation&quot;:null,&quot;portfolioCompanyName&quot;:null,&quot;prMetaInfo1&quot;:null,&quot;prMetaInfo2&quot;:null,&quot;prMetaInfo3&quot;:null,&quot;prMetaInfo4&quot;:null,&quot;prMetaInfo5&quot;:null,&quot;primaryEditorialService&quot;:null,&quot;profileType&quot;:null,&quot;pubSeries&quot;:null,&quot;publishDate&quot;:null,&quot;questionText&quot;:null,&quot;redlined&quot;:false,&quot;registrationDate&quot;:null,&quot;renditionId&quot;:&quot;I1A0FD0301DD211B2831F8800820C0E34&quot;,&quot;royaltyId&quot;:&quot;0&quot;,&quot;rulebookNViews&quot;:null,&quot;serialNumber&quot;:&quot;2019808227&quot;,&quot;status&quot;:null,&quot;subContentType&quot;:&quot;Caselaw - NRS&quot;,&quot;subContentTypeId&quot;:&quot;27&quot;,&quot;subTitle&quot;:null,&quot;targetCompany&quot;:null,&quot;testimonyType&quot;:null,&quot;titleHtml&quot;:&quot;Amgen Inc. v. F. Hoffman-La Roche Ltd&quot;,&quot;titleText&quot;:&quot;Amgen Inc. v. F. Hoffman-La Roche Ltd&quot;,&quot;totalAmountIssuedWithCurrency&quot;:null,&quot;totalPages&quot;:&quot;&quot;,&quot;trademarkStatus&quot;:null,&quot;transactionAmountWithCurrency&quot;:null,&quot;transactionValue&quot;:null,&quot;valuationComb&quot;:null,&quot;viewExpressions&quot;:&quot;EDR|EVD|EZ5|E3I|P3D|000&quot;,&quot;westlawDatabaseIdentifier&quot;:&quot;AWFED2&quot;,&quot;westlawDocumentNumber&quot;:&quot;1032682&quot;}" type="hidden"><input id="co_document_documentNavigation_Search_Search-v1-results-navigation-i0ad6ad3e0000016314b8705c8686bce0-Nav-CUSTOMDIGEST-fragmentIdentifier-Ie59924e3a21711dea82ab9f4ee295c21-startIndex-1-contextData--28sc.CustomDigest-29-transitionType-CustomDigestItem_CUSTOMDIGEST_170" value="{&quot;AnswerSnippetId&quot;:null,&quot;CurrentDocumentGuid&quot;:&quot;Ie59924e3a21711dea82ab9f4ee295c21&quot;,&quot;CurrentPosition&quot;:170,&quot;CurrentWatsonAnswerText&quot;:null,&quot;EnableConceptCounts&quot;:false,&quot;HighlightPoints&quot;:null,&quot;HighlightTerms&quot;:null,&quot;InPlanUrl&quot;:null,&quot;IsSnapSnippet&quot;:false,&quot;ListCount&quot;:718,&quot;Message&quot;:null,&quot;NextDocument&quot;:{&quot;SkipLinkOutDoc&quot;:false,&quot;Title&quot;:&quot;Abbott Laboratories v. Sandoz, Inc.&quot;,&quot;Url&quot;:&quot;/Document/Ic0acd4ce445311dea82ab9f4ee295c21/View/FullText.html?navigationPath=Search%2Fv1%2Fresults%2Fnavigation%2Fi0ad6ad3e0000016314b8705c8686bce0%3FNav%3DCUSTOMDIGEST%26fragmentIdentifier%3DIc0acd4ce445311dea82ab9f4ee295c21%26startIndex%3D1%26contextData%3D%2528sc.CustomDigest%2529%26transitionType%3DCustomDigestItem&amp;listSource=Search&amp;list=CUSTOMDIGEST&amp;rank=171&amp;grading=na&amp;sessionScopeId=35b024c40cf4110fbdaaf6a30272ec9b29310adb8108a3d6fb727f98020766f7&amp;originationContext=Custom%20Digest&amp;transitionType=CustomDigestItem&amp;contextData=%28sc.CustomDigest%29&amp;listPageSource=1b34510ac2bede0102300be6a61ae1f3#co_anchor_F92018850794&quot;},&quot;NovusQueryType&quot;:null,&quot;NovusSearchResult&quot;:null,&quot;NumberOfSnips&quot;:0,&quot;ParagraphId&quot;:null,&quot;PreviousDocument&quot;:{&quot;SkipLinkOutDoc&quot;:false,&quot;Title&quot;:&quot;Amgen Inc. v. F. Hoffman-La Roche Ltd&quot;,&quot;Url&quot;:&quot;/Document/Ie59924e3a21711dea82ab9f4ee295c21/View/FullText.html?navigationPath=Search%2Fv1%2Fresults%2Fnavigation%2Fi0ad6ad3e0000016314b8705c8686bce0%3FNav%3DCUSTOMDIGEST%26fragmentIdentifier%3DIe59924e3a21711dea82ab9f4ee295c21%26startIndex%3D1%26contextData%3D%2528sc.CustomDigest%2529%26transitionType%3DCustomDigestItem&amp;listSource=Search&amp;list=CUSTOMDIGEST&amp;rank=169&amp;grading=na&amp;sessionScopeId=35b024c40cf4110fbdaaf6a30272ec9b29310adb8108a3d6fb727f98020766f7&amp;originationContext=Custom%20Digest&amp;transitionType=CustomDigestItem&amp;contextData=%28sc.CustomDigest%29&amp;listPageSource=1b34510ac2bede0102300be6a61ae1f3#co_anchor_F142019808227&quot;},&quot;ReturnTo&quot;:{&quot;SkipLinkOutDoc&quot;:false,&quot;Title&quot;:&quot;list&quot;,&quot;Url&quot;:&quot;/Search/Results.html?jurisdiction=CTAF&amp;contentType=CUSTOMDIGEST&amp;querySubmissionGuid=i0ad6ad3e0000016314b8705c8686bce0&amp;tocGuid=I4aee2539c6f64c1812a4c2f3395c2607&amp;categoryPageUrl=Home%2FWestKeyNumberSystem&amp;searchId=i0ad6ad3a0000016314b861eab2033b51&amp;collectionSet=w_cs_cd_toc&amp;transitionType=ReturnToList&amp;contextData=%28sc.CustomDigest%29#Ie59924e3a21711dea82ab9f4ee295c21&quot;},&quot;SearchQuery&quot;:null,&quot;SearchQueryType&quot;:null,&quot;SearchWithinQuery&quot;:null,&quot;SecondaryHighlightTerms&quot;:null,&quot;ShowSkipOutOfPlanOption&quot;:false}" type="hidden"><div id="co_nrsOutline" class="co_hideState"></div><input id="co_documentContentCacheKey" value="WestlawNext|none|Ie59924e3a21711dea82ab9f4ee295c21|||||||Search|Search/v1/results/navigation/i0ad6ad3e0000016314b8705c8686bce0?Nav=CUSTOMDIGEST&amp;fragmentIdentifier=Ie59924e3a21711dea82ab9f4ee295c21&amp;startIndex=1&amp;contextData=%28sc.CustomDigest%29&amp;transitionType=CustomDigestItem|CUSTOMDIGEST|170|False|True|{&quot;HighlightPoints&quot;:null,&quot;HighlightTerms&quot;:null,&quot;SearchWithinQuery&quot;:null,&quot;SecondaryHighlightTerms&quot;:null}|False|||False|False|||True|S|False|Core|||001|False|False|False|False|False|" type="hidden"><input id="co_documentFlagInfo" value="{&quot;docGuid&quot;:&quot;Ie59924e3a21711dea82ab9f4ee295c21&quot;,&quot;flags&quot;:[],&quot;metas&quot;:[{&quot;contentType&quot;:&quot;CASELAW&quot;,&quot;docCollection&quot;:&quot;w_cs_fed1&quot;,&quot;docFamilyGuid&quot;:&quot;Ie59924e4a21711dea82ab9f4ee295c21&quot;,&quot;legacyId&quot;:&quot;2019808227&quot;,&quot;sourcePubId&quot;:&quot;506&quot;}]}" type="hidden">




							<div id="co_chunkNavTwo"><div class="co_chunkPagination" id="co_bottomChunkNav"><ul class="co_navFooter_pagination" id="co_bottomDocumentChunkNavFooter_pagination"><li><strong>Part:</strong></li><li><a id="co_bottomPreviousChunkButton" class="co_prev co_tbButton co_disabled" href=""><span class="icon25 icon_prev_arrow">Previous Part</span></a></li><li><label><span class="co_accessibilityLabel">Go To Document Part</span><input id="co_bottomCurrentChunkStatus" size="1" maxlength="4" type="text"></label> of <strong id="co_bottomChunkCountStatus">2</strong></li><li><a id="co_bottomNextChunkButton" class="co_next co_tbButton" href=""><span class="icon25 icon_next_arrow">Next Part</span></a></li></ul><div class="co_clear"></div><div></div></div></div></div>

				</div>
			</div>
		</div>
	</div>
	<!-- LEFT COLUMN -->  
	<div id="co_leftColumn">
		<div class="co_innertube">
			<div id="coid_website_folderingWidgetDiv"></div>
		</div>
	</div>
			<!-- RIGHT COLUMN -->
			<div id="co_rightColumn" class="co_addFocusCorrection">
				<div class="co_innertube">		
					<div id="coid_website_relatedInfoIPWidgetDiv" style="display: none;" aria-expanded="false">
					</div>




<div id="coid_website_documentToolWidgetDiv"></div>
		<div id="coid_website_relatedInfoWidgetDiv"> </div>
		<div id="coid_website_recommendedDocuments" class="co_recommendedDocumentContainer">
		</div>

<div id="downloadUserDocument"></div>
					<div id="downloadUserDocument"></div>
				</div>
			</div>

 <input class="hideTopTopics" id="hideTopTopics" name="hideTopTopics" type="hidden">
		<div class="co_clear"></div>
	</div>


	<!-- BEGIN FOOTER -->
	<div id="co_footerContainer"><div id="co_cookiePolicyContainer">
	<div class="co_cookiePolicyContent">
			<h3><b>Our policy towards the use of cookies</b></h3>
			<p>All Thomson Reuters websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.</p>
			<ul class="co_inlineList">
				<li>
					<a id="coid_website_cookiePolicyLinkOut" href="javascript:void(0)">Read cookie policy</a>
				</li>
				<li>
					<a id="coid_website_closeCookiePolicy" href="javascript:void(0)">Close</a>
				</li>
			<p></p>
			<button type="button" id="coid_website_cookiePolicyAcknowledged" title="Close message to acknowledge cookie policy" class="co_absolute">
				<span class="icon25 icon_close_x"></span>
			</button>
	</ul></div>
</div>


		
		<div class="co_innertube co_clearfix" id="co_footer" style="display: none;">







<div class="co_floatLeft">
	<div id="co_footerLinks">
		<ul class="co_inlineList">
					<li><a id="coid_websiteFooter_userSettings" href="javascript:void(0);"><span class="icon25 icon_gear_document"></span>Preferences</a></li>
				<li><a id="coid_websiteFooter_helplink" href="javascript:void(0);"><span class="icon25 icon_question_mark"></span>Training &amp; Support</a></li>
				
					<li><a id="coid_websiteFooter_signofflink" href="javascript:void(0);"><span class="icon25 icon_exit_door"></span>Sign Off</a></li>

		</ul>
	</div>
	<div id="co_footerCopyright">
		<ul class="co_inlineList">

			<li>Westlaw. <a href="/Copyright?transitionType=Default&amp;contextData=(sc.Default)"> © 2018</a> Thomson Reuters</li>
			<li><a id="coid_websiteFooter_privacyPolicyLink" href="javascript:void(0)">Privacy Statement</a></li>
			<li><a href="/Accessibility?transitionType=Default&amp;contextData=(sc.Default)">Accessibility</a></li>
				<li id="co_footer_supplier"><a id="coid_website_supplierTerms" href="javascript:void(0);">Supplier Terms</a></li>
				<li id="co_footerContactUs"><a href="/ContactUs?transitionType=Default&amp;contextData=(sc.Default)">Contact Us</a></li>
				<li id="co_footerCs">1-800-REF-ATTY (1-800-733-2889)</li>
				<li id="co_footer_improve"><strong><a id="coid_websiteFooter_pageSurvey" href="javascript:void(0);">Improve Westlaw</a></strong></li>
		</ul>


	</div>
</div>





<div id="co_trLogo" class="co_floatRight">

	<a id="co_trLogo_link" href="#">
		<img alt="Thomson Reuters" src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/v2/co_logo_thomsonReuters.png" width="134" height="30">
	</a>
</div>



		</div>
	</div>
			<div id="coid_Trmr" style="display:none; visibility:hidden"></div>
		</div>
	</div>
	
	<!--static content version number-->
<script type="text/javascript">





	
		window['Server/Routing'] = {
			Search: 'search.int.next.westlaw.com',
			TypeAhead: 'typeahead.int.next.westlaw.com',
			Nlu: 'nlu.int.next.westlaw.com',
			Document: 'document.int.next.westlaw.com',
			Foldering: 'foldering.int.next.westlaw.com',
			CSS: 'ca.next.westlaw.com/StaticContent_40.1.1015',
			Images: 'ia.next.westlaw.com/StaticContent_40.1.1015',
			JavaScript: 'ja.next.westlaw.com/StaticContent_40.1.1015',
			RelatedInfo: 'relatedinfo.int.next.westlaw.com',
			Events: 'events.int.next.westlaw.com',
			KM: 'NONE',
			RequestDirector: 'www.westlaw.com',
			SocialPlatform: 'https://community-sso.thomsonreuters.com',
			Sync: 'sync.westlaw.com',
			Video: 'v1.next.westlaw.com',
			FormsAssembly: 'formsassembly.int.forms.westlaw.com',
			Publishing: 'publishing.int.next.westlaw.com',
			WebContent: 'webcontent.int.next.westlaw.com',
			Alert: 'alert.int.next.westlaw.com',
			Report: 'report.int.next.westlaw.com',
			ProductMetadata: 'pmd.int.next.westlaw.com/pmd',
			Website: '1.next.westlaw.com',
			WebsiteDefault: '1.next.westlaw.com',
			HistoryListener: 'historylistener.int.next.westlaw.com',
			FormsAssemblyTest: ''
		};
	
		
			if (window.location.host !== '1.next.westlaw.com') {
				window['Server/Routing'].ProxiedWebsite = '1.next.westlaw.com';
				window['Server/Routing'].Website = window.location.host;
				window['Server/Routing'].WebsiteDefault = window.location.host;
			}
		
</script>

<script type="text/javascript"></script>

	<script type="text/javascript" src="https://1.next.westlaw.com/v2/js/UrlRouting.40.1.1013.0.js"></script>
	
	<script type="text/javascript" crossorigin="anonymous" charset="utf-8" src="https://ja.next.westlaw.com/StaticContent_40.1.1015/External/vendor/datejs@1.0/cultures/en-US.js"></script>
<script type="text/javascript" crossorigin="anonymous" charset="utf-8" src="https://ja.next.westlaw.com/StaticContent_40.1.1015/v2/Products/WestlawNext/js/LocalizationResources/Localized/Messages.js"></script>

	
<script type="text/javascript">

	







</script>





















	
	














<script type="text/javascript">
window['Server/User'] = {
  "FirmName": "SEOUL NATIONAL UNIV (LV A)",
  "_AlertsIsAdmin": false,
  "_FeatureExposure": "Released",
  "ClientId": "SEOUL NU - WL NEXT",
  "_AlertsAccessFunctionalityTurnedOn": true,
  "_AlertsAccessCategoryApplied": false,
  "_ShowErrorDetails": false,
  "OnePassUserName": "5405685",
  "OnePassUserNameEncoded": "5405685",
  "ClientMatter": {
    "ClientId": "SEOUL NU - WL NEXT",
    "CompositeClientMatter": "SEOUL NU - WL NEXT",
    "DefaultClientId": "Seoul NU - WL Next",
    "ClientIdPromptText": "",
    "IsClientNonChargeable": "False",
    "NoClientId": "False",
    "TrackableCode": "D",
    "UserTurnedTrackingOn": false
  },
  "ClientReportingAttributes": {
    "PracticeArea": "",
    "ResearchReasonCode": "",
    "ResearchDescription": ""
  },
  "BillingMethodForDisplayOnly": "TRANSACTIONAL",
  "HasFlashPlayer": false,
  "IsUltra": true,
  "CustomerStorageKey": "E41F133AB8A01ED395E1D85D67D9406C",
  "SessionCreatedDateTime": "04/30/2018 04:03:25",
  "HasLoggedAggregateNotificationCount": false
};


window['Server/ViewModelData'] = {
  "DocumentGuid": "Ie59924e3a21711dea82ab9f4ee295c21",
  "DocumentCitation": "580 F.3d 1340",
  "DocumentTitle": "Amgen Inc. v. F. Hoffman-La Roche Ltd",
  "DocumentMetaDescription": "View on Westlaw or start a FREE TRIAL today, Amgen Inc. v. F. Hoffman-La Roche Ltd, Cases",
  "ViewType": "FullText",
  "Rank": 170,
  "Grading": "na",
  "KMEnableTermNavigation": false,
  "KMEnableDocumentNavigation": false,
  "LegacyId": "2019808227",
  "DocumentSource": {
    "Key": "9215f2df364c46cd90476a95a1bde2b7",
    "NavigationPath": "Search/v1/results/navigation/i0ad6ad3e0000016314b8705c8686bce0?Nav=CUSTOMDIGEST&fragmentIdentifier=Ie59924e3a21711dea82ab9f4ee295c21&startIndex=1&contextData=%28sc.CustomDigest%29&transitionType=CustomDigestItem",
    "ListSource": "Search",
    "List": "CUSTOMDIGEST",
    "ListPageSourceKey": "1b34510ac2bede0102300be6a61ae1f3"
  },
  "HasDraftingNotes": false,
  "HasDocumentSections": false,
  "EnableBestPortion": true,
  "SubContentTypeId": "27",
  "DisableDocMetaInfoRetrievalOnWarningPage": false,
  "TermNavigationPreference": "AllTerms",
  "ShowMainToolbar": true,
  "ShowRelatedAnalysis": false,
  "ListSource": "Search",
  "IsRelatedFullTextView": false,
  "KeyCiteAlertWarning": "None",
  "DocketTrackWarning": "None",
  "DocumentSections": [],
  "RulebookMode": false,
  "RulebookModeContent": false,
  "NotesOfDecisionsCount": 0,
  "TocReportDocGuids": [],
  "TocReportViewMode": false,
  "IsMedLitStubDocument": false,
  "TrackableCode": "D",
  "NonTrackableCode": "H",
  "FullTocOnDoc": false,
  "ViewExpressions": []
};


window['Server/WidgetDomIds'] = {
  "DocToolbar": "co_docToolbar",
  "DocDisplay": "coid_website_documentWidgetDiv",
  "DocTools": "coid_website_documentToolWidgetDiv",
  "DocTopToolbar": "co_docTopToolbar",
  "DocRightToolbar": "co_newDocToolbar",
  "TopTopics": "coid_website_relatedInfoWidgetDiv",
  "DocBottomToolbar": "co_docFooterToolbar"
};


window['Server/PageData'] = {
  "DocumentTabView": {
    "IsSkipOutOfPlanChecked": false,
    "IsUserDocument": false,
    "UserDocumentData": {
      "documentGuid": "Ie59924e3a21711dea82ab9f4ee295c21"
    },
    "HasProfileSubTab": false,
    "DisplayOptions": {
      "showMainToolbar": true,
      "isNewDocumentView": false,
      "disableDocToolbar": false,
      "isAbstractView": false,
      "chunkSize": "L",
      "chunkableHeadnotes": false,
      "doCompleteSizeChecking": true,
      "ViewType": "FullText",
      "stickyHeader": true,
      "displayRelatedContentLink": true,
      "snippetRelocationInfo": {
        "contentType": "Cases",
        "subContentTypeId": "27"
      }
    },
    "ShowMainToolbar": true,
    "DocumentPersisted": false,
    "DocumentGuidNotFound": false,
    "ContentType": "Cases",
    "ExpandDocumentLevelTOC": true
  },
  "CobaltPageHeader": {
    "ShowPauseLink": false,
    "ShowCommunityContainer": false,
    "EnablePageHeaderV2": true,
    "ShowBetaFeedbackLink": false,
    "Notifications": {
      "HideNotificationToastAfterDuration": false,
      "NotificationClickGoDirectlyToAlerts": false
    }
  },
  "CompartmentStartPageId": "",
  "CobaltMasterFooterInSession": {
    "TRLogoImageLinkUrl": "http://www.thomsonreuters.com",
    "ShowWhatIsNewLink": false,
    "Unreleased": false,
    "IsAnonymousSession": false,
    "ShowMyContacts": false,
    "ShowPromotions": false,
    "ShowResetPromotions": false,
    "ShowCampusPolicy": false,
    "IsTransferContentAvailable": false,
    "ShowProductStartGuide": false,
    "HelpGuideDisplayName": "",
    "HelpGuideFileName": "",
    "HelpGuidePath": "",
    "CampusPolicyDisplayName": "",
    "CampusPolicyPath": "",
    "ShowAnalyticsLink": false,
    "AnalyticsPath": "Session/SignOn.html?transitionType=Default&contextData=(sc.Default)",
    "ShowMyAccountLink": false,
    "MyAccountPath": "WESTLAW/Common/Landing/MyAccountLanding",
    "LegalSolutionsLink": "http://legalsolutions.thomsonreuters.com/law-products/westlaw-legal-research/training-support",
    "SupplierTermsUrl": "http://legalsolutions.com/westlaw-additional-terms",
    "PrivacyPolicyPath": "https://www.thomsonreuters.com/en/privacy-statement.html"
  },
  "ActOnTracking": {
    "EnableActOnTracking": false,
    "ActOnTrackingInstanceId": ""
  },
  "CobaltPage": {
    "SetInCache": [
      {
        "Vertical": "Global",
        "Name": "ResultsPerPage",
        "Value": 20
      },
      {
        "Vertical": "Global",
        "Name": "ResultsPerPageAllowableValues",
        "Value": [
          "100",
          "20",
          "50"
        ]
      },
      {
        "Vertical": "Global",
        "Name": "Locale",
        "Value": ""
      },
      {
        "Vertical": "Global",
        "Name": "TimeZone",
        "Value": "Central Standard Time"
      },
      {
        "Vertical": "Global",
        "Name": "MultiFacetsEnabled",
        "Value": false
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_CASE",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_ANALYTICAL",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_PENDINGREG",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_PENDINGLEG",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_KNOWHOW",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "JurisdictionsContentType",
        "Value": "default"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_DOCKET",
        "Value": "CASE_TITLE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_BRIEF",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_TRIAL-TRANSCRIPTS",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_ADMINDECISION",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_FORM",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_NEWS",
        "Value": "DATE_DESCENDING"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_ORAL-ARGUMENTS",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "InstantSuggestions",
        "Value": true
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_TCO",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultNews_DuplicateIdentifier",
        "Value": false
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_REGULATION",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_EXPERTWITNESS",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "SliderDetail",
        "Value": "default"
      },
      {
        "Vertical": "Search",
        "Name": "ViewExpression",
        "Value": ""
      },
      {
        "Vertical": "Search",
        "Name": "DefaultPage",
        "Value": "ALL"
      },
      {
        "Vertical": "Search",
        "Name": "JurisdictionsGlobal",
        "Value": "CTAF"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_PMM",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_STATUTE",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_JURYVERDICT",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "SuppressRecentFiltersTooltip",
        "Value": false
      },
      {
        "Vertical": "Document",
        "Name": "HeadnotesDualColumnView",
        "Value": false
      },
      {
        "Vertical": "Document",
        "Name": "CiteAdvisorRulesSet",
        "Value": "standard"
      },
      {
        "Vertical": "Document",
        "Name": "CiteAdvisorItalicizeTitle",
        "Value": false
      },
      {
        "Vertical": "Document",
        "Name": "CiteAdvisorParallelCites",
        "Value": "CAFormat"
      },
      {
        "Vertical": "Document",
        "Name": "CiteAdvisorUseForCopyWithReference",
        "Value": true
      },
      {
        "Vertical": "Document",
        "Name": "CiteAdvisorCitationStyle",
        "Value": "LegalBriefs"
      },
      {
        "Vertical": "Document",
        "Name": "CiteAdvisorIncludeHistory",
        "Value": true
      },
      {
        "Vertical": "Document",
        "Name": "CiteAdvisorUnderlineTitle",
        "Value": true
      },
      {
        "Vertical": "Document",
        "Name": "HideHeadnotesBox",
        "Value": false
      },
      {
        "Vertical": "Foldering",
        "Name": "ShowAnnotationsPreferenceKey",
        "Value": "checked"
      },
      {
        "Vertical": "Website",
        "Name": "ShowKeyboardInstructions",
        "Value": true
      },
      {
        "Vertical": "Website",
        "Name": "DocumentFullscreenShowTerms",
        "Value": true
      },
      {
        "Vertical": "Website",
        "Name": "NewFeatureLightboxDisplayBlackList",
        "Value": ""
      },
      {
        "Vertical": "Website",
        "Name": "DocumentFullscreenTextSize",
        "Value": ""
      },
      {
        "Vertical": "Website",
        "Name": "DocumentFullscreenMargin",
        "Value": ""
      },
      {
        "Vertical": "Website",
        "Name": "DeliveryOptionSelected",
        "Value": "None"
      },
      {
        "Vertical": "Website",
        "Name": "DocumentFullscreenShowLinks",
        "Value": true
      },
      {
        "Vertical": "Website",
        "Name": "LastViewNotificationDate",
        "Value": ""
      },
      {
        "Vertical": "Website",
        "Name": "DocumentDisplayTextSize",
        "Value": ""
      },
      {
        "Vertical": "Website",
        "Name": "DisplaySearchTerms",
        "Value": true
      },
      {
        "Vertical": "Website",
        "Name": "KnowHowSpeedReadExpandAll",
        "Value": true
      },
      {
        "Vertical": "Website",
        "Name": "DocumentDisplayFont",
        "Value": ""
      },
      {
        "Vertical": "Website",
        "Name": "DocumentDisplayMargin",
        "Value": ""
      },
      {
        "Vertical": "Website",
        "Name": "DocumentFullscreenFont",
        "Value": ""
      },
      {
        "Vertical": "SAP",
        "Name": "PLAN ICONS",
        "Value": "NO"
      },
      {
        "Vertical": "SAP",
        "Name": "SKIP OUT OF PLAN",
        "Value": "NO"
      },
      {
        "Vertical": "SAP",
        "Name": "WARNING FLAG",
        "Value": "N"
      }
    ],
    "PingSync": "false",
    "ViewData": {
      "IsSponsorSession": true,
      "SearchWidgetParameters": {
        "search": {
          "renderCustomPageSearchWidget": false,
          "categoryPageTitle": "291 PATENTS",
          "isCategoryPageTopical": false,
          "topicKeyText": "291 PATENTS",
          "filters": {
            "jurisdiction": "CTAF",
            "sequence": 0,
            "content": "CUSTOMDIGEST",
            "index": false,
            "customDigest": true,
            "collectionSets": [
              "w_cs_cd_toc"
            ],
            "tocNode": "I4aee2539c6f64c1812a4c2f3395c2607",
            "keyNumber": "291",
            "displayJurisdictionSelector": true,
            "displayAdvancedSearchLink": false,
            "categoryPageUrl": "Home/WestKeyNumberSystem",
            "categoryPageContentType": "CUSTOMDIGEST",
            "categoryPageCheckboxLimit": 0,
            "resultsLimit": 0,
            "categoryPageAlertClippable": false,
            "isAdvancedSearchTemplatePage": false
          },
          "CustomPageSetForZone": false,
          "supportedFeatures": [],
          "skipSpellCheck": false,
          "browseHierarchyPathFromRoot": []
        },
        "SearchCompartmentName": "WestlawNext",
        "SearchDropDownItems": [],
        "grading": "na",
        "searchWidgetPosition": "Default",
        "hideSearchWidget": false,
        "makeSearchWidget": true,
        "prefersForceTnc": false,
        "prefersForceTncSingleQuote": true,
        "forceTncCounter": 0,
        "forceTncCounterThreshold": 5,
        "enableFavoriteSearch": false,
        "dynamicPage": false,
        "isAdvancedSearchTemplatePage": false
      },
      "ShowClientIdWidget": true,
      "OpenFindDropDown": false,
      "TimeoutInMinutes": 90,
      "FeatureConfigurations": {
        "FOLDERS": false,
        "HISTORY": true,
        "FOLDER_SHARING": false,
        "HIGHLIGHTS": false,
        "NOTES": false,
        "ANNOTATIONS": false,
        "BLOCK NOTES SHARING": false,
        "CONTACTS": false,
        "FAVORITES": false,
        "USER PROFILE": false,
        "KM": false,
        "FolderCachingDisabled": true,
        "KM IPAD": false,
        "SAO_INVITING": true,
        "SAO_SAMEEMAILDOMAIN": false,
        "CASENOTEBOOKEXPORT": false,
        "DOWNLOADDELIVERY": true,
        "DROPBOXDELIVERY": false,
        "EMAILDELIVERY": true,
        "EMAILWITHREFERENCEDELIVERY": false,
        "KINDLEDELIVERY": false,
        "PRINTDELIVERY": true,
        "KEYCITEALERTS": false,
        "LEGACYALERTACCESS": false,
        "BLOCKPERSISTENTINFO": true,
        "BLOCK100KANCILLARY": false,
        "DISPLAYMASHUPCHARGEWARNING": false,
        "SHOWCHARGEONWARNINGSCREEN": false,
        "SHOWCHARGELINKONWARNINGSCREEN": false,
        "USERISTRANSACTIONAL": true,
        "USER FORM UPLOAD": false,
        "MATTERUPLOADUSERDOC": false,
        "FOLDERUPLOADUSERDOC": false,
        "DISPLAY SESSION PAUSE LINK": false,
        "PASSTHRUPDFS": false,
        "processRIHistoryAsynchronously": true,
        "processDocumentHistoryAsynchronously": true,
        "PRINTBLANKFORMS": false,
        "WFBTRIALBLOCKSHARE": false,
        "ATTORNEY PORTAL": false,
        "SMALLLAWWORKBENCHMATTERTREE": false,
        "JUDICIALCHAMBERS": false,
        "CITATIONUS": false,
        "CITATIONCAN": false,
        "MYPLANSTATICDOC": true,
        "ALLOWFOLDERSHAREACROSSORGS": true,
        "BLOCKFOLDERSHAREFROMORGS": true,
        "ALLOWOFFLINEACCESS": false,
        "WEBHOSTEDCLIENTID": false,
        "WEBHOSTEDCLIENTIDIPAD": false,
        "WEBHOSTEDCLIENTIDSELECTION": false,
        "PRERELCONTENTFEAT": false,
        "ALERTS": false,
        "ALERTS ENHANCED": false,
        "ISEMULATEUSER": false,
        "WCLP": false,
        "NEWSLETTER": false,
        "KCALERT": false,
        "COINV ALERTS": false,
        "CITRANSITION": false,
        "BLCALERT": false,
        "DKTALERT": false,
        "DKTTRACK": true,
        "PUBALERT": false,
        "CWALERT": false,
        "POB ALERT": false,
        "POB WATCH": false,
        "CWALERTPremium": false,
        "CAPITOLWATCH": false,
        "ALERT SUMMARY REPORT": false,
        "WCLP CONTINUOUS": false,
        "KCALERT CONTINUOUS": false,
        "CWALERT CONTINUOUS": false,
        "POBA CONTINUOUS": false,
        "POBW CONTINUOUS": false,
        "NEWSLETTER DLY": false,
        "NEWSLETTER WKDY": false,
        "KCALERT DLY SINGLE": false,
        "KCALERT WKDY SINGLE": false,
        "BIALERT DLY SINGLE": false,
        "BLCALERT DAILY": false,
        "BLCALERT MULTI DAILY": false,
        "CWALERT DAILY": false,
        "BIALERT WKDY SINGLE": false,
        "BLCALERT BIWEEKLY": false,
        "BLCALERT CONTINUOUS": false,
        "WCLP WEEKLY": false,
        "NEWSLETTER WEEKLY": false,
        "KCALERT WEEKLY": false,
        "BIALERT WEEKLY": false,
        "BLCALERT WEEKLY": false,
        "DKTALERT WEEKLY": false,
        "DKTTRACK WEEKLY": true,
        "POBA WEEKLY": false,
        "POBW WEEKLY": false,
        "WCLP BIWEEKLY": false,
        "KCALERT BIWEEKLY": false,
        "BIALERT BIWEEKLY": false,
        "DKTALERT BIWEEKLY": false,
        "DKTTRACK BIWEEKLY": true,
        "NEWSLETTER BIWEEKLY": false,
        "POBA BIWEEKLY": false,
        "POBW BIWEEKLY": false,
        "WCLP MONTHLY": false,
        "NEWSLETTER MONTHLY": false,
        "KCALERT MONTHLY": false,
        "BIALERT MONTHLY": false,
        "BLCALERT MONTHLY": false,
        "DKTALERT MONTHLY": false,
        "DKTTRACK MONTHLY": true,
        "POBA MONTHLY": false,
        "POBW MONTHLY": false,
        "WCLP DLY SINGLE": false,
        "WCLP DLY MULT": false,
        "WCLP WKDY SINGLE": false,
        "WCLP WKDY MULT": false,
        "PUBALERT DLY SINGLE": false,
        "PUBALERT WKDY SINGLE": false,
        "DKTALERT WKDY SINGLE": false,
        "DKTALERT DLY SINGLE": false,
        "DKTTRACK WKDY SINGLE": true,
        "DKTTRACK DLY SINGLE": true,
        "CAPITOLWATCHTRACK DLY SINGLE": false,
        "CAPITOLWATCHTRACK DLY MULT": false,
        "CAPITOLWATCHTRACK WKDY SINGLE": false,
        "CAPITOLWATCHTRACK WKDY MULT": false,
        "CAPITOLWATCHTRACK WEEKLY": false,
        "CAPITOLWATCHTRACK BIWEEKLY": false,
        "CAPITOLWATCHTRACK MONTHLY": false,
        "POBA DLY SINGLE": false,
        "POBA DLY MULT": false,
        "POBA WKDY SINGLE": false,
        "POBA WKDY MULT": false,
        "POBW DLY SINGLE": false,
        "POBW DLY MULT": false,
        "POBW WKDY SINGLE": false,
        "POBW WKDY MULT": false,
        "showMatterTree": false,
        "WELCOME TO WLN BOX": false,
        "dataRoomReadSource": "Original",
        "dataRoomWriteDestination": "Single",
        "dataRoomFoldersWriteDestination": "SingleDataRoom",
        "showNapaContent": true,
        "PublicRecordsAccess": false,
        "PublicRecordsEnhancedSecurity": false,
        "PublicRecordsBlockRoaming": false,
        "PublicRecordsBlockHomeTrust": false,
        "PublicRecordsAllowRoamTrust": false,
        "PublicRecordsBypassCountry": false,
        "PublicRecordsBlockIPUndefined": false,
        "PublicRecordsBlockUndefinedTrust": false,
        "PublicRecordsDowngradeEmailIPRoaming": false,
        "PublicRecordsDowngradeEmailIPUndefined": false,
        "PublicRecordsUnmaskRoam": false,
        "DISABLE PR ANC MASK": false,
        "PublicRecordsSsnOnlyOK": false,
        "ReversePhoneGateway": false,
        "QSentReport": false,
        "CreditHeaderContentDatabaseGroup": false,
        "PolkGateway": false,
        "PolkReport": false,
        "DriversLicenseRecordsContentDatabaseGroup": false,
        "UCC COLUMN RESULTS": false,
        "matterTreeType": "None",
        "ISCAMPUSUSER": false,
        "ISCAMPUSNEWSUSER": false,
        "ISCAMPUSBUSINESSUSER": false,
        "isUnreleasedFeatureExposure": false,
        "WLANALYTICS ACCESS": false,
        "NEWSALERTAUTHOR": false,
        "NEWSALERTEDITOR": false,
        "UNRELEASED CAT PAGES": false,
        "INTERNAL ADMIN LIMITS": false,
        "DATAROOMALERTS": false,
        "DLVRY SESSION LIMIT": false,
        "DLVRY DAILY LIMIT": false,
        "DLVRY SESSION LIMIT PRAC LAW": false,
        "DLVRY DAILY LIMIT PRAC LAW": false,
        "DLVRY SESSN LIMIT PRAC LAW TRL": false,
        "DLVRY DAILY LIMIT PRAC LAW TRL": false,
        "CONTENT DLVRY RSTRCT": true,
        "BLOCKAUWLN": false,
        "BLOCKCANWLN": false,
        "BLOCKHKWLN": false,
        "BLOCKUKWLN": false,
        "ALERTS ADDRESS BOOK": true,
        "ALERTS BATCH PROCESSING": false,
        "ALERTS CALENDARING": true,
        "ALERTS FUNCTIONALITY": true,
        "ECHACCESS": false,
        "PMD VERSION": "5209",
        "USER ACADEMIC": true,
        "USER CORPORATE": false,
        "USER DEVELOPER": false,
        "USER GOVERNMENT": false,
        "USER INTERNAL": false,
        "USER LARGE LAW": false,
        "USER MEDIUM LAW": false,
        "USER SMALL LAW": false,
        "SIGNOFF SURVEY": false,
        "INLINE KC CASES BRIEF": false,
        "BYPASS WARN INLINE KC": false,
        "BLOCK PL ITEMS": false,
        "PRACTICAL LAW": false,
        "PRDCT PLCUK": false,
        "PRDCT PLCAU": false,
        "DISABLE PL REL CONTENT CACHE": false,
        "HISTORY UI": true,
        "EDSECTIONALLOW": false,
        "TAPSELECTED": false,
        "REDLINING": false,
        "WLNBYPASSBLOCK": false,
        "BLOCK NATIVE SIGNIN": false,
        "BLC ZONE": false,
        "CUSTOM PAGES": false,
        "CUSTOM PAGES READ": false,
        "CUSTOM PAGE ADMIN": false,
        "ELIBRARIES CP ZONE": false,
        "TYPE AHEAD": false,
        "PATRONHELP": false,
        "HISTORY RETENTION 1": false,
        "HISTORY RETENTION 180": false,
        "BLC POWERSEARCH": false,
        "PRDCT CORRECTIONAL": false,
        "EASY EDIT": false,
        "ENHANCED RB": false,
        "ENHANCED RB STICKY": false,
        "WMGRAPHICAL": false,
        "PRPTSUBSCRIBER": false,
        "BLOCK PRPT BLC": false,
        "PLCT DISPLAY LEGAL ANALYTICS": false,
        "PRPT SMALL": false,
        "PRPT CORPCOUNSEL": false,
        "PRPT LARGE": false,
        "BLOCK PRPT LARGE PAGES": false,
        "PRPT GOVT": false,
        "PRPT NONTRACKABLE": false,
        "PRPT KM LITIGATION": false,
        "PRPT KM TRANSACTIONAL": false,
        "WAYWO": false,
        "AnonymousSession": false,
        "AnonymousSessionBlock": false,
        "SOCIAL PLATFORM": false,
        "BLOCK TNP PLUS": false,
        "TNP TEPC CALC": false,
        "TNP CORTC CALC": false,
        "APFF ACCESS": false,
        "TDRC": false,
        "FPC": false,
        "FPP": false,
        "TAXHYPERION NLTR": false,
        "WCO ACCESS": false,
        "BLOCKMYSTARTPAGELINK": false,
        "TNP CEC CALC": false,
        "TNPNATLANG": false,
        "TAXNEWSCATEGORIES": false,
        "TNPDIGMCMECHAN": false,
        "TNPDIGBROWN": false,
        "TNPDIGNIKOLAKAKIS": false,
        "TNPDIGHAYHOETAXATION": false,
        "TNPDIGKERZNER": false,
        "TNPDIGSCHWARTZ": false,
        "TNPDIGINNES": false,
        "TNPDIGARON": false,
        "TNPDIGCARR": false,
        "TNPDIGGAMBLE": false,
        "TNPDIGTAXATIONOFREALESTATE": false,
        "TNPDIGBROOKS": false,
        "TNPDIGMUNRO": false,
        "TNPDIGTHAW": false,
        "TNPDIGVINER": false,
        "TNPDIGFRIEDLANDER": false,
        "TNPDIGBUTCHER": false,
        "TNPDIGALEXANDER": false,
        "TNPDIGHAYHOECASELAW": false,
        "TNPDIGHAYHOEFEDPROVLEGIS": false,
        "TNPDIGHAYHOEGOVPUBLICATIONS": false,
        "TNPDIGJOLIN": false,
        "TNPDIGSTILLABOWER": false,
        "TNPDIGCASESINDEXCITATOR": false,
        "TNPDIGSEGUIN": false,
        "TNPDIGWISE": false,
        "TNPDIGBOWEN": false,
        "TNPDIGBISCOTT": false,
        "TNPDIGEDMUNDS": false,
        "TNPDIGMANNGUIDETOREVIEW": false,
        "TNPDIGCOMPILATIONENGAGEMENTS": false,
        "TNPDIGGUIDETOESTATEANDTRUSTS": false,
        "TNPDIGITIZATION": false,
        "TNPLITIGATOR": false,
        "TNPCROSSREFFILTER": false,
        "RESULTLISTEASYEDIT": false,
        "RESULTLISTQDRAFT": false,
        "DISPLAY TEST PREF TAB": false,
        "BlindLog": false,
        "EncryptLog": false,
        "MASS EMAILER": false,
        "ADCVERREDLININGTOGGLE": false,
        "ENVHEALTHSAFETYPRACPG": false,
        "INSURCOMPLIANCEPRACPG": false,
        "BLOCK WLN PATRON": false,
        "DSP INT HEADNOTE INFO": false,
        "PRDCT WLNLINKS": false,
        "GAO LH PDFS OPEN IN LINKS": false,
        "WLNLINKS UK": false,
        "BLOCK WLNLINKS EMBEDDED LINKS": false,
        "BLOCK LICENSE AGREEMENT": false,
        "FIRMSTYLE": false,
        "SMART BREADCRUMB DISPLAY": false,
        "IRS WLN PAGE": false,
        "FORMSAUTOSHAREOFF": false,
        "WLNPLTRACK": false,
        "WLNPL GOVTHOMEPAGE": false,
        "WLNPL CORPHOMEPAGE": false,
        "WLNPL DEFAULTHOMEPAGE": true,
        "ENABLE-LEGI-GOV-LINKS": false,
        "ENABLE BAILII LINKS": false,
        "BLOCK SHARE NOTE LINK": false,
        "BLCCAN ZONE": false,
        "BLCCAN SUBSCRIBER": false,
        "BLOCKBLCCAN": true,
        "BLOCKBLC": false,
        "WM SEARCH RESULTS": false,
        "WMHK SEARCH RESULTS": false,
        "WMAU SEARCH RESULTS": false,
        "TAX PWC USER": false,
        "TAX KPMG USER": false,
        "COPY USER DATA": false,
        "ASSIGNCLIENTFILE": false,
        "RESEARCH REPORT": false,
        "FOLDER ANALYSIS": false,
        "FOLDER ANALYSIS ADDL CONTENT": false,
        "TIME ZONE AUSTRALIA": false,
        "TIME ZONE NEW ZEALAND": false,
        "EY WLN PAGE": false,
        "FOLDER DESCRIPTION": false,
        "ENABLE CONTRACT EXPRESS": false,
        "CONTRACT EXPRESS PL AU": false,
        "CONTRACT EXPRESS PL US": false,
        "ASK-EDITOR": false,
        "BLOCK OPEN WEB": false,
        "PLUK SUBSCRIBER": false,
        "WLUK SUBSCRIBER": false,
        "LIBRARY SUBSCRIBER": false,
        "CHECKPOINTDIRECTLINK": false,
        "BLOCKCHECKPOINTLINKS": false,
        "LINK BUILDER": false,
        "BCICALCULATOR": false,
        "PLUK-ENAB-ALLCONTACTS": false,
        "ALLOW ICLR": true,
        "BLOCK PROVIEW FEDERATED SEARCH": false,
        "DOC ANALYSIS": false,
        "DT DocAnalysis": false,
        "GENERATE WLUK TRANSTOKEN": false,
        "WFB USEMOCKFORMS": false,
        "BLOCKSESSIONPAUSEDISPLAY": false,
        "PWC WLN PAGE": false,
        "KPMG WLN PAGE": false,
        "CROSSBORDER DASHBOARD": false,
        "TR DISCOVER SEARCH": false,
        "VIRTUAL ASSISTANT": false,
        "BLCDEALTRACKALERT": false,
        "BLCDEALTRACKALERT BIWEEKLY": false,
        "BLCDEALTRACKALERT CONTINUOUS": false,
        "BLCDEALTRACKALERT DAILY": false,
        "BLCDEALTRACKALERT MONTHLY": false,
        "BLCDEALTRACKALERT MULTIDAY": false,
        "BLCDEALTRACKALERT WEEKLY": false,
        "EY MIGRATION POP UP": false,
        "KPMG MIGRATION POP UP": false,
        "PWC MIGRATION POP UP": false,
        "IRS MIGRATION POP UP": false,
        "TAX MIGRATE": false,
        "SEARCH TABS": false,
        "JOURNAL PURCHASE FORM": false,
        "WLUK EDITORS PICKS TAB": false,
        "LEGAL LIT ANALYTICS": false,
        "UKMATTERMAPS": false,
        "USMATTERMAPS": false,
        "DISPLAY PL MESSAGE 1": false,
        "DISPLAY PL MESSAGE 2": false,
        "GRADING TOOL": false,
        "MODERN DOC DISPLAY": false,
        "INDIGO SEARCH": false,
        "INDIGO DISPLAY": false,
        "PSEUDO BLOCK INDIGO DISPLAY": true,
        "INDIGO DISPLAY PREF": false,
        "INDIGO HOT DOCS": false,
        "INDIGO RESEARCH REPORT": false,
        "COMPARE BLACKLINING": false,
        "NOTIFICATION CENTER": false,
        "PRIOR USER INTERACTIONS": false,
        "COLD START": false,
        "TOC FOR CASES": false,
        "MATERIAL KEY FACT FILTER": false,
        "PROCEDURAL POSTURE FILTER": false,
        "FAVORITE SEARCHES": false,
        "FOLDER KEYCITE CHANGE": false,
        "FOLDER RECOMMEND CHANGE": false,
        "FOLDER RECOMMEND ALERT": false,
        "RECENT FILTERS": false,
        "SEARCH RESULT CITING REFS": false,
        "SEARCH RESULT NEG HISTORY": false,
        "QUESTIONANSWERING": false,
        "ITDEPENDS": false,
        "ITDEPENDSQUESTIONANSWER": false,
        "WLUK DOC ALERTS": false,
        "WLUK JCL ALERTS": false,
        "PA REGULATIONS STATUS FILTER": false,
        "ALWAYS CLIENT ID PROMPT": false,
        "PL US BANNER": false,
        "ANSWERS FEEDBACK": false,
        "KC IMPLIED OVERRULINGS": false,
        "ENHANCED THEME": false,
        "DOC ANALYZER TOUR": false,
        "LIT ANALYTICS TOUR": false,
        "HOME PAGE TOUR": false,
        "BUSINESS DEVELOPMENT PL US": false,
        "WLNPL SLF HOMEPAGE": false
      },
      "IsUserMigrated": false,
      "SupportedFeatures": [
        "PRACTICALLAW",
        "ALERTS",
        "BROWSE",
        "BROWSEPREVIEW",
        "CASEEVALUATORWLN",
        "CDN",
        "CLIENTID",
        "CONTACTS",
        "CONTENTTYPEDELIVERYLIMIT",
        "COREUI",
        "CUSTOMPAGES",
        "DELIVERY",
        "DOCKETS",
        "DOCUMENTORDERING",
        "DOCUMENTS",
        "DROPBOX",
        "ERRORS",
        "FAVORITESORGANIZER",
        "FINDANDPRINT",
        "FOLDERS",
        "FOLDERSEXTERNALSHARING",
        "GLOSSARY",
        "WAYWO",
        "IOS",
        "IPAD",
        "FACTORANALYSIS",
        "KEYNUMBERSEARCH",
        "KM",
        "LINKIN",
        "LINKOUT",
        "LIVECHAT",
        "MOBILE",
        "MYPLAN",
        "NYOFFICALDIGEST",
        "PRICINGGUIDE",
        "PROMOTIONS",
        "PUBLICATIONFAVORITES",
        "RELATEDINFORMATION",
        "RELATEDTOPICS",
        "REPORTSHARED",
        "REVERSEPROXY",
        "SEARCH",
        "SHAREPOINTSEARCH",
        "SHAREPOINTWIDGETS",
        "SOCIALPLATFORM",
        "SURVEY",
        "USERAGREEMENT",
        "USERDOCUMENTS",
        "USEREMULATION",
        "USERSETTINGS",
        "BANKRUPTCYEXPLORER",
        "BUSINESSINVESTIGATOR",
        "BUSINESSLAWCENTER",
        "CASENOTEBOOK",
        "DUNANDBRADSTREETBUSINESS",
        "EXPERIANBUSINESSCREDIT",
        "EXPERTDUEDILIGENCE",
        "EXPERTEVALUATOR",
        "MATTERBENCHMARKING",
        "RECENTHISTORY",
        "WEB2MASHUP",
        "AUTHORITYCOMPILER",
        "SEARCHTEMPLATEPREVIEW",
        "PEOPLEMAP",
        "PUBLICRECORDS",
        "DOCKETGATEWAY",
        "WEBCONTENT",
        "PROFESSIONAL",
        "SUGGESTEDDOCUMENTS",
        "EMBEDDEDTEXT",
        "PRODUCTVIEW",
        "PRIVATEFILES",
        "STATEQACOMPARE",
        "SOURCELINK",
        "PMDPROTECTEDCONTENT",
        "ROADRUNNER",
        "REDLINE",
        "SUPERBROWSE",
        "TOCREPORTVIEW",
        "DATACOMPARISONREPORT",
        "GRAPHICALFACETS",
        "COPYUSERDATA",
        "SHAREDNOTES",
        "RESEARCHACCELERATOR",
        "WEBINARS",
        "READINGMODE",
        "ANALYTICS",
        "HIDESEARCHTERMHIGHLIGHTINGPREFERENCE",
        "MONETIZATION",
        "SHOWDOCUMENTANALYZEROVERVIEWPREFERENCE",
        "SHOWLITANALYTICSOVERVIEWPREFERENCE",
        "SHOWHOMEPAGEOVERVIEWPREFERENCE",
        "FOUNDATION"
      ],
      "ActiveBrowserPingInitialWaitInMinutes": 3,
      "ActiveBrowserPingFrequencyInMinutes": 3,
      "ShowClientIdToast": false,
      "DataRoomFeatures": [],
      "SocialPlatformProductId": "140",
      "MaxFileUploadSize": 157286400,
      "SnapEngageScriptUrl": "",
      "DeliveryQueueQueried": false,
      "DeliveryQueueTotal": 0,
      "DeliveryQueueInProgress": 0,
      "DeliveryQueueDocketsInProgress": 0,
      "DeliveryQueueInError": 0,
      "DeliveryQueueNotification": 0
    },
    "WidgetDomIds": {
      "FooterDivId": "co_footer",
      "ErrorSummaryWidget": "coid_website_errorsSummaryPlaceHolder",
      "DockWidget": "co_dockContainer",
      "RecentFoldersWidget": "co_recentFoldersContainer",
      "RecentHistoryWidget": "co_recentHistoryContainer",
      "FrequentFavoritesWidget": "co_frequentFavoritesContainer",
      "AlertsCenter": "co_alertsCenterContainer",
      "ClientIdWidget": "co_clientIdContainer",
      "SignOff": "co_signOffContainer",
      "WhatIsNext": "co_whatIsNextContainer",
      "SearchWidget": "coid_website_searchWidget"
    },
    "RedirectError": {
      "Show": false
    },
    "DomStorageHasBeenCleared": false,
    "LiveChat": {
      "Show": false,
      "Options": {
        "QueueNumber": 0
      }
    },
    "WelcomeLightbox": {
      "Show": false
    },
    "SyncInitiated": false,
    "SyncCapable": false,
    "SubscriptionRenewalBanner": {
      "Show": false
    },
    "IsBusinessLawCenter": false
  },
  "TabScripts": {
    "DocSource": "9215f2df364c46cd90476a95a1bde2b7",
    "DocGuid": "Ie59924e3a21711dea82ab9f4ee295c21",
    "NavigationPath": "Search/v1/results/navigation/i0ad6ad3e0000016314b8705c8686bce0?Nav=CUSTOMDIGEST&fragmentIdentifier=Ie59924e3a21711dea82ab9f4ee295c21&startIndex=1&contextData=%28sc.CustomDigest%29&transitionType=CustomDigestItem",
    "ListSource": "Search",
    "List": "CUSTOMDIGEST",
    "Rank": 170,
    "DocumentVersionNumber": 0
  }
};


window['Server/KM'] = {
  "SessionId": "",
  "FirmName": "",
  "FirmLogoUri": "",
  "FirmWelcomeUri": "",
  "Protocol": "http"
};


window['Server/Configuration'] = {
  "CompartmentName": "WestlawNext",
  "CookieDomain": "next.westlaw.com",
  "EnableIpad": false,
  "EnableIphone": false,
  "IsIPadAppRenderingMode": false,
  "IsIPhoneAppRenderingMode": false,
  "IOSNativeVersion": "0.0.0",
  "EnableSync": false,
  "EnableDeliveryQueue": true,
  "EnableDeliveryWidget": true,
  "ProductName": "WestlawNext",
  "ProductDisplayName": "Westlaw",
  "ProductDisplayDelimiter": "|",
  "ProductViewName": "none",
  "DailyDeliveryLimit": -1,
  "DailyDeliveryCount": -1,
  "SessionDeliveryLimit": 20,
  "SupportedAlertTypes": [
    "WestClip",
    "KeyCite",
    "DocketAlert",
    "DocketTrack",
    "DealTrack",
    "PublicationAlert",
    "Newsletter",
    "BusinessInvestigator",
    "CourtWire",
    "BusinessLawCenterAlert",
    "PeopleMap",
    "CapitolWatchTrack"
  ],
  "EnableDataRoomAlerts": true,
  "GlobalizationKeyMode": "Default",
  "IsAnonymousSession": false,
  "EnableAccessibleLightbox": true,
  "EnableContactsPaging": true,
  "IsCrawlerSession": false,
  "IsGlobalizationI18NLocaleEnabled": false,
  "IsGlobalizationI18NLibraryLookupEnabled": true,
  "IsProcessCategoryPagesWithDifferentLocalesOn": false,
  "OverrideResultsPerPage": 0,
  "UseExpandableToc": true,
  "Locale": "en-US",
  "IsSmartFoldersEnabled": true,
  "IsFeatureOverlayEnabled": true,
  "IsTRDiscoverEnabled": true,
  "IsVideoTourEnabled": true,
  "IsBestPortionNavigationEnabled": true,
  "UsePageHeaderV2": true,
  "UseTypeAhead": true,
  "UseSnapshots": true,
  "IsBriefAnalyzerEnabled": true,
  "IsChargeableByDefaultForSession": true,
  "IsIssueFinderEnabled": true,
  "IsWestlawAnswersEnabled": true,
  "IsSharedHighlightsEnabled": true,
  "IsRealTimeNotificationEnabled": true,
  "EnableA11YLightboxKeyboardScroll": true,
  "IsA11YRedesignedHeaderEnabled": true,
  "IsA11YPreferencesLightboxEnabled": true,
  "SpeechToTextCustomizationIdOverride": "default",
  "InfrastructureAccessControls": [
    "iac-a11y-asbuilder-tmpl",
    "iac-a11y-header-redesign",
    "iac-accessible-clientid-widget",
    "iac-add-timezone",
    "iac-alert-admin-settings",
    "iac-alert-ny-sct-hourly",
    "iac-alerts-cal",
    "iac-alerts-customerinfo-olc",
    "iac-alerts-cw",
    "iac-alerts-docket-guid",
    "iac-alerts-productaware-history",
    "iac-alerts-standart-email-format",
    "iac-all-citations",
    "iac-allow-robots-indexing-sitemap-wln",
    "iac-analyticsclientidfeaturesenabled",
    "iac-analytics-related-filings",
    "iac-annotation-filtering",
    "iac-anonymous-cdn",
    "iac-appcommand",
    "iac-asm-policy",
    "iac-au-compartments",
    "iac-au-seo",
    "iac-autosuggest-au",
    "iac-batch-getsynopsis",
    "iac-bestlaw-tracking",
    "iac-blc-filersearch",
    "iac-blc-fs-next",
    "iac-blc-redlining",
    "iac-blc-ri-agreementsenh",
    "iac-blc-ri-newpathway",
    "iac-blc-ri-privateequity",
    "iac-blind-encrypted",
    "iac-blind-encrypted-header-enabled",
    "iac-block-uk-westlaw",
    "iac-blt-alertfulltext",
    "iac-blt-alert-type-mna-trans",
    "iac-blt-alert-type-sec-insider",
    "iac-blt-alert-type-sec-noninsider",
    "iac-blt-feature18",
    "iac-blt-feature3",
    "iac-blt-hoovers",
    "iac-blt-incorporationdata",
    "iac-blt-news",
    "iac-blt-oct2014-release",
    "iac-blt-officerlinks",
    "iac-blt-report-advisors",
    "iac-blt-securities",
    "iac-blt-securities-alerts",
    "iac-blt-subsidiaries",
    "iac-blt-table-sections",
    "iac-blt-tagged-sections",
    "iac-blt-tickercik",
    "iac-blt-webkitpdf",
    "iac-blt-xmlmindrtf",
    "iac-businesslawcenter-tdr",
    "iac-canadian-content",
    "iac-casetracking",
    "iac-change-uk-ntz-clientid",
    "iac-cig-addfoldereditem",
    "iac-cig-facet-orphan",
    "iac-cig-group-orphan",
    "iac-cig-orphan",
    "iac-cig-orphan-ind",
    "iac-cig-report-orphan",
    "iac-ci-resultlist",
    "iac-citation-reordering",
    "iac-client-chargeable-by-default",
    "iac-clientid-new-validation",
    "iac-concourselibrary-wln",
    "iac-content-finder",
    "iac-correct-dock-user-property-value",
    "iac-courtexpress",
    "iac-cpet-browseparts-novus",
    "iac-cr-effective-date-display",
    "iac-crossborder-dashboard",
    "iac-crossborder-itg",
    "iac-display-applied-filter-names-on-ssp",
    "iac-display-recent-items",
    "iac-docanalyzer-caselc-atlaslc",
    "iac-docanalyzer-cited-statutes",
    "iac-docanalyzer-filter",
    "iac-docanalyzer-footnotes",
    "iac-docanalyzer-rdintegration",
    "iac-docanalyzer-relevantportion",
    "iac-docanalyzer-secondarysources",
    "iac-docanalyzer-statutes",
    "iac-docanalyzer-ui-march-release",
    "iac-doc-medical-entities-link-out",
    "iac-docversioning-wln",
    "iac-dpa-browse-juris-landing-pg",
    "iac-dpa-curated",
    "iac-dpa-delivery-watson-answer",
    "iac-dpa-enforcementmap",
    "iac-dpa-featured-content",
    "iac-dpa-keyword-newjurs",
    "iac-dpa-keyword-novus",
    "iac-dpa-knowledgegraph",
    "iac-dpa-related-concepts",
    "iac-dpa-usabilla",
    "iac-dpa-watson-v11",
    "iac-dpa-watson-v12",
    "iac-dr-client-missed",
    "iac-dtp-bankruptcy-claims",
    "iac-dtp-dktptynmtbl",
    "iac-dtp-experts",
    "iac-dtp-openweb",
    "iac-dyn-stem-exceptions",
    "iac-enable-news-summary-alerts-delivery",
    "iac-enacted-legislation-link",
    "iac-enhanced-search-term-tooltip",
    "iac-factoranalysis-history",
    "iac-fa-searchbilling",
    "iac-fastdom-standarddocument",
    "iac-feature-overlay",
    "iac-findandprint",
    "iac-firmlibrary-wln",
    "iac-foldering-get-descendants-new",
    "iac-folderingshareacrossorgs",
    "iac-forcesignon-orphansession",
    "iac-gateway-do",
    "iac-get-renewalandtrialdata",
    "iac-grantonlyfacsinsessionbindings",
    "iac-guid-chasing-disable",
    "iac-hide-docket-monthly-frequency",
    "iac-hide-territorial-options",
    "iac-historical-datacorrections",
    "iac-image-module",
    "iac-improved-navigation",
    "iac-indigo-coldstart",
    "iac-indigo-cpet-browseparts",
    "iac-indigo-display-pref",
    "iac-indigo-fav-searches",
    "iac-indigo-folder-kc-change",
    "iac-indigo-folder-recommend-change",
    "iac-indigo-hot-docs",
    "iac-indigo-notification-center",
    "iac-indigo-paymenttype",
    "iac-indigo-pui",
    "iac-indigo-recent-filters",
    "iac-indigo-research-report",
    "iac-indigo-statutes-compare",
    "iac-indigo-typeahead",
    "iac-inlinehtmldelivery-dockettrackalert",
    "iac-internationalfind",
    "iac-ios-newadvancedsearch",
    "iac-ip2-markman",
    "iac-ip-trademark-viennacode-facet",
    "iac-itdepends",
    "iac-itg-tab",
    "iac-kc-alerts-patents",
    "iac-kc-citing-references",
    "iac-kc-citing-refs-enhanced-sw",
    "iac-kc-flags",
    "iac-kc-flags-green-c-by-boolean",
    "iac-kc-judicial-history",
    "iac-kc-negative-treatment",
    "iac-kc-rules-affected-by",
    "iac-kc-statutes-affected-by",
    "iac-kc-table-of-authorities",
    "iac-kc-validity",
    "iac-kc-wave-the-white-flag",
    "iac-keycite-nod-redesign-old-rels",
    "iac-keycite-sort-by-court-level",
    "iac-keynumber-facets",
    "iac-km-aliveserverconnection",
    "iac-km-fiacctprefs",
    "iac-la-case-outcomes",
    "iac-la-case-types",
    "iac-la-courts",
    "iac-la-delivery",
    "iac-la-law-firms",
    "iac-linkbuilder-docandcatpages",
    "iac-linkbuilder-searchresultspages",
    "iac-linkbuilder-topic-search",
    "iac-linkouturl-pubandserial",
    "iac-log-prdct-wlus-deny",
    "iac-lt-dpa-watson-integration",
    "iac-master-page",
    "iac-mattermaps-deliver-image",
    "iac-mattermaps-editmap",
    "iac-matters-by-number-wln",
    "iac-medlit",
    "iac-modal-footnotes",
    "iac-modernization-wln-ios-doc",
    "iac-most-cited-sort",
    "iac-move-menus-down",
    "iac-multipart-pdf",
    "iac-new-newsletter-template",
    "iac-newsroom-images",
    "iac-non-unique-cites",
    "iac-novustimezone",
    "iac-nyofficial-digestlink",
    "iac-oversized-and-error-email-delivery",
    "iac-pa-regulations-status-facets",
    "iac-partytype-checkbox",
    "iac-patron-category-page",
    "iac-pdf-multipart-check",
    "iac-planz-application-enabled",
    "iac-plconnect-tasks-and-synonyms",
    "iac-plconnect-tasks-ux-redesign",
    "iac-plc-rss-feeds",
    "iac-plct-crossclientid",
    "iac-plct-crossproductclientid",
    "iac-plct-globalsearch",
    "iac-plct-linkbuilder",
    "iac-plct-smalllawfirmmgmt",
    "iac-plct-ssrulebooks",
    "iac-plct-startupssmallbus",
    "iac-plct-viewalltasks",
    "iac-plc-viewonlydraftingnotes",
    "iac-plc-waywo",
    "iac-plplus-application-enabled",
    "iac-plplus-calendar",
    "iac-pl-scrollissues",
    "iac-pluk-asset-page-enable-wln-links",
    "iac-pluk-cdn-available-for-ip",
    "iac-plus-clientidinsession",
    "iac-plus-clientidpromptpltowl",
    "iac-plus-documentononepage",
    "iac-plus-feedback",
    "iac-plus-homebanner",
    "iac-plus-knowhowbooleanquery",
    "iac-plus-linkbuilder",
    "iac-plus-notesformating",
    "iac-plus-searchcontext",
    "iac-plus-truncatejurinsearch",
    "iac-plus-unhideannotations",
    "iac-plus-viewmorelessdetails",
    "iac-portalmanager-combined",
    "iac-portalmanager-contentlinks",
    "iac-portalmanager-findbypartyname",
    "iac-portalmanager-search",
    "iac-practical-law-display-changes",
    "iac-practicallaw-itg-dropdown",
    "iac-practical-law-subheadings",
    "iac-practiceareas-asterisknote",
    "iac-practicepoint-smartsearch-onesynonym",
    "iac-practicepoint-smartsearch-synonyms",
    "iac-practicepoint-smartsearch-treatises",
    "iac-practitioner-insights-alerts-no-logo",
    "iac-pr-add-bing",
    "iac-pr-addfoldereditem",
    "iac-pr-entity-extraction",
    "iac-pr-fein-plus3",
    "iac-price-guide-link",
    "iac-pricing-guide-redirect",
    "iac-privacy-policy",
    "iac-pr-polkrpt",
    "iac-pr-qsentrpt",
    "iac-pr-section-delivery",
    "iac-pr-ssn-only-search",
    "iac-pr-use-pipl-v5",
    "iac-public-record-prod-gateway",
    "iac-public-records",
    "iac-public-records-alerts",
    "iac-public-records-firstamerican",
    "iac-public-records-report-excel-delivery",
    "iac-public-records-report-filtering",
    "iac-pubrec-real-time-monitor",
    "iac-qanda",
    "iac-qanda-pinpoint",
    "iac-qanda-typeahead",
    "iac-raise-document-limit",
    "iac-ra-no-rank1docs-cache",
    "iac-remove-nyor-hard-coded-collections",
    "iac-remove-securedatatoken",
    "iac-research-accel",
    "iac-research-accel-synopsis",
    "iac-ri-bill-activity",
    "iac-ri-bill-tracking",
    "iac-ri-capitol-watch",
    "iac-ri-category-delivery",
    "iac-ri-citestyles-endpoint-v2-enable",
    "iac-ri-context-analysis",
    "iac-ri-editorial-materials",
    "iac-ri-filings",
    "iac-ri-fnd-newpathway",
    "iac-ri-form-families",
    "iac-ri-legislative-timeline",
    "iac-ri-no-single-rn-uds-post",
    "iac-ri-notes-of-decisions",
    "iac-ri-opinions",
    "iac-ri-professional-references",
    "iac-ri-reduce-uds-rn-data",
    "iac-ri-topics",
    "iac-ri-versions",
    "iac-sb-list-items-delivery",
    "iac-search-como-group1",
    "iac-search-como-group2",
    "iac-search-como-group3",
    "iac-search-como-group4",
    "iac-search-como-group6",
    "iac-search-como-group7",
    "iac-search-como-group8",
    "iac-search-como-public-records",
    "iac-search-como-recodocs",
    "iac-search-como-reghist",
    "iac-search-custom-nyor-reranking",
    "iac-search-delivery-group1",
    "iac-search-delivery-group2",
    "iac-search-delivery-group3",
    "iac-search-delivery-group4",
    "iac-search-delivery-group5",
    "iac-search-firmcentral",
    "iac-search-knowhowrankoption",
    "iac-search-matterroom",
    "iac-search-nl-thresholding-option",
    "iac-search-pmd-result-types",
    "iac-search-result-duplicate-identifier",
    "iac-search-suggestions",
    "iac-search-within-favourites-plcuk",
    "iac-searchwithin-ios",
    "iac-shared-highlights",
    "iac-share-folders-with-cobalt-contacts",
    "iac-sharing-with-the-same-domain",
    "iac-show50statesurvey-inlineflags",
    "iac-small-law-survey-redirect",
    "iac-smartbreadcrumb-add-navid",
    "iac-smartbreadcrumbs-au",
    "iac-smartfolders-ss",
    "iac-snapshots-state",
    "iac-snowdonia-beta",
    "iac-sortoption-courtlevel-pref",
    "iac-starpages-plcuk",
    "iac-staticqa",
    "iac-staticqa-history",
    "iac-staticqa-searchbilling",
    "iac-statutes-new-ast-pdfs",
    "iac-superbrowse-mult-gradeheads",
    "iac-superbrowse-paging",
    "iac-taxpage-eylogo",
    "iac-term-frequency-sorting",
    "iac-transfer-content",
    "iac-trd-alternate-search",
    "iac-trd-juris-facet",
    "iac-trd-legalanalytics",
    "iac-trd-lpafacet-subsearch",
    "iac-trillium-crsw-doc-enhance",
    "iac-trillium-link",
    "iac-uk-a11y-clientid-lightbox",
    "iac-uk-clientid",
    "iac-uk-compartments",
    "iac-uk-fd-and-fs",
    "iac-uk-keywordfinder",
    "iac-uk-linkbuilder",
    "iac-uk-linkbuilder-copy",
    "iac-uk-nonpltracking",
    "iac-uk-performance-new-static-content-or",
    "iac-unlink-unmigrated",
    "iac-use-new-training-user",
    "iac-userdoclink-wln",
    "iac-us-knowhow-algorithm",
    "iac-v3inapplibrary",
    "iac-validity-highlighting",
    "iac-verify-eaddress-against-existance",
    "iac-webinars",
    "iac-website-throttle",
    "iac-westsearch-cases-keynumberfacet",
    "iac-westsearch-cases-partyfacet",
    "iac-westsearch-cases-synopsis",
    "iac-westsearch-cases-topicfacet",
    "iac-westsearch-enhancements",
    "iac-without-flash-dependencies",
    "iac-wln-cig-linkedreport",
    "iac-wlndoc-sharednotes",
    "iac-wln-global-search-judicial-chambers",
    "iac-wln-historicalheader",
    "iac-wln-ios-display-toa",
    "iac-wln-newfiletype",
    "iac-wlnopenweb-serverbrowsepage",
    "iac-wln-ri-tabs",
    "iac-wln-save-snippet",
    "iac-wln-strong-downgrade-email",
    "iac-wlntax-blue-flag",
    "iac-wln-toc-keyciteflag",
    "iac-wl-startpage",
    "iac-wl-striphash",
    "iac-wordsphrases-snippet-support"
  ],
  "IsTypeAheadNewUiEnabled": true,
  "ContactsPageSize": 300,
  "ShowPrivacyPolicy": true,
  "ShowCookiePolicy": true,
  "ResearchReportDocumentLimit": 1000,
  "IsSaveSnippetEnabled": true,
  "IsHideAnnotationsSharedByInactiveUsersEnabled": true,
  "AllowPauseOnLinkOut": true,
  "IsMaintainDocumentPositionRIEnabled": true,
  "IsFormsEngine2Enabled": false,
  "IsFormsEngine2DownloadEnabled": false,
  "IsIndigoDisplayEnabled": false
};


window['Server/Mobile'] = {
  "IsNativeIPad": false,
  "IsNativeIPhone": false
};


window['Server/Messages'] = {
  "ProductName": "Westlaw",
  "ProductSupportNumber": "1-800-WESTLAW (1-800-937-8529)"
};


window['Server/Net'] = {
  "PageContextData": "(sc.CustomDigest)",
  "CacheScopeList": [
    "^/RelatedInfo/v[3456]/keycite/content/",
    "^/RelatedInfo/v3/content/json/",
    "^/RelatedInfo/v1/wlncCaselawHistory\\\\?",
    "^/RelatedInfo/v1/wlncCitingReferences\\\\?",
    "^/RelatedInfo/v1/wlncCourtDocs\\\\?",
    "^/RelatedInfo/v1/wlncLegalMemos\\\\?",
    "^/RelatedInfo/v1/kcJudicialHistory\\\\?",
    "^/RelatedInfo/v1/kcCitingReferences\\\\?",
    "^/RelatedInfo/v1/riFilings\\\\?",
    "^/RelatedInfo/v1/kcNegativeTreatment\\\\?",
    "^/RelatedInfo/v1/kcTableOfAuthorities\\\\?",
    "^/RelatedInfo/v1/kcBillDrafts\\\\?",
    "^/RelatedInfo/v1/kcLegislativeMaterials\\\\?",
    "^/RelatedInfo/v1/kcRegulatoryHistory\\\\?",
    "^/RelatedInfo/v1/kcValidity\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnAgreements\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnAgreementsTwoStep\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnSecCommentLetters\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnSecCommentLettersTwoStep\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFilingsAndDisclosures\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFilingsAndDisclosuresTwoStepViaMA\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFilingsAndDisclosuresExhibits\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFilingsAndDisclosuresExhibitsTwoStep\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFilingsAndDisclosuresExhibitsTwoStepViaMAAndFD\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnMergersAndAcquisitions\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnMergersAndAcquisitionsEnhanced\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnMergersAndAcquisitionsEnhancedTwoStep\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnMergersAndAcquisitionsRelated\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnRandPTransactionFullTextCategory\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnRandPTransactionFullTextCategoryTwoStep\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFilingFullTextCategory\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFundsInvestments\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFundsInvestmentsV2\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFundsInvestmentsTwoStepViaMA\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFundsInvestmentsTwoStepViaFDAndMA\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnPefundsFundsFirms\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnAgreementsEnh\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnAgreementsEnhTwoStep\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnAgreementsEnhTwoStepViaMA\\\\?",
    "^/RelatedInfo/v1/tnpCases\\\\?",
    "^/RelatedInfo/v1/tnpCommentary\\\\?",
    "^/RelatedInfo/v1/tnpCompliance\\\\?",
    "^/RelatedInfo/v1/tnpGovernmentDocuments\\\\?",
    "^/RelatedInfo/v1/tnpHistory\\\\?",
    "^/RelatedInfo/v1/tnpHistoryAndTreatments\\\\?",
    "^/RelatedInfo/v1/tnpLegislation\\\\?",
    "^/Search/v1/search/external/results",
    "^/Search/v3/search/results",
    "^/Search/v1/results",
    "^/Document/v1/fulltext/",
    "^/Document/v1/list/fulltext/",
    "^/Document/v1/Mobile/FullText/",
    "^/Document/v1/fixedheader/",
    "^/Document/v1/list/fixedheader/",
    "^/Document/v1/list/Mobile/Fulltext/",
    "^/Document/v[12]/MetaInfo/"
  ],
  "SessionScope": "35b024c40cf4110fbdaaf6a30272ec9b29310adb8108a3d6fb727f98020766f7",
  "UserScope": "5405685",
  "CacheScope": "cae8eee3c04ed06647dc9438484c6bc4"
};


window['Server/Events'] = {
  "PageEventIdentifier": "ca212829d49d4400ad508650f2921908",
  "PageName": "Cobalt.Website.ServerPage.Document",
  "ResourceToken": "v1|04a180b71c7db30f509504117e957c33013c96cc8caf99975ef836a2a8376767"
};

</script>


	
	

<!-- View Path: ~/Document/Views/DocumentTabView.cshtml -->
<script type="text/javascript">
window.__viewName = '~/Document/Views/DocumentTabView.cshtml';
</script>
<script type="text/javascript" crossorigin="anonymous" charset="utf-8" src="https://ja.next.westlaw.com/StaticContent_40.1.1015/webpack/Products/WestlawNext/webpack-loader.js"></script>

	

<div id="co_searchDisableDiv" class="co_screenOverlay co_hideState"></div><div id="co_dragDrop_parent_0"></div></body></html>